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Abstract 
Melanogrammus aeglefinus, commonly known as haddock, is a commercially important 
marine fish species closely related to cod.  Preliminary investigations into the immune 
function of this species has revealed several unique and interesting features, including 
an unusually high number of expressed alleles of Major Histocompatibility (MH) Class I 
genes.  The goal of this project was to examine the sequences of alleles, including the 
untranslated regions, for potential regulatory mechanisms which may limit the number of 
alleles expressed to the point of functional molecules.   
Using a cDNA library from an individual haddock, a total of 22 unique alleles were 
isolated and sequenced, and three putative mechanisms for limiting expression were 
revealed.  The first mechanism was the inversion of the open reading frame within the 
transcript.  The second mechanism was the linking of the MH Class I transcript with the 
transcript of another gene.  The third mechanism was non-classical substitutions at the 
nine amino acid residues involved in peptide anchoring.  These three mechanisms 
represent novel ways of limiting expression and effectively reduced the number of 
alleles which could be expressed into functional classical MH Class I molecules. 
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1. Introduction 
Melanogrammus aeglefinus, commonly known as haddock, is an economically 
important species of fish.  Currently, haddock is caught in the wild rather than raised.  
Attempts to begin farming these fish are being made (Chambers and Howell, 2006; 
Treasurer et al., 2006), and one of the biggest hurdles to overcome when farming any 
species is disease (Bricknell et al., 2006).  As a result, research investigating the 
immune function of these fish, as well as other related species, is increasing in 
importance.  Many aspects of the fish immune system are in-line with the general 
features commonly seen.  However, haddock demonstrate some striking differences 
from not only the well-studied mammalian immune system, but also from other fish 
species (Miller et al., 2002; Persson et al., 1999).   
The focus of this research is on the Major Histocompatibility (MH) Class I molecules in 
haddock.  Unlike most species, haddock have an unusually high number of alleles 
(Fujiki, unpublished data).  It is unclear how many alleles are expressed and how their 
expression is regulated.  Cloning and sequencing of the entire transcripts of all MH 
alleles will shed light on this unique feature of the haddock immune system. 
1.1. General Overview of Immune Function 
The immune system is a fundamental requirement for all species.  It provides protection 
against invading pathogens as well as maintenance and healing of the body.   Immune 
function jawed vertebrates, can be loosely divided into two interdependent sub-systems:  
the innate and the adaptive.  The innate immune system is the initial line of defense. It 
has no specific recognition of antigen, and is present at all times.  The adaptive immune 
response, however, is capable of highly specific recognition of antigens, and develops 
in response to antigen exposure.  (Dixon and Stet, 2001; Watts et al., 2001). 
The main cells of the adaptive immune system are the B-cells and T-cells.  During their 
development, each of these cell types undergoes similar developmental processes 
wherein they develop highly specific antigen receptors which are used to drive the 
antigen-specific immune response (Larosa and Orange, 2008).   Once activated, B-cells 
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are capable of secreting antibody, which is known as the B-cell receptor when bound to 
the B-cell surface (Schroeder and Cavacini, 2010).  T-cells, on the other hand, do not 
produce a secreted equivalent to the T-cell receptor (TCR).  Based on signals received 
during development in the thymus T-cells can become either cytotoxic T-cells (TC) or 
helper T-cells (TH) (Laky and Fowlkes, 2008; Picchietti et al., 2009).  Cytotoxic T-cells, 
as their name suggests, are involved in killing infected cells (Fischer et al., 2006).  
Helper T-cells secrete molecules known as cytokines which are necessary to promote 
and direct other immune processes (Fietta and Delsante, 2009).  The two types of T-
cells can be easily identified by cell surface proteins.  Cytotoxic T-cells have the co-
receptor CD8 on their cell surface, whereas helper T-cells have the co-receptor CD4 on 
their cell surface (Laky and Fowlkes, 2008). 
T-cell activation is a complicated process that begins with the interaction of the TCR 
with its specific antigen, yet TCRs cannot recognize antigen by itself. Rather, they 
require that the antigen be bound to a specialized molecule known as the Major 
Histocompatibility (MH) receptor (Costantini et al., 2008; Garcia, 1999).  Cells of the 
body display MH molecule:antigen complexes on their cell surfaces with which T-cells 
are then able to interact.  
1.2. Major Histocompatibility Molecules – Structure and Function 
Major Histocompatibility molecules are a fundamental component to the adaptive 
immune system.  As such they have highly conserved structure and function across all 
species possessing an adaptive immune system.  These molecules are well studied in 
mammalian species and accurate parallels can be drawn between mammals and fish 
(Sullivan and Kim, 2008).  There are, however, some differences.  In mammals, and 
interestingly in the cartilaginous fishes, the genes encoding the MH molecules are 
contained within a tightly linked sets of genes referred to as the Major Histocompatibility 
Complexes (MHCs).  Within these complexes are several genes, many of which encode 
products with immune system functions.  As a result, MH molecules in these species 
are referred to as Major Histocompatibility Complex (MHC) molecules.  In bony fishes, 
however, there is no apparent linkage of these genes resulting in the term MH instead 
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of MHC (Stet et al., 2003). The MHC and MH molecules themselves, however, maintain 
the same characteristics. 
MHC molecules can be divided into two similar yet unique types, referred to as Class I 
and Class II.  Both types of molecules are responsible for presenting peptide antigens 
on the cell-surface to T-cells.  The types of molecules differ in the origin of the peptide 
antigen they present, the type of T-cell they interact with, and the cell types in which 
they are expresses.  MHC Class I molecules present peptide antigens that are 
intracellular in origin, for example viral peptides, and interact with the T-cell co-receptor 
CD8 (Bjorkman and Parham, 1990).  MHC Class II molecules present extracellular-
derived peptide antigens, such as bacterial components, and interact with the T-cell co-
receptor CD4 (Lanzavecchia, 1990; Sultmann et al., 1993).  All nucleated cells express 
MHC Class I molecules, whereas only Antigen Presenting Cells (namely macrophages, 
dendritic cells and B-cells) express MHC Class II molecules (Dijkstra et al., 2003; 
Sultmann et al., 1993). 
The basic structure of the MHC Class I molecule appears to be conserved across all 
species with an adaptive immune system (Janeway, 2001; Randelli et al., 2008; Stern 
and Wiley, 1994).  Figure 1.1 shows a diagram of the structural features.  The entire 
structure is composed of two non-covalently linked peptides:  a heavy chain comprised 
of three sub-units α1, α2, and α3, and a smaller peptide called β2-microglobulin. Sub-
units α1 and α2 form a “binding cleft” in which the antigen peptide is bound.  The amino 
acid sequence of the binding cleft is in general highly variable, although nine specific 
residues have been identified as necessary for anchoring the peptide N- and C-termini 
to the binding grove, and therefore are highly conserved through most species (Shum et 
al., 1999).  As a result of this variability, different MHC molecules are able to bind 
various peptides with differing affinities.  Each MHC molecule is encoded by a unique 
allele.   
As previously mentioned, the role of MHC Class I in the immune response is to present 
intracellular-derived antigens to CD8 T-cells.  This process begins in the endoplasmic  
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Figure 1.1:  Diagram of the structural features of MHC Class I.  The complete 
molecule is made up of two non-covalently linked peptides, the β2-
microglobulin and the heavy chain.  The heavy chain is comprised of three 
domains, α1, α2, and α3.  The α1 and α2 domains make up the binding cleft 
where peptide antigen is bound prior to cell surface expression.  
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reticulum.  Digested peptide fragments are actively transported into the endoplasmic 
reticulum and are combined, with the help of a series of chaperone proteins, with the 
immature MHC Class I molecules.  These molecules are then transported to the cell 
surface where they can be “surveyed” by T-cells (Pamer and Cresswell, 1998). T-cell 
interaction requires that the bound peptide is a “match” for the highly specific TCR and 
the interaction of the MHC Class I molecule with the co-receptor CD8.   Along with other 
ligand and co-receptor interactions between the two cells, a complex signaling cascade 
is initiated and results in the activation of the T-cell into an armed effector T-cell 
(Guselnikov et al., 2003; Nel, 2002; Park et al., 2002).  In this case, the T-cells become 
cytotoxic T-cells, capable of inducing apoptosis of infected cells. 
Major Histocompatibility molecules also play a vital role in T-cell selection.  In the 
thymus, T-cells undergo a selection process which removes undesirable T-cells from 
the population.  A review by Takahma outlines the details of this process.  To 
summarize, developing T-cells interact through their TCRs with MHC:self-peptide 
complexes present on the surface of stromal cells in the thymus cortex.  The strength of 
the interaction determines the fate of the T-cell.  A weak interaction signals survival and 
the T-cells undergo further maturation, whereas a strong interaction signals apoptosis 
and the T-cells are deleted from the population.  This process allows T-cells expressing 
TCRs capable of interacting with MHC molecules to continue maturing, while removing 
T-cells expressing TCRs against self-peptides.  Only a small proportion of thymocytes 
survive to become mature T-cells. 
In addition to the MHC molecules described above, there exists a group of molecules 
with similar structures referred to as non-classical MHC molecules.  Although this set of 
molecules is not as well studied as the classical MHC molecules research suggests a 
diverse array of functions, both immunological and non-immunological.  For example, a 
growing body of research has linked non-classical MHC molecules with tumor immune 
responses (Gomes et al., 2007).  In rainbow trout, a specific non-classical MH molecule 
has been shown to impact resistance to Bacterial Cold Water Disease (Johnson et al., 
2008).  Hemochomatosis is an iron-metabolism disorder resulting from a defect in the 
gene coding for HFE-A, a non-classical MHC molecule (Ehrlich and Lemonnier, 2000).  
7 
 
A key difference between classical and non-classical molecules is the amino acid 
residues located at the nine conserved sites discussed earlier.  Changes at two or more 
of these sites sufficiently changes the function of these molecules so that they are 
termed non-classical rather than classical MHC molecules (Shum et al., 1999).   
1.3. Unique Immune System Features of Cod and Haddock 
Cod and haddock possess several immune system features that are very unlike those 
of most other species.  Natural antibodies, which react non-specifically to a multitude of 
antigens, are present in most fish species to a varying degree.  In cod, however, these 
antibodies are extremely abundant.  Furthermore, cod do not appear to produce any 
antigen-specific antibodies (Magnadottir et al., 2001).  In haddock, no MH Class II 
genes have yet been identified, despite rigorous attempts.  Also, the β2-microglobulin is 
also unusual in that it is glycosylated (unpublished data).  These findings lead to further 
study of the apparently very unusual immune system of these fish. 
1.4. Allelic Frequency 
The MHC Class I molecules are encoded by genes that are highly polymorphic and 
polygenic, that is to say there are a high number of alleles within the population and 
each individual possess several copies of the gene.  For example, in humans there are 
over 100 alleles, and each individual has three genes (therefore, six expressed alleles).  
This results in billions of possible combinations of alleles.  The population is therefore 
equipped with a wide range of alleles capable of participating in immune responses to a 
wide range of diseases.  By increasing the number of expressed alleles, however, the 
T-cell selection process would become more stringent, leading to an increased number 
of T-cells being deleted.  The dodecaploid species Xenopus has been shown to remove 
sections of chromosomal DNA to reduce the number of excess alleles (Sammut et al., 
2002).  This demonstrates the importance of limiting the number of expressed alleles. 
A paper by Perrson et al published in 1999 investigated alleles of MC Class I in Atlantic 
cod (Gadus morhua), a species closely related to haddock.  Using a combination of 
hybridization screening, PCR amplification and Southern blotting, an unusually high 
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number of unique MH Class I sequences were identified.  In most teleost fish species 
studied an individual typically only has a few alleles of MH Class I.  Cod, however, 
showed 17 genes in one individual.  To validate this result, Southern blots of genomic 
DNA digested with the restriction enzyme Ssp I of four individuals were performed and 
confirmed the presence of many more alleles per individual than is usually seen in other 
fish species.  The experiments performed however relied heavily on PCR, and the 
untranslated regions of the transcripts were not studied.  As a result, possible regulatory 
mechanisms within the untranslated regions could not be investigated. In 2002, Miller et 
al. showed further evidence of the unusually high number of MH Class I genes present 
in cod by isolating an analyzing 83 MH Class I sequences from one individual. 
1.5. Previous Work 
Prior to the beginning of this project, much of the ground work had already been 
completed.  Southern blotting of haddock DNA and the construction of a cDNA library 
were completed and screening of the library had begun.  
Genomic DNA was collected from an individual haddock and aliquots were digested 
with four restriction enzymes.  A Southern blot was performed, the results of which can 
be seen in Figure 1.2.  The multiple bands seen are comparable with the results 
obtained from the cod experiments.  Therefore, further study began.  A cDNA library 
was constructed using mRNA from liver, spleen and head kidney of an individual 
haddock.  The cDNA library was divided into 18 sub-libraries. 
Based on MH Class I sequences from cod a set of degenerate primers were made and 
the cDNA library was screened using PCR.  The products were sequenced and used to 
generate a probe, which was then used to screen the library.  The four MH Class I 
sequences were initially found are shown in Figure 1.3.  
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Figure 1.2:  Southern blot of haddock DNA for MH Class I genes.  Four DNA 
samples, each digested with a different restriction enzyme, were 
compared.  In each lane several bands are present, indicating the 
presence of multiple genes.    
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Figure 1.3:  Haddock MH Class I Sequences.  The ORF of each sequence is shown 
in upper case letters.  A) Sequence of Haddock UA pBK-CMV-1.  This 
sequence is comprised of two sequences.  The first is the sequence of the 
ribosomal protein L12.  The second is that of the MH Class I sequence.  B) 
Sequence of Haddock UA pBK-CMV-3.  The antisense orientation of this 
sequence codes for an allele of MH Class I.  C)  Sequence of Haddock UA 
pBK-CMV-4.  This sequence was used as the template for probe synthesis 
as well and the positive control for experiments.  D)  Sequence of Haddock 
UA pBK-CMV-6.   
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Haddock UA pBK-CMV-1  
 
ggtaaacggtcgtcccgaatctgggttcatccgacaccatcaccaaccaagctgaacagagcactactaccagatcagc
atcatgcctcccaaattcgaccccagcgaaattaaagttgtgtacatgagatgtactggcggggaagttggtgccacctctg
cacttgctcccaaaattggacctctgggtctgtctcccaagaaagttggtgatgacatcgccaaggccaccggagactgg
aagggcctcaggatcaccgtgaagctgaccatccagaacagacaggctgtggttgaggttgttccctctgcatctgccctg
atcatcaaggctcttaaggagcccccacgtgaccggaagaaggtcaagaacatcaagcacagtgggtccgtgacgtttg
acgagatcgttgctatcgctcgtgttatgaggcatcgctctattgccagggaactctctggaaccatcaaggaaatccttggt
acctctcagtcagtaggctgcaccatcgatggccgcctcccccacgatgtcattgatgacatcaacagtggaaagattgaa
tgcccagcagagtaatgcttgacaataaaattgactaaattggagtcggagtcccgtctctgtggataatctcatcgagctgt
tcttctgaatacatcgatATGAAGGCGCTAATAGGGCTGCTGCTGCTGTTGGTCTTTGGTCA
CGGTGTGTCCTCACTGCTTCACTCTCTCCATTATTTCTACACGGGGTCGTCTGGAC
TCTCAACCTTCCCAGAGTTTGTTTCTGTGGGGATGGTGGATGGAGTTCAGTTTGAC
TACTATGACAGCAACACCCAGAAAACAGTCTTCAAACAGGACTGGATGGAGCAGG
TCACCAGAGGTGACCCCGACTACCTGGAGAGGAACACTGGAAGTGCTCAGAATGC
CCAGCAGGTCTTCAAAGTCAACATTGTGACTGCCAAGCAGCGCTTTAACCAGACAG
GAGGTGCCCATATAAATCAGAGGATGTATGGTTGTGAGTGGGATGATGAGGATGA
TTCTACTGAAGGTTATGACCAGCATGGTTATGATGGAGAGGACTTCATATCGTTGG
ACCTGAAGACCCTGACCTGGGTCGCTCCAGTACGTCAGGCCTTCGCCACCAAACA
GAAATGGGATCAGAATAAAGCTAGATTACAACATGATAAGAACTACTACACCAAGG
AGTGTGTTGATTGGCTGAAGAAGCACCTGGCCTATGGGAAGAGCACTCTGCTGAG
AACAGAGCGTCCGCGGGTGTCTCTGCTCCAGAGGAGCCCCTCCTCCCCAGTGGT
GTGCCATGCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGCTCTGGAGGAGAGAC
GGTCAGGAGCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCCAACCACGAC
GGGACCTTCCAGGTCAGCGTGGACCTCAACCTCAAGGCCGTCCCACAGGAGGAC
TGGAGGAGGTACGAGTGTGTGGTCCAGCTGAGAGGCATCGAGGACATCTCCACC
CCCCTGGACCCCGCCCTCATCAGGACCAACGGGGGCAAGAGTGGCATCACCGTC
CCCATCATCATTGGGTTCGTTGTTCTCCTCCTCGCTGCTGCTGCTGCTGCTGTTGG
AGTCCTTCTGTACAAGAAGAGGAACGATTCACACAAGCAGCACAAACCAGTTGGTT
CTTCTGACACCAGCTCTGAGAACACAGAGGGGCAGAATCTGGCTCCTGAGGCCCG
ACCTCTGACAGAAGTTCGAAGTTAAatcatgaagagtcttctcacgttcagcttcctaaagcagggtggag
tggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaactaaagatgctacatttgctaaattacaataa
catccatacttaactttattttgataacaatcatgaatctgaaagatctgtatatcaatgagatctctgtatttgtaatagatttgatt
aattctctggctttaacctgcaatgtttcactgacgcttggaaaccatgacgacacaaactcgccatgatggccattttgttttg
gttcctgccgcttcaagttataacctttgaatcatgttatagtgtttagtaatatttaagtttcaaataatggtcaaaggttctgaga
ctagtttttggacagtgagatccggtcaagtttgaatacaataatcgttaaattgtatgttttttcttaaataatattatttgaattgca
tcgctacataggctaccacgatcgagctaggcagctttagccttaatccttttgttgtactattttctttgttctttggggaatttgatc
atagatactttggttattctgtcaataaagtacatccaaa 
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Haddock UA pBK-CMV-3 
 
ggaaatattcatatctttattgagctgtatttgatgtacagttttcttcagacaagcagcaatacacaagagttttatgcactggtgagtatcc
acatacaagtccaacacaacacataataagttgttcatagcacataaagcacatgcgtgttgaatatgtacgtgtccgtgtatgtctttgc
ttgcatgagtttccgcatgcatgtatgaagtgaggtgtgtgtgtgtgtgtgtgtgagtgtgtgtgtgtgagatcaaaagctattgagtcccac
cattctgttgcagagaaagtgcatcaatttggcttcacacaaagaagtagcggtgtgtgtgtgtgtctgtgtgtgtgtgtgtgtgcgtgtgtgt
gtatgtatgtgtgggggtctgagagaagaagggggtaggggggagaaaatgaaggaatgatacatagggggacaaagacggag
agattagtcggcaggaagcgggtggttgtggagcgtgtctagctcctggccatggcggcggcgagggtctcgtagagcatgatgagc
ttggctctggcctcctcgaccagggggtctgccttggccttcagactctccacatggggggacacctgcttcttgatgccttcgatgtccag
ggagccggcggcggcctgggcgtcggtgaaggccttggtcagctgctccttgtactcctccacgtagggggaggctatggtcttgagg
ccctgcaggcgctcggtcagcttgccgcgcacggactccacgaggggcatgagggcggtcttggtctcctccacgttcttggacaccg
tggcggttcagctgcaaagtatctatgatcaaattccccaaagaacaaagaaaatagtacaacaaaaggattaaggtctaaagctgc
ctagctcgatcgtggtagcctatgtagcgatgcaattcaaataatattatttaagaaaaaacatacaatttaacgattattgtattcaaactt
gaccggatctcactgtccaaaaactagtctcagaacctttgaccattatttgaaacttaaatattactgaacactataacatgattcaaag
gttataacttgaagcggcaggaaccaaaacaaaatggccatcatggcgagtttgtgtcgtcatggtttccaagcgtcagtgaaacattg
caggttaaagccagagaattaatcaaatctattacaaatacagagatctaattgatttacagatctttcagattcatgattgttatcaaaat
aaagttaagtatggatgttattgtaatttagcaaatgtagcatctttagttagctgaagtcccaagcctgtttgtaaggattataaatgaactg
cgatccactccaccctgctttaggaagctgaacgtgagaagactcttcatgatTTAACTTCGAACTTCTGTCAGAGGT
CGGGCCTCAGGAGCCAGATTCTGCCCCTCTGTGTTCTCAGAGCTGGTGTCAGAAGAACCA
ACTGGTTTGTGCTGCTTGTGTGAATCGTTCCTCTTCTTGTACAGAAGGACTCCAACAGCAG
CAGCAGCAGCAGCGAGGAGGAGAACAACGAACCCAATGATGATGGGGACGGTGATGCCA
CTCTTGCCCCCGTTGGTCCTGATGAGGGCGGGGTCCAGGGGGGTGGAGATGTCCTCGAT
GCCTCTCAGCTGGACCACACACTCGTACCTCCTCCAGTCCTCCTGTGGGACGGCCTTGAG
GTTGAGGTCCACGCTGACCTGGAAGGTCCCGTCGTGGTTGGGGAGGACCTCCCCGTGGT
CCACCTGCTCCTGGAGCTCCTGACCGTCTCTCCTCCAGAACACCACCACCCTGTCAGGGA
AGAAGCCTGTAGCATGGCACACCACTGGGGAGGAGGGGCTCCTCTGGAGCAGAGACACC
CGCGGACGCTCTGTTCTCAGCAGAGTGCTCTTCCCATAGGACAGGTACTTCTTCAGCCAAT
CAACACACTCCTTGGTGTAGTAGTTCTTATCATGTTGTAATCTAGCTTTATCCTGATTCCATT
TCTGTTTGGTGGTGAAGGCCTGACGTACTGGAGCGACCCAGGTCAGGGTCTTCAGGTCCA
ACGATATGAAGTCCTCTCCATCATAACCATGCTGGTTATAACCATCAGTAGAATCATCCTCA
TCATCCCACTCACAACCATACATCCTCTGAGCCATGTGGGCACCTCCTGTCTGGTTAAAAC
GCTGCTTGGCAATCACAATGTTGACTTTGAAGCTCTGCTGGTGACCCTGAGATTTTCCAGT
TTCCCTCTCCAGGTAGGCGGGGTCATCTCTGGTGACCTGCTCCATCCAGTCCTGTTTGAG
GACCTTTTTCTGGGTGTTGCTGTCATAGTAGTTAAACTGAACTCCATCCACCATCCCCACAG
CAACAAACTCTGGGAAGGTTGAGAGTCCAGACGACGCCGTGTAGAAAAACTGCATAGAGT
GAAGCACTGAGGACACACCGTGACCAAAGACCAACAGCAGCAGCAGCCCTATTAGCGCCT
TCATatcgatgtattcagaagaacagctcgatgagattatccacagaggaagaactcaaccagtgaagatcaaccttctagacatg
gctgcagtgagctttaaactgttggtggagactgctgatggcaacaagagagctgaatacaaacctgcttcgcacgcccgccagtac
ctcggttgggcgttgaatgaatatgaagattcagtctcaaacttcagtttcaaaactgcaggcaaatttggattgccagcctatttgaccc
aggtgacttttgataataacacttttaccaaaactgagaacagcttctggacaattctggtcaaaaaccacaacatggtaacacctgttg
gactctacaactacgttgtccaggacagtgacgtggtcatcctgcgctacacgaccgggtgattctgactgtggcgccatcttcctgcag
gatcctgaattacactgagtgcctctcgacgctcctttaacatgaagattatttagtcttaaaatgtcaaatgttacaaatatgatcaattga
accgatataggtgaaacatataacggaataaaggattgtaattaaaaaaaaaaaaaaaaa 
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Haddock UA pBK-CMV-4 
 
ggttgcgtctttgtggataatctcatcgagctattcttccgattacatcgatATGAAGGCGCTAATAGGGCTGCT
GTTGTTGGTCTTTGGTCACGATGTGTCCTCAGTGATTCACTCTCTGCAGATTTTCTA
CACGTCGTCTTCTGGACTCTCAACCTTCCCAGAGTTTGTGAGGGTTGAGATGGTGG
ATGAGGTTCAGACTGAGTACTATGACAGCAACACCCAGAGAATCATAACCAAACAG
GACTGGGTGGTCCAGGCCAACAGAGACAAAGTCCCCGACTACCTGGAGAGGGCG
ACTGAAAGCAGAAAGGTTAACCAGCAGGTCTTCAAAGGCAACATTGGGACCCTGA
AGCAGCGCTTTAACCAGACAGGAGGTGCCCACATTGTTCAGTGGATGTCTGGTTG
TGAGTGGGATGATGAGGATGATGCCACTGATGGTTATGAGCAGTATGGTTATGATG
GAGAGGACTTCCTATCGTTGGACCTGAAGACCCTGACCTGGGTCGCTCCAGTACA
TCAGGCTTTCACCACCAAACTGAGATGGGAACACAATAGAGCTTATAATCAAGCCA
AGAACAACTACTACACCAAGGAGTGTGTTGATTGGCTGAAGAAGTACCTGAGCTAC
GGGAAGAGCACTCTGCAGAGAACAGAGCGTCCGTGGGTGTCTCTGCTCCAGAGG
AGCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTAATAGGGGGG
TGGTGTTCTGGAGGAGAGACGGCCAGGAGCTCCAGGAGCAGGTGGACCACGGG
GAGGTCCTCCCCAACCACGACGGGACCTTCCAGGTCAGCGTGGACCTGAACCTAA
CGGCCGTCCCACAGGAGGACTGGAGGAGGTACGAGTGTGTGGTCCAGCTGAAAG
ACATCGAGGACATCTCCATCCTCCTGGACCCCGCCCACATCAGGACCAACGGGGC
TAAGACTGGTGTTGGAGGGGATGGAGGGGACAAGAGTCTCATCCTTGCTTTCATC
CTCACTGGTGTTGCTGTTGTTGTTGTTGCTGCTGTTGTTGGAGTCTTTCTGTACCG
GAAGAGGAACGATTCAGACAAGCGTCACAAACCACTTGGTTCTTCTGACACCAGCT
CTGAGAACACTGAGGTGCAGAAGCTGTCTCCTGAGGCCCAACCTCTGACCACAGG
TCAAAGTTAAatcatgaagaggcttgtcacgttcggcttcctaaaccaggatggagtggattgctggtcatttataatcc
ttacaatcaggcttgggacttcagctaactgcagagtctgcatttgctaaattacaattttcaaacttaactttattgtgataaca
atcatcaatgtgttagaagtgtcaatcaattacatctctctatttgtgatatatttgaataactcgctggcttaaacctgcaatcttt
cactgacgcttggaaaccatcgcaacacgacgtcgccatgatggccatttgggttccgccgcttcacgttataaccttttaatt
atgttatattgtttagtaatatttaagtttcaaataatgttcaaagattctgaatcaagatttttgacagtgagattttgtcaagtttca
atacaataatcgattaatttaaattgtttcattaaaatatattatttagcgttctgcaagctagaggattgcattgctacataggct
accacaatcctgctaggccgctttagcctcaattctttttgttgtattttctgtgttcttttgggaattggatagtatacttgggttattct
gtcaataaaatacataaaaattgaaaaaaaa 
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Haddock UA pBK-CMV-6 
 
gcgtctctgtggataatctcatcgagctgttcttctgaatacatcgatATGAAGGCGCTAATAGGGCTGCTG
CTGCTGTTGGTCTTTGGTCACGGTGTGTCCTCAGTGCTTCACTCTATGCAGTATTT
CTACACGGCGTCGTCTGGACTCTCAGCCTTCCCAGAGTTTGTTGTTGTGGGGATG
GTGGATGAAGTTCAGATGGTTCACTATGACAGCAACAGTAAGAGAACAGTCCTCAA
ACAGGACTGGATGGAGCAGGTCACCAGAGGTGACCCCGCCTACCTGGAGAGGAA
CACTGGAAACTTTCTGGGTGCCCAGCAGGTCTTCAAAGGCAACATTGGGATTGCC
AAGCAGCGCTTTAACCAGACAGGAGGTACCCACTTATATCAGTGGATGTATGGTTG
TGAGTTGGATGATGAGGATGATTCTACTGATGGTTATCACCAGTATGGTTATGATG
GAGAGGACTTCATATCGTTGGACCTGAATACCCTGACCTGGGTCGCTCCAGTACG
TCAGGCCTTCCCCAACAAACAGAGATGGGATGGGGACAGAGCTAGGAATGAACGG
CATAAGCACTACTACACCAAGGAGTGTGTTGATTGGCTGAAGAAGCACCTGGCCTA
TGGGAAGAGCACTCTGCTGAGAACAGATCGTCCGCGGGTGTCTCTGCTCCAGAGG
AGCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTGACAGGGTGG
TGGTGTTCTGGAGGAGAGACGGTCAGGAGCTCCAGGAGCAGGTGGACCACGGGG
AGGTCCTCCCCAACCACGACGGGACCTTCCAGGTCAGCGTGGACCTCAACCTCAA
GGCCGTCCCACAGGAGGACTGGGGGAGGTACGAGTGTGTGGTCCAGCTGAGAGG
CATCGAGGACATCTCCACCCCCCTGGACCCCGCCCTCATCAGGACCAACGGGGG
CAAGAGTGGCATCACCGTCCCCATCATCATTGGGTTCGTTGTTCTCCTCCTCGCTG
CTGCTGCTGCTGCTGTTGGAGTCCTTCTGTCCAAGAAGAGGAACGATTCACACAA
GCAGCACAAACCAGTTGGTTCTTCTGACACCAGCTCTGAGAACACTGAGGGGCAG
AATCTGGCTCCTGAGGCCCGACCTCTGACAAAAGTTTGAagttaaatcatgaagagtcttctca
cgttcagcttcctaaagcagggtggagtggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaactaa
agatgctatatttgcttaattacaataacattaactttattttgataacaatcatgaatctgaaagatctgtaaatcaattagatct
ctgtatttgtaatagatttgaataattcactggctttaacctgcaatgtttcactgacgcttggaaaccatgacaacataaactc
gccatgatggccattttgttttggttcctgccgcttcaagttataacctttgaatcatgttatagtgtttagtaatatttaagtttcaaat
aatggtcaaagcttttgaaactagtttttggacagtgagattcggtcaagcttgaatacaataatcgttaaattgtgtgttttttctt
aaataatattatttgaattgcatcgctacataggctaccacgatcgagctaggcagctttagccttaatccttttgttgtactatttt
ctttgttctttggggaattttatcatagatactttggttattctgtcaataaagtacatccaaattgaaaaaaaaaaaaaaaaaa
a
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Two of the sequences show interesting properties.  The first sequence, Haddock UA 
pBK-CMV-1, appears to be attached to the sequence of a ribosomal protein L12.  
Joining these two sequences is a short “linker” sequence, which was not used when 
creating the library.  The second sequence, Haddock UA pBK-CMV-3, has an inverted 
open reading frame (ORF).  The ORF and portions of the 5’ and 3’ untranslated regions 
(UTRs) align with the other MH Class I alleles in the antisense orientation, yet the poly-
A tail is in the sense orientation.  Since functional protein would not be produced from 
either of these sequences, these anomalies could represent mechanisms used in this 
species to limit the number of expressed alleles.  Figure 1.4 diagrams the structure of 
these alleles. 
Using Haddock UA pBK-CMV-4 as a template for a probe, four additional clones were 
isolated using hybridization screening.  These clones were sequenced as part of this 
project. 
1.6. Purpose of Study  
The goal of this project was to sequence MH Class I alleles in haddock and to 
investigate the UTRs of the mRNA transcripts for possible regulatory mechanisms.  
Preliminary research suggests that mechanisms are in place at the DNA level which 
limit the number of MH Class I alleles that are expressed.  Hybridization and PCR 
screening were performed on clones of a haddock cDNA library and the sequences of 
the isolated clones were analyzed.   
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Figure 1.4:  Schematic representation of the structure of Haddock UA pBK-CMV-1 
and Haddock UA pBK-CMV-3.  The sequence for Haddock UA pBK-CMV-
1 appears to be attached to the sequence of the ribosomal protein L12.  
The ORF of Haddock UA pBK-CMV-3 is in the antisense orientation 
although the poly-A tail is in the sense orientation. 
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5’ UTR 3’ UTR with sense poly-A tail Antisense UTRs and ORF of MH Class I Allele 
#
1 
#
2576 
#
3118 
Haddock UA pBK-CMV-3 
#
827 
Sense Ribosomal Protein L12 Sense MH Class I Allele Joining Sequence 
#
1 
#
615 
#
2394 
#
606 
Haddock UA pBK-CMV-1 
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2. Materials and Methods 
Please refer to Appendix I for explanation of the vector system used for the cDNA 
library.   
2.1. PCR Screening of Haddock cDNA Library 
2.1.1. Heat-treating Phage Sub-Libraries 
Removal of the protein coat of the phage particles was necessary to allow PCR 
amplification of the desired sequences.  This was accomplished by heat-treating 
aliquots of all sub-libraries.  Aliquots of each sub-library were placed into separate tubes 
and boiled for 10 minutes.  They were then allowed to cool to room temperature.  Heat 
treated samples were stored after use at -20ºC.  
2.1.2. PCR Screening 
Each of the 18 sub-libraries of the haddock cDNA library were screened using haddock 
specific primers for MH Class I.  The sense primer (5’ CACCAAGGAGTGTGTTGATT 
3’) and antisense primer (5’ AGGGAAGAAGCCTGTAGCAT 3’) amplified expected 
fragments of 142 base pairs.  Figure 2.1 shows the primer binding sites on a previously 
cloned haddock MH Class I sequence, Haddock UA p-BK-CMV-4.  The fragments were 
amplified under the following conditions:  95ºC for 5 minutes, followed by 30 cycles of 
95ºC for 30 seconds, 53ºC for 30 seconds and 72ºC for 30 seconds, followed by a 5 
minute extension at 72ºC.  The results of the PCR screens were run on 1.5% an 
agarose gel.  Those sub-libraries with amplified fragments were considered to have 
clones containing MH Class I transcripts. 
2.2. Maintenance of Cultures and Phage Stocks 
2.2.1. Escherichia coli cultures XL1-Blue-MRF’ and XLOLR 
Two strains of Escherichia coli, XL1-Blue-MRF’ and XLOLR, were used for experiments.  
These strains were provided as part of the ZapExpress® vector system used for the 
cDNA library.  Both strains were stored long term as glycerol stocks (25% glycerol, 75% 
culture) at -80ºC.  For short term use, both strains were maintained as streak plates on   
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Figure 2.1:  Primer map of haddock specific primers “Haddock UA Sense” and 
“Haddock UA Antisense” with haddock MH Class I sequence, Haddock UA pBK-
CMV-4.  
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3’ 
5’ 3’ 
5’ 
#
589.CACCAAGGAGTGTGTTGATTGGCTGAAGAAGTACCTGAGCTACGGG
AAGAGCACTCTGCAGAGAACAGAGCGTCCGTGGGTGTCTCTGCTCCAGA
GGAGCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCT 
#
730 
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LB-tetracycline agar plates (0.5% yeast extract, 1% tryptone, 0.17M sodium chloride, 
2% agar, 0.0015% tetracycline) and stored at 4ºC.   
2.2.2. Helper Phage Stocks 
The helper phage stocks provided as part of the ZapExpress® vector system was 
amplified and stored at -80ºC.  To amplify the helper phage a 10mL culture of XL1-Blue-
MRF’ in a supplemented LB broth (0.5% yeast extract, 1% tryptone, 0.17M sodium 
chloride, 0.1M magnesium sulfate, 0.006M maltose) with an optical density at 600nm of 
0.3 was inoculated with approximately 2.5 x 108 phage particles.  The culture-phage 
mixture was incubated at 37ºC for 15 minutes without shaking followed by an overnight 
incubation at 37ºC with shaking at 225rpm.  The mixture was then heated at 65ºC for 15 
minutes and centrifuged at 10,000rpm for 5 minutes at room temperature.  The 
supernatant, which contained the phage, was recovered.  An aliquot was removed to 
titer the new helper phage stock.  The new helper phage stock was prepared for long 
term storage by adding DMSO (final concentration 7%), aliquoting and storing at -80ºC. 
2.3. Hybridization Screening of Haddock cDNA Library 
2.3.1. PCR Synthesis of DIG-Labeled Probe 
A haddock MC Class I sequence was previously cloned into pBK-CMV.  This clone, 
referred to as Haddock UA pBK-CMV-4, was used as the template for the DIG-labeled 
probe synthesis using PCR DIG Probe Synthesis Kit (Roche #11 636 090 910).  The 
probe was amplified using a sense primer (5’ AAGCAGCGYTTYAACCARAS 3’) and an 
antisense primer (5’ GGGTAGAARCCTGTMGCRTG 3’) which gave an estimated 
product of 377 base pairs.  Figure 2.2 shows the primer map as well as the probe 
sequence.  The probe was synthesized under the following conditions:  95ºC for five 
minutes followed by 35 cycles of 95ºC for 30 seconds, 55ºC for 30 seconds, and 72ºC 
for 2 minutes, followed by a 5 minute extension at 72ºC.  The products were run on a 
1.5% agarose gel to verify proper synthesis. 
2.3.2. Screening of library as phage 
Two different methods were used to screen the library.  Initially, the library was 
screened keeping the clones as phage.  This is the method that was used previously.   
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Figure 2.2:  Primer map of “Teleost UA univsense” and “Teleost UA 
univantisense” primers with Haddock UA p-BK-CMV-4 and probe 
sequence used for hybridization screening.    
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5’ 
3’ 
3’ 
5’ 
#
353.AAGCAGCGCTTTAACCAGACAGGAGGTGCCCACATTGTTCAGTGGATGTCTGGTTGTGAGT
GGGATGATGAGGATGATGCCACTGATGGTTATGAGCAGTATGGTTATGATGGAGAGGACTTCCT
ATCGTTGGACCTGAAGACCCTGACCTGGGTCGCTCCAGTACATCAGGCTTTCACCACCAAACTG
AGATGGGAACACAATAGAGCTTATAATCAAGCCAAGAACAACTACTACACCAAGGAGTGTGTTGA
TTGGCTGAAGAAGTACCTGAGCTACGGGAAGAGCACTCTGCAGAGAACAGAGCGTCCGTGGGT
GTCTCTGCTCCAGAGGAGCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCC 
#
729 
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However, problems with this method arose which required the clones be converted from 
phage to plasmid.   
It was necessary to perform several rounds of screening.  Phage diffuse through the 
agar beyond the boundaries of the plaque.  To ensure an individual clone was isolated, 
the positive plaques collected were re-screened.  The first round of screening was done 
using 150mm diameter plates with approximately 5000 pfu1/plate and a total of 10 
plates.  After hybridization and collection (see below) the positive isolates, which were 
collected individually, were re-screened (the second round of screening) using 100mm 
plates, a total of one plate per isolate.  Positive isolates from the second round of 
screening were pooled and then underwent a third round of screening identical to the 
second round. 
2.3.2.1. Plating 
A culture of XL1-Blue-MRF’ was grown in supplemented LB broth to an optical density 
at 600nm of 0.6 and infected with sub-library 16 phage.  The phage were allowed to 
adsorb to the cells by incubation at 37ºC for 15 minutes.  NZY top agar (2.2% (w/v) 
NZCYM powder [Gibco # M36550B], 0.7% (w/v) agar) at approximately 50ºC was added 
to the culture-phage mixture and then poured onto pre-warmed NZY agar (2.2% (w/v) 
NZCYM powder, 1.5% (w/v) agar) plates.  Plates were incubated at 30ºC over night2.   
2.3.2.2. Hybridization Screening 
Plates were removed from the incubator and allowed to cool at 4ºC for approximately 
two hours.  Sterile nylon membrane was then aseptically laid on the surface of each 
plate.  A 23G needle was then used to poke holes through the membrane and agar.  A 
coloured Sharpie was used to mark the position of the holes on the bottom of the agar 
plate.  The membranes were then peeled off the surface of the plate an allowed to dry, 
plaque-side up, for approximately 30 minutes.  The plates were then stored in bags at 
                                            
1
 Plaque Forming Unit (pfu). 
2
 Optimal growth conditions were determined by growing plates at 37ºC, 30ºC, and room temperature 
overnight.  Plaques on plates grown at 37ºC were larger than those grown at lower temperatures and 
2
 Optimal growth conditions we e determined by growing pl tes at 37ºC, 30ºC, and room temp rature 
overnight.  Plaques on plates grown at 37ºC were larger than those grown at lower temperatures and 
were therefore less well isolated.  Plaques on plates grown at room temperature were too small to be 
easily collected.  The plaques on plates grown at 30ºC, however, were of sufficient size to be collected 
but were still well isolated, thereby limiting contamination from diffusion of phage from adjacent plaques. 
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4ºC.  Once dry, the membranes were dipped, plaque-side up, in a series of solutions:  
denaturing solution (0.2M sodium hydroxide, 1.5M sodium chloride) for 20 seconds, 
followed by neutralizing solution (0.2M Tris-HCl pH 7.4, 0.3M sodium chloride, 0.03M 
sodium citrate) for five minutes, followed by wash solution (0.3M sodium chloride, 0.03 
sodium citrate) for 5 minutes.  The membranes were then allowed to dry, plaque-side 
up, for approximately one hour.  Once dry, the membranes were exposed to UV, 
12,000µJ for one minute, to fix the DNA to the membrane. 
The next step was pre-hybridization.  The prepared membranes were rolled up, plaque-
side in, and placed into a hybridization bottle.  Approximately 20mL of hybridization 
buffer (0.75M sodium chloride, 0.075M sodium citrate, 0.1% sarkosyl, 0.02% SDS, 1% 
nucleotide blocking solution) was added.  The bottles placed in the hybridization 
chamber and incubated at 60ºC for two hours and six revolutions per minute. 
Following the pre-hybridization was the hybridization.  The hybridization buffer was 
removed from the bottles3 and 6mL of probe solution (2µL of PCR probe synthesis 
product per milliliter of hybridization buffer) was added.  The bottles were returned to the 
hybridization chamber and incubated at 60ºC over night at six revolutions per minute. 
Once hybridization was complete the probe solution was recovered4 and the 
membranes were washed.  The first two washes were done in the hybridization 
chamber.  The first wash used approximately 50mL 2X wash solution (0.3M sodium 
chloride, 0.03M sodium citrate) per bottle at less than 40ºC for 5 minutes and six 
revolutions per minute.  The second wash used approximately 25mL 0.1X wash solution 
(0.015M sodium chloride, 0.0015M sodium citrate) per bottle at 60ºC for 30 minutes and 
12 revolutions per minute.  The membranes were then removed from the hybridization 
bottles and placed back-to-back (i.e. plaque-sides out) into dishes (i.e. two membranes 
per dish).  The membranes were then washed twice with DIG Buffer I (0.1M maleic acid, 
0.15M sodium chloride, pH 7.5) for five minutes per wash on an orbital shaker at 
approximately 15 rpm.   
                                            
3
 Hybridization Buffer was collected and re-used several times.  It was stored at 4ºC for short periods (one 
to two days) or at -20ºC for longer periods. 
4
 The Probe Solution was re-used several times.  With each successive use more probe was added. 
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Following these washes the membranes were incubated in DIG Buffer II (0.1M maleic 
acid, 0.15M sodium chloride, 1% (w/v) nucleotide blocking solution [Roche #11 096 176 
001], autoclaved to dissolve the blocking solution) for 30 minutes on an orbital shaker at 
approximately 15 revolutions per minute.  The membranes were then removed and 
placed back-to-back in Petri dishes containing antibody solution5 (0.2µL anti-DIG-
alkaline phosphatase antibody [Roche #11 093 274 910] per milliliter of DIG Buffer II).  
The antibody solution was re-used up to five times.  Initially the incubation time was 30 
minutes.  With each successive use, however, the incubation time was increased by 15 
minutes.  
After incubation with antibody, the membranes were returned to the dishes was washed 
three times with DIG Buffer I for 15 minutes per wash on an orbital shaker at 
approximately 15 revolutions per minute.  The membranes were then washed in DIG 
Buffer III (0.1M Tris-HCl pH 9.5, 0.1M sodium chloride, 0.05M magnesium chloride) for 
approximately three minutes. 
The final step in the hybridization screening was the colour detection.  This was done by 
placing the membranes, back-to-back, in Petri dishes containing colour-detecting 
solution6(0.4mM nitro blue tetrazolium chloride, 0.4mM 5-bromo-4-chloro-3-indolyl 
phosphate toluidine salt in DIG Buffer III).  The membranes were incubated in the dark 
at 37ºC until colour developed on the membranes.  The solution could be used for up to 
five sets of two membranes, however, the length of incubation time increased with each 
successive set of membranes.  Once colour developed the membranes were removed 
from the colour-detecting solution and placed in water. 
2.3.2.3. Plaque Collection 
Membranes were removed from the water and placed on cellophane on the bench top.  
An overhead transparency sheet was placed on top.  Using a Sharpie, the holes poked 
                                            
5
 The volume of antibody solution used depended on the size of membranes being screened.  Large 
membranes used approximately 50mL per Petri dish, whereas small membranes used approximately 
25mL per Petri dish. 
6
 Colour-detecting solution was prepared immediately prior to use.  The volumes used varied in a similar 
way to those of the antibody solution. 
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in the membrane were marked on the transparency sheet.  Using a different colour 
Sharpie, the positive plaques were marked on the transparency sheet.   
The transparency sheet was placed up-side-down on the bench top and the 
corresponding plate was placed overtop, with the poked holes aligning.  Using sterile, 
truncated pipetteman tips, the positive plaques were “sucked-up” and put into a 
microfuge tube containing 500µL SM Buffer (0.1M sodium chloride, 0.008M magnesium 
sulfate, 0.05M Tris-HCl pH 7.5, 0.01% gelatin).  Once all plaques were collected, 20µL 
of chloroform was added to each tube and the tubes were vortexed.  Plaques were 
stored at -20ºC. 
2.3.3. Screening of the library as plasmid 
The conversion of the sub-libraries from phage to plasmid was done through the 
process of mass excision. 
2.3.3.1. Mass Excision 
Separate 50mL cultures of XL1-Blue-MRF’ and XLOLR were grown in supplemented LB 
broth.  The cultures were pelleted at 5000rpm for 5 minutes and the pellets were re-
suspended in 10mM magnesium sulfate to an optical density at 600nm of 1.0.   The 
XL1-Blue-MRF’ culture was then inoculated with sub-library phage and helper phage (2 
x 108 pfu sub-library phage and 2 x 1010 pfu helper phage into 2 x 109 cfu of culture) and 
incubated at 37ºC for 15 minutes. Following the incubation, 20mL supplemented LB 
broth was added and the mixture was incubated again for approximate 2.5 to 3 hours at 
37ºC with shaking at 225rpm.  The mixture was then heated at 70ºC for 20 minutes 
followed by centrifugation at 1000xg for 10 minutes.  The supernatant was collected.  A 
100µL aliquot of the supernatant was combined with 20mL of the adjusted XLOLR 
culture and incubated at 37ºC for 15 minutes.  Following the incubation 4mL of 6X NZY 
broth (12.12% (w/v) NZCYM powder) was added and the mixture was re-incubated at 
37ºC for 45 minutes.  An aliquot was removed to titer the stock and glycerol stocks were 
prepared and frozen at -20ºC.   
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2.3.3.2. Plating and Hybridization 
Plates of the mass-excised sub-libraries were prepared by the spread plate method, up 
to 1000 cfu7 per plate on 150mm diameter plates.  The plates were incubated at 37ºC 
overnight. 
The protocol for hybridization was identical to that outlined in Section 2.3.2.2 with one 
exception.  After the membranes were removed, the plates were placed back at 37ºC 
and allowed to incubate over night.  This was done because, as the membranes were 
peeled off, the colonies would peel off as well, leaving nothing to collect after the 
hybridization was complete.  Re-incubating allowed for the re-growth of the colonies.  
Even with the re-incubation, however, not all colonies would re-grow.  This source of 
error will be discussed in following sections. 
2.3.3.3. Colony Collection 
Colony collection was very similar to plaque collection.  Transparency sheets were 
prepared in the same way they were for plaque collection.  To collect the colonies, 
however, sterilized toothpicks were used to touch the positive colony and transfer the 
bacteria to a tube containing 5mL LB broth with Kanomycin (0.005%).  These culture 
tubes were incubated overnight at 37ºC with shaking.  Glycerol stocks were then 
prepared and stored at -20ºC.  These cultures were also used for PCR screening and 
mini-preping (see below). 
2.4. PCR Screening of Positive Clones 
Cultures grown from positive hybridization isolates were used as template.  The same 
primers and PCR conditions used for screening the haddock cDNA library (see section 
2.3.1) were used to screen the positive isolates.  Following the PCR reactions the 
products were run on a 1.5% agarose gel to verify. 
                                            
7
 Colony Forming Unit (cfu). 
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2.5. Mini-prep of Positive Clones 
The cultures which were confirmed positive by PCR were mini-prepped and the plasmid 
DNA was sent for sequencing.  Mini-preps were done either by kit (Fermentas #K0502) 
or using the following protocol. 
A volume of 1.5mL of each culture was spun down at 10,000rpm for 5 minutes.  The 
supernatant was removed and the pellet was re-suspended by vortexing in 100µL of 
Solution 1 (0.05M glucose, 0.025M Tris-HCl pH 8.0, 0.1M EDTA).  Next, 200µL of 
Solution 2 (0.2M sodium hydroxide, 1% SDS) was added.  The mixtures were mixed by 
inverting 8 times and then placed on ice for five minutes.  This was followed by the 
addition of 150µL of Solution 3 (3M potassium acetate, 2M acetic acid).  The mixtures 
were mixed by inverting eight times and then placed on ice for five minutes.  The 
mixtures were then spun down and the supernatant recovered.  To the supernatant 
20µL of 0.1% RNaseA [Sigma # R6513] was added and the samples were incubated at 
37ºC for 30 minutes.  After the incubation, 300µL of chilled isopropanol was added.  The 
samples were inverted 15 times and placed on ice for at least 20 minutes.  The samples 
were then centrifuged.  The supernatant was discarded and the pellet was washed 
twice with chilled 70% ethanol.  After removal of the supernatant from the final wash, 
the pellet was allowed to air dry completely before re-suspending in 20µL of water.  The 
samples were then heated at 65ºC for 10 minutes before measuring the DNA 
concentration using the NanoDrop Spectrophotometer.  If necessary, the samples were 
diluted to approximately 350ng/µL and the concentration re-measured. 
2.6. Sequencing 
Samples were sent for sequencing to TAGC Sequencing Facility at the Hospital for Sick 
Children and were prepared for sequencing according to the Facility’s instructions.  
Samples of the four previously identified clones, A9, A16, B9 and C7, were also 
submitted.  The samples were sequenced using primers for the T3 and T7 promotor 
regions, which flank the multiple cloning site (MCS) of pBK-CMV, and were provided by 
the sequencing facility.  The T3 promotor lies upstream of the MCS and therefore 
sequencing using a primer to T3 gives the 5’ end of the sequence.  Sequencing using a 
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primer to T7 gives the 3’ end of the sequence in the antisense orientation.  To achieve a 
complete sequence the 5’ sequence was aligned with the 3’ sequence.  In most cases, 
the sequences were sufficiently long that there was an overlap.  As a result, the entire 
sequence of the clone was achieved. 
Sequencing using primers to T3 and T7 did not always result in complete sequences.  
Several clones were too long to have the T3 sequence and T7 sequence overlap, and 
therefore, the middle of the sequence was missing.  Also, in the case of Clone 17.3 the 
sequencing from the T7 primer was unsuccessful, despite repeated attempts. There 
was also difficulty obtaining a reliable sequence of Clone 1.2 from the T7 promotor 
primer.   Therefore, specific primers were designed so that the entire transcript could be 
sequenced.  Table 2.1 gives the sequences and primers used to complete the 
sequencing.  For Clone 17.3 two specific forward primers were required to complete the 
sequencing.  The first primer was made using the sequence from the T3 primer 
sequencing.  A subsequent primer was made using the sequence from the first specific 
primer.   
2.7.   Analysis 
Sequences were initially analyzed using the alignment editor BioEdit (Hall, 1999; 
http://www.mbio.ncsu.edu/BioEdit/bioedit.html).  Each the four possible orientations 
(forward, reverse, complement, reverse complement) of each of the sequences were 
individually compared to the Haddock UA p-BK-CMV-4 sequence.  Those sequences 
that showed significant alignment were aligned with each other in their alignment 
orientation using ClustalW as an accessory application through BioEdit.   
Several of the sequences contained portions that did not align with the other MH Class I 
sequences.  Using BLAST (NCBI) these portions were checked for similarity to 
sequences from other genes.   
An alignment of the DNA and amino acid sequences were generated using ClustalW.  
The sequences of DNA that were translated were all in the alignment orientation.  In the  
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Table 2.1:  Allele specific primers used to complete sequencing.  Sequencing 17.3 
was unsuccessful from the T7 promotor primer.  Therefore, only the 5’ end 
of the sequence was known.  As a result only forward primers were used to 
complete the sequencing.  This required two sequence specific primers.  
The first was made from the sequence obtained from the T3 primer 
sequencing and the second primer was made from the sequence obtained 
from the first specific primer sequencing.  Completion of the sequencing of 
Clone 1.2 only required the one specific forward primer.  Clones C7, 16.16 
and 16.22 were successfully sequenced by using only one set of sequence 
specific primers each.  For these clones sequencing using the T3 and T7 
primers was successful.  Therefore, both forward and reverse specific 
primers could be made. 
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Sequence  First Primer Sequence (5’ to 3’) Second Primer Sequence (5’ to 3’)  
C7 
Forward CCGGGCATACCACCAGCACC  
Reverse AGAGGTCGGGCCTCAGGAGC  
1.2 Forward TGATGAGGGCGGGGTCCAGG  
16.16 
Forward ACGGGTGGCGACTCTGCATC  
Reverse ACTCGACATGATGGCCGGACT  
16.22 
Forward GACGGGAGTTGGCGTTGGCA  
Reverse AGAGGTCGGGCCTCAGGAGC  
17.3 Forward GCGACGTCTGACCCCCGTTG TCCGACTCCAGGACGACGCC 
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case of sequences that contained portions belonging to other genes those portions 
were removed so that the sequences used were of the MH Class I sequences only. 
Three neighbour-joining phylogenetic trees were generated using MEGA version 4 
(Tamura et al., 2007).  All alleles were in their alignment orientation, and as in the case 
of the DNA and amino acid sequence alignments, only the MH Class I portions of the 
sequences were used.  The first tree was generated using the amino acid sequences of 
all identified haddock MH Class I alleles, six partial and 4 full length cod MH Class I 
alleles (Miller et al., 2002; Persson et al., 1999) and six full length rainbow trout MH 
Class I alleles (Kiryu et al., 2005).  The tree used the Poisson correction model with 
complete deletion of gaps and missing data, and bootstrap values based on 1000 
replicates.  The second tree was generated using only full length alleles of haddock and 
cod.  This tree used the same parameters as the first tree.  The third tree was 
generated using the nucleotide sequences of the α1 and α2 domains of the full length 
haddock and cod alleles.  This tree used the Jukes and Canter model with complete 
deletion of gaps, and bootstrap values were based on 1000 replicates. 
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3. Results 
3.1. Screening 
The haddock cDNA library that was used in this project was previously sub-divided into 
18 sub-libraries.  An initial screening of these sub-libraries was done using PCR to 
narrow down the sub-libraries containing MH Class I transcripts.  The PCR used the 
haddock specific set of primer Figure 3.1 shows the results of this PCR.  A total of nine 
sub-libraries showed a band of the appropriate size: sub-libraries 1, 2, 8, 12, 13, 15, 16, 
17, and 18.  Hybridization screening of all sub-libraries was done, except for sub-library 
18 which had been previously screened by Stephen DeBoer.   
Hybridization screening began on sub-library 16.  Initially, the sub-library was screened 
as plaques, as described in section 2.3.2.  During each round of screening it was 
noticed that there were two distinct plaque morphologies on the plates.  The first was 
typical of the library phage while the second was typical of the helper phage.  The first 
two rounds of screening appeared not to be affected by having to different types of 
phage growing.  However, when the third round of screening began almost all of the 
second round phage stocks showed no growth of phage (i.e. there was confluent growth 
of bacteria with few to no plaques).  Various attempts to re-grow the phage stocks were 
made.  The first attempt was to amplify the phage stocks by growing them in an E. coli 
culture overnight prior to plating.  When this failed the phage stocks from the first round 
of screening were re-plated, but these also showed no growth.  One potential source of 
error was the presence of the second type of phage, assumed to be helper phage.   
Acting on the assumption that the library phage had been previously contaminated with 
helper phage, the entire sub-library was converted from phage to plasmid through the 
process of mass excision, described in section 2.3.3.1.  Hybridization screening 
continued and a total of 100 plates with approximately 500 to 1000 cfu per plate were 
screened.  The positive colonies were collected, grown overnight and screened with 
PCR using the haddock specific primers.  Figure 3.2 shows a typical PCR screen.  The  
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Figure 3.1:  Initial PCR screen of haddock cDNA library screen.  Clearly visible 
bands at approximately 150bp can be seen from Sub-libraries 1, 2, 8, 12, 
13, 16, 17 and 18 as well as the positive control.  The positive control used 
Haddock UA pBK-CMV-4 for template DNA.  In the negative control water 
was added instead of template DNA. 
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Figure 3.2:  PCR Screen of clones isolated from Sub-library 16.  A total of 30 clones 
were collected from sub-library 16 were screened.  Only isolates 3, 10, 11, 12, 13, 14, 
15, 16, 19, 24, and 26 showed a positive result. 
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cultures which gave a positive PCR screen were then prepared for sequencing by mini-
prepping the plasmid DNA.   
Sub-libraries 1, 2, 8, 12, 13, 15 and 17 were screened in a similar fashion.  Although not 
all sub-libraries showed the two morphologies of plaques, they were all converted from 
plaques to plasmid to maintain method consistency.  These sub-libraries were screened 
on eight plates with approximately 500 cfu per plate. 
3.2. Sequence Analysis 
In addition to the four alleles previously sequenced, 18 unique alleles were obtained 
from all screened libraries.  Four of the alleles obtained were from clones previously 
isolated by Stephen DeBoer.   The alleles were initially divided into two groups based 
on their alignment orientation.  The first group of 12 sequences aligned with Haddock 
UA pBK-CMV-4 in the sense orientation.  These sequences are shown in Figure 3.3.  
The second group of six sequences aligned with Haddock UA pBK-CMV-4 in the 
reverse complement orientation and are shown in Figure 3.4.  None of the sequences 
aligned in the reverse or complement orientations with the Haddock UA pBK-CMV-4 
sequence.     
3.2.1. Sequence Orientation 
Since orientation of the ORF was a possible inactivation method for alleles it was 
necessary to confirm the directional cloning of transcripts during the cDNA library 
construction.  Please refer to Appendix II for a description of the cDNA library 
construction method.  Since the alleles were sequenced using primers to the vector it 
was possible to compare the 5’ and 3’ ends of the sequences to the vector sequences 
to verify directionality.  The 5’ end of a given sequence should contain vector sequence 
followed by the EcoR I adaptor sequence (5’ GAATTCGGCACGAGG3’), and the 3’ end 
should contain the Xho I site (CTCGAG) followed by vector sequence.  
As expected, all clone sequences had 5’ vector sequence at their 5’ ends and 3’ vector 
sequence at their 3’ ends.  However, two clones, B9 and 16.26 had no EcoR I adaptor  
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Figure 3.3 :  MH Class I sequences isolated from haddock cDNA found in the 
sense orientation.  Sequences are shown with the ORF in uppercase 
letters.  A) Clone A9; B) Clone B9; C) C7; D) Clone 1.1; E)  Clone 2.4;  F)  
Clone 2.10; G)  Clone 16.11; H)  Clone 16.12; I)  Clone 16.13; J)  Clone 
16.15; K)  Clone 16.22; L)  Clone 16.60.3  
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A9 
 
tactcgcctgctgtcgacactagtggatccaaaggtttactcaagtgcgaagtcaaaaacggacagcataacataaaaacgtttaatc
aacatttttactcaactaaattgtttaatcttgaaataactcccaaaataatatccagaaatcatgaacttcattgtaggttttggttaacaaa
gtaaatccctcatgtaattaagctcttaacattgtttgctacaggctaacaaaggcttatcaagcctaaatgaggataactaaaagcgag
aaatcgctccgcgccccgtttggttcatcgtgacagatgtttctcagcaraaactgccaattaatttgctctcaaatccacctggaggattt
ggcatgactgactaataaaaaaacacattaagaataactattcttcagaatgcaagaattgatttaaactgtcctaaaaaattaaaaaa
cacaacaaaaccaagttgacatgtttttctacctccccaaccccttggtagagataaccctccctcgacagtcttcgacaggtcaggtca
gcgaggttccgacccccccgctgttggttcaaagcgaccaggaagtggctgttagcccaccctgagtggcggagctacaagaacca
ctccgtctcctctgacaaacagcatggggatgttccttttggtggacttgtacagctcctcgtacgtctcctcgtcgatctccaccgtggtca
ccgtctcctccacagcacccaggatcatgttcaggtgctggtcgtatgcatgcaatctgccgcggagctcccgatcgttcctcatcttgac
gtagatcctctcgtccaaactgagcctgatcaggtccaggggctcctccaccgtcggagttccgtctctgtggataatctcatcgagctgt
tcttctgaatacatcgatATGAAGGCGCTAATAGGGCTGCTGCTGCTGTTGGTCTTTGGTCACGGTG
TGTCCTCACTACTTCACTCTATGCAGTTTTTCTACACGGCGTCGTCTGGACTCTCAACCTTC
CCAGAGTTTGTTGTTGTTGGGATGGTGGATGGAGTTCAGATGGTTCACTATGACAGCAACA
GTAAGAGAGCCGTACCCAAACATGACGCGGCGGACCAGCTCTACAGAGATCATCCGGGTG
ACCTCGAGGGGGACACTGGAGGATTTCAGGCTGACCAGCAGGCCTTCAAAGCCAACATTG
GGATTGCCAAGCAGCGCTTTAACCAGACAGGAGGTACCCACATGGTTCAGTGGATGGTTG
GTTGTGAGTGGGATGATGAGGATGATTCTACTGATGGTTATAACCAGCATGGTTATGATGG
AGAGGACTTCATATCGTTGGACCTGAAGACCCTGACCTGGGTCGCTCCAGTAGACGAGGC
TTGTGCTACCAAACGGAGATGGGATGGGGATAGGGCCCGAAATCAATACTGGAAGAACTA
CTTCACCAAGGAGTGTGTTGATTGGCTGAAGAAGCTCCTGTCCTATGGGAAGAGCACTCTG
CTGAGAACAGATCGTCCGCGGGTGTCTCTGCTCCAGAGGAGCCCCTCCTCCCCAGTGGTG
TGCCATGCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGTTCTGGAAGAGAGACGGTCAG
GAGCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCCAACCACGACGGGACCTTCCA
GGTCAGCGTGGACCTCAACCTCAAGGCCGTCCCACAGGAGGACTGGGGGAGGTACGAGT
GTGTGGTCCAGCTGAGAGGCATCGAGGACATCTCCACCCCCCTGGACCCGCCCCTCATCA
GGACCAACGGGGGCAAGAGTGGCATCACCGTCCCCATCATCATTGGGTTCGTTGTTCTCC
TCCTCGCTGCTGCTGCTGCTGCTGCTGTTGGAGTCCTTCTGTACAAGAAGAGGAACGATTC
ACACAAGCAGCACAAACCAGTTGATTCACACAAGCGACCCATATCAGTTGGTTCTTCTGAC
ACCAGCTCTGAGAACACTGAGGTGCAGAATCTGGATCCTGAAGCCCGACTTCTGACAGAA
GGTCGAAGTTAAatcatgaagagtcttctcacgttcagctccctaaagcagggtggagtggatcgcagttcatttataatccttac
aaacaggcttgggacttcagctaactaaagatgctatatttgcttaattacattaacatccatgctttattttgataaaaaacataaatccgt
aagtaaatcaataagtgtgaatcaattagatctctgtagcctatttgtgattgattaactcaatggattaattctgcaatctttcactgaccctt
ggaaaccatggcaacatgaccccgccattatggccattttgttttgcttctaactgtttcatcttataagcttttaattatgttatattgtttagtca
tattgaagtttcaaataatgttcaaagattctgaatgaagatttgggacagtgagattctgttgagtttgaatacaataatcattaaatgtaat
gtgtttccttgaaatatttaatttcagctagctagagaattgcatcgctacataggctaccacagtcaagctgttttagctttaatggtctttgtt
gtgttttctgtgttctttggggaattggatcatatatactttgcttattctgtcaataaatacacaaaaaagtacttctagagcggccgcgggc
ccatcgattccacccgggtgggtaccagtaaac 
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B9 
 
caactgcggtcgacactagtggatccaaagctggagtcggagtcccgtctctgtggataatctcatcgagctgttcttctgaatacatcg
atATGAAGGCGCTAATAGGGCTGCTGCTGCTGTTGGTCTTTGGTCACGGTGTGTCCTCAGG
GCTTCACTCTCTCCATTATTTCTACACGGCGTCGTCTGGACTCTCAACCTTCCCAGAGTTTG
TTTCTGTGGGGATGGTGGATGGAGTTCAGATTGACTACTATGACAGCAACACCCAGAGAGT
AGTCCTCAAACAGGACTGGATGGAGCAGGTCACCAGAGGTGACCCCGCCTACCTGGAGA
GGGAAACTGGAATCAGAAAGGGTAACCAGCAGTTCTTCAAAGTCGGCGTTGGAACTCTGA
AGCAGCGCTTTAACCAGACAGGAGGTGCCCACATGGTTCAGGTCATGTATGGTTGTGAGT
GGGATGATGAGGATGATTCTACTGAAGGTTATGACCAGCTTGGTTATGATGGAGAGGACTT
CCTATCGTTGGACCTGAAGACCCTGACCTGGGTCGCTGCAGTACGTCAGGCCTTCACCAC
CAAACAGAGATGGGATGGGGACAGAGCTCAGAATGAACGGTATAAGCACTACTACACCAA
GGTCTGTGTTGATTGGCTGAAGAAGCACCTGGCCTATGGGAAGAGCACTCTGCTGAGAAC
AGATCGTCCGCGGGTGTCTCTGCTCCAGAGGAGCCCCTCCTCCCCAGTGGTGTGCCATGC
TACAGGCTTCTTCCCTGACAGGGTGGTGGTGTTCTGGAGGAGAGACGGTCAGGAGCTCCA
GGAGCAGGTGGACCACGGGGAGGTCCTCCCCAACCACGACGGGACCTTCCAGGTCAGCG
TGGACCTCATCCTCAAGGCCGTCCCACAGGAGGACTGGGGGAGGTACGAGTGTGTGGTC
CAGCTGAGAGGCATCGAGGACATCTCCACCCCCCTGGACCCCGCCCTCATCAGGACCAAC
AGGGGCAAGAGTGGCAGCACCGTCCCCATCATCATTGGGTTCGTTGTTCTCCTCCTCGCT
GCTGCTGCTGCTGTTGGAGTCTTTCTGTACAAGAAGAGGAACGATTCACACAAGCAGCACA
AACCAGTTGGTTCTTCTGACACCAGCTCTGAGAACACTGATGGGCAGAATCTGGCTCCTGA
GGCCCGACCTCTGACAGAAGTTTTAAGTTAAatcatgaagagtcttctcacgttcagcttcctaaagcagggtgga
gtggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaactaaagatgctacatttgctaaattacaataacatccat
acttaactttattttgataacaatcatgaatctgaaagatctgtaaatcaattagatctctgtatttgtaatagatttgattaattctctggctttaa
cctgcaatgtttcactgacgcttggaaaccatgacgacacaaactcgccatgatggccattttgttttggttcctgccgcttcaagttataac
ctttgaatcatgttattgtgtttagtaatatttaagtttcaaataatggtcaaaggttctgagactagtttttggacagtgagatccggtcaagttt
gaatacaataaatgttaaattgtatgttttttcttaaataatattatttgaattgcatcgctacataggctaccacgatcgagctaggcagcttt
agccttaatccttttgttgtactattttctttgttctttggggaatttgatcatagatactggttattctgtcaataaagtacatccaaa 
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C7 
 
gtgtcattgcgaaaactggtatacaaaatatttgtggggaattggcaacttctttaaacaaatttgatccctgtagtgaggcaaactaaca
gtacaaatacaaatgtgatcccttgaaccctatttttttttatttagatgacgctcaacaactcaaatgatggcaagactcaagcattgagg
gttacactttagtgatctcttcactagttgctgggtttgatgtttagtcgacctcttcgatggtggggccagatgagccaccgccgcctgggg
cagcacctccagcaccggggaagccaccgggcataccgtcgggcatgccaccgggcataccaccagcaccctggtacagcttgg
tgacgatggggttgcagaccttctccagctccttctgctggtgctcgtactcttccttctcggccgtctggttcttgtctagccagctgatgact
tcgttgcacttctccatgatcttctgcttgtcctcgtcgctgatcttgccggtgagcttctcatcctccacggtggacttcatgttgaaggcgta
cgactccagagagttcttggaggagaccttgtcacgctgggaatcatcttcagccttgtatttctcggcatcctgcaccatgcgctcgtcc
cgtctctgtggataatctcatcgagctgttcttctgaatacatcgatATGAAGGCGCTAATAGGGCTGCTGCTGCTG
TTGGTCTTTGGTCACGGTGTGTCCTCACTGCTTCACTCTATGCAGTATTTCTACACGGGGT
CGTCTGGACTCTCAACCTTCCCAGAGTTTGTTGTTGTTGGGATGGTGGATGGAGTTCAGAT
GGTTCACTATGACAGCAACACCCAGAGAACAGTCCTCAAACAAGACTGGATGAAGCAGGT
CACCAGAGGTGACCCCGCCTACCTGGAGAGGAACACTGGAAACTTTCAGGGTGCCCAGCA
GACCTTCAAAGTCGGCATTGGGACTCTGAGGCAGCGCTTTAACCAGACAGGAGGTACCCA
CTTATATCAGTTGATGTATGGTTGTGAGTTGGATGATGAGGATGATTCTACTGATGGTTATC
ACCAGTATGGTTATGATGGAGAGGACTTCCTATCGTTGGACCTGAAGACCCTGACCTGGGT
CGCTCCAGTACGTCAGGCCTTCCCCACCAAACAGAGATGGGATGGGGACAGAGCTTATAA
TGAACGGCAGAAGCACTACTACACCAAGGTCTGTGTTGATTGGCTGAAGAAGTACCTGTCC
TATGGGAAGAGCACTATGCTGAGAACAGAGCGTCCGCGGGTGTCTCTGCTCCAGAGGAGC
CCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGTTC
TGGAGGAGAGACGGTCAGGAGCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCCAA
CCACGACGGGACCTTCCAGGTCAGCGTGGACCTCAACCTCAAGGCCGTCCCACAGGAGG
ACTGGGGGAGGTACGAGTGTGTGGTCCAGCTGAGAGGCATCGAGGACATCTCCACCCCC
CTGGACCCCGCCCTCATCAGGACCAACTGGGGCAAGAGTGGCATCACCGTCCCCATCATC
ATTGGGTTCGTTGTTCTCCTCCTCGCTGCTGCTGCTGCTGCTGCTGTTGGAGTCCTTCTGT
ACAAGAAGAGGAACGATTCACACAAGCAGCACAAACCAGTTGGTTCTTCTGACACCAGCTC
TGAGAACACTGAGGGGCAGAATCTGGCTCCTGAGGCCCGACCTCTGACAAAAGTTCAAAG
TTAAatgaagagtcttctcacgttcagcttcctaaagcagggtggagtggatcgcagttcatttataatccttacaaacaggcttggga
cttcagctaactaaagatgctatatttgctaaattacaataacatccatacttaactttattttgataacaatcatgaatctgaaagatctgta
aatcaattagatctctgtatttgtaacagatttgattaattctctggctttaacctgcaatgtttcactgacgcttggaaaccatgacaacaca
aactcgccatgatggccattttgttttggttcctgccgcttcaagttataacctttgaatcatgttatagtgtttagtaatatttaagtttcaaataa
tggtgaaaggttctgagactagtttttggacagtgagattcggtcaagtttgaatacaataatcgttaaattgtatgttttttctttaataatatta
tttgaattgcatcgctacataggctaccacgatcgagctaggcagctttagccttaatccttttgttggactattttctttgttcttttgggaatttg
atcatagatactttggttattctgtcaataaagtacatccaaa 
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1.1 
 
AGAGCCGTACCCAAACATGACACGGCGGACCAGTTCTACAGAGATCATCCGGGTGACCTC
GAGAGGGACACTGGAAACTTTCTGGGTTCCCAGCAGACCTACAAAGCCAACATTGGGATT
CTGAAGCAGCGCTTTAACCAGACAGGAGGTGCCCACATGTTTCAGTTCATGTATGGTTGTG
AGGTGGATGATGAGGATGATTCTACTGATGGTTATAGACAGTATGGTTATGATGGAGAGGA
CTTCCTATCGTTGGACCTGAAGTCCATGACCTGGGTCGCTCCAGTACGTCAGGCCTTCCC
CACCAAACAGAGATGGGATCAGGATAAAGCTGATCTACAATACATTAAGAACTACCAAACC
AAGGAGTGTGTTGATGGGCTGAAGAAGCTCCTGGCCTATGGGAAGAGCACTCTGCTGAGA
ACAGAGCGTCCGTGGGTGTCTCTGCTCCAGAGGAGCCCCTCCTCCCCAGTGGTGTGCCAT
GCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGTTCTGGAGGAGAGACGGTCAGGATCTC
CAGGAGCAGGTGGACCACGGGGAGGTCCTCCCCAACCACGACGGGACCTTCCAGGTCAG
CGTGGACCTCAACCTCAAGGCCGTCCCACAGGAGGACTGGGGGAGGTACGAGTGTGTGG
TCCAGCTGAGAGGCATCGAGGACATCTCCACCCCCCTGGACCCCGCCCTCATCAGGACCA
ACGGGGGCAAGAGTGGCATCACCGTCCCCATCATCATTGGATTCGTTGTTCTCCTCCTCG
CTGCTGCTGCTGCTGCTGTTGGAGTCCTTCTGTCCAAGAAGTGGAACGATTCACACAAGCA
GCACAAACCAGTTGGTTCTTCTGACACCAGCTCTGAGAACACTGAGGGGCAGAACCTGGC
TCCTGAGGCCCGACCTCTGACAAAAGTTTGAagttaaatcatgaagagtcttctcacgttcagcttcctaaagcag
ggtggagtggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaactaaagatgctatatttgcttaattacaataac
atccatacttaactttattttgataacaatcatgaatctgaaagatctgtaaatcaattagatctctgtatttgtaatagatttgattaattcactg
gctttaacctgcaatgtttcactgacgcttggaaaccatgacgacacaaactcgccatgatggccattttgttttggttcctgctgcttcaag
ttataacctttgaatcatgttatagtgtttagtaatatttaagtttcaaataatggtcaaaggttctgagactagtttttggacagtgagattcgg
tcaagcttgaatacaataatcgttaaattgtgtgttttttcttaaaaaatattatttgaattgcatcgctacataggctaccacgatcgagctag
gcagctttagcattaatccttttgttgtactattttctttgttctttggggaattttatcatagatactttggttattctgtcaataaagtacatcaaaa
ttgaaaaaa 
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2.4 
 
GTTCAGTTCATGTATGGTTGTGAGTGGGATGATGAGGATGATTCTACTGATGGTTATGACC
AGTATGGTTATGATGGAGAGGACTTCATATCGTTGGACCTGAAGACCATGACCTGGGTCGC
TCCAGTACGTCAGGCCTTCACCACCAAACAGAGATGGAATCAGAATAAAGCTAGATTACAA
TACAATAAGAACTACTACACCAAGGTCTGTGTTGATTGGCTGAAGAAGTACCTGGCCTATG
GGAAGAGCACTCTGCTGAGAACAGATCGTCCGCGGGTGTCTCTGCTCCAGAGGAGCCCCT
CCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGTTCTGGA
GGAGAGACGGTCAGGAGCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCCAACCAC
GACGGGACCTTCCAGGTCAGCGTGGACCTCAACCTCAAGGCCGTCCCACAGGAGGACTG
GAGGAGGTACAAGTGTGTGGTCCAGCTGAGAGGCATCGAGGACATCTCCACCCCCTTGGA
CCCCGCCCTCATCAGGACCAACGGGGGCAAGAGTGGCATCACCGTCCCCATCATCATTGG
GTTCGTTGTTCTCCTCCTCGCTGCTGCTGCTGCTGCTGTTGGAGTCCTTCTGTACAAGAAG
AGGAACGATTCACACAAGCAGCACAAACCAGTTGGTTCTTCTGACACCAGCTCTGAGAACA
CTGAGGGGCAGAATCTGTCTCCTGAGGCCCGACCTCTGACAGAAGTTCAAAGTTAAatcatga
agagtcttctcacgttcagcttcctaaagcagggtggagtggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaa
ctaaagatgctatatttgctaaattacaataacatccatacttaactttattttgataacagtcatgaatctgaaagatctgtaaatcaattag
atctctgtatttgtaatagatttgattaattcactggctttaacctgcaatgtttcactgacgcttggaaaccatgacaacacaaactcgccat
gatggccattttgttttggttcctgccgtttcaagttataacctttgaatcatgttatagtgtttagtaatatttaagtttcaaataatggtcaaagg
ttctgagactagtttttggacagtgagatccggtcaagtttgaatacaataatcgttaaattgtatgttttttcttaaataatattatttgaattgca
tcgctacataggctaccacgatcgagctaggtagcttcagccttaatccttttgttgtactattttctttgttctttggggaatttgatcatagata
ctttggttattctgtcaataaagtacatccaaa 
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2.10 
 
GTCTTTGGTCACGATGTGTCCTCAGTGATTCACTCTCTGCGGATTTTCTACACGTCGTCTTC
TGGATTCTCAACCTTCCCAGAGTATGTGACAGTTCAGATGGTGGATGAGGTTCAGATTGAG
TACTATGACAGCAACACCCAGAGAATCATAACCAAACAGGACTGGGTGGTCCAGGCCAAC
AGATACAACATCCCCGACTACCTGGAGAGGTCAACTGAAAACAGAAAGGGTCAACAGCAG
GTCGCCAAAGTCAACATTGGGACCGCGAAGCAGCGCTTTAACCAGACAGGAGGTGCCCAC
ATTGTTCAGAGGATGTCTGGCTGTGAGTGGGATGATGAGGATGATACCACTGATGGTTATG
AGCAGTATGGTTATGATGGAGAGGACTTCCTATCGTTGGACCTGAAGACCCTGACCTGGG
TCGCTCCAGTACATCAGGCTCTCACCATCAAACTGAGATTGGATCACGATACAGCTTGGAA
ACAATACTTGAAGAACTTCTACACCAAGGAGTGTGTTGATTGGCTGAAGAAGTACCTGAGC
TACGGGAAGAGCACTCTGCAGAGAACAGAGCGTCCGCGGGTGTCTCTGCTCCAGAGGAG
CCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTAACAGGGTGGTGGTGTT
CTGGAGGAGAGACGGCCAGGAGCTTCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCC
AACCACGACGGGACCTTCCAGGTCAGCGTGGACCTGAACCTAACGGCCGTCCCACAGGA
GGACTGGGGGAGGTACGAGTGTGTGGTCCAGCTGAAAGGCATCGAGGACATCTCCATCCT
CCTGGACCCCGCCCACATCAGGACCAACGGGGGGGACAAGAGTCTCATCCTTGCTTTCAT
CCTCACTGGTGTTGCTGTTGTTGCTGTTTTTGTTGCTGTTGTTGTTGGAGTCTTTCTGTACC
GGAAGAGGAACGATTCAGACAAGCGTCACAAACCAGTTGGTTCTTCTGACACCAGCTCTGA
GAACACTGAGGTGCAGAAGCTGTCTCCTGAGGCCCAACCTCTGACCACTGGTCAAAGTTA
Aatcatgaagaggcttgtcacgttcggcttcctaaaccaggatggagtggatcgctggtcatttataatccttacaatcaggcttgggact
tcaaacctgcaatctttcactgacgcttggaaaccatagcaacacgacgtcgccatgatggccatttgggtcccgccgcttcacgtcat
aaccttttaattatgttatattgttaagtaatatttaagtttcaaataatgttcaaagattctgaatcaagatttttgacagtgaggttttgtcaagt
ttcaatacaataatcgattaatttaagttgtttcattaaaatatattatttagcgttctgctagctagagaattgcattgctgcataggctaccac
aatcctgctaggccgctttagcctcaattctttttgttgtattttctgtgttctttggggaattggatagtatacttgggttattctgtcaataaaatg
cataaaaattgaaaaaaaaaaa 
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16.11 
 
CTGAGCTGGGTCGCTCCAGTAGACGAGGCTTGTGCTACCAAACGGAGATGGGATGGGGA
TAGGGCCCGAAATCAATACTGGAAGAACTACTTCACCAAGGAGTGTGTTGATTGGCTGAAG
AAGCTCCTGTCCTATGGGAAGAGCACTCTGCTGAGAACAGATCGTCCGCGGGTGTCTCTG
CTCCAGAGGAGCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTGACAGG
GTGGTGGTGTTCTGGAAGAGAGACGGTCAGGAGCTCCAGGAGCAGGTGGACCACGGGGA
GGTCCTCCCCAACCACGACGGGACCTTCCAGGTCAGCGTGGACCTCAACCTCGAGGCCG
TCCCACAGGAGGACTGGGGGAGGTACGAGTGTGTGGTCCAGCTGAGAGGCATCGAGGAC
ATCTCCACCCCCCTGGACCCCGCCCTCATCAGGACCAACGGGGGCAAGAGTGGCATCAC
CGTCCCCATCATCATTGGGTTCGTTGTTCTCCTCCTCGCTGCTGCTGCTGCTGCTGCTGTT
GGAGTCCTTCTGTACAAGAAGAGGAACGATTCACACAAGCAGCACAAACCAGTTGATTCAC
ACAAGCGACCCATATCAGTTGGTTCTTCTGACACCAGCTCTGAGAACACTGAGGTGCAGAA
TCTGGATCCTGAAGCCCGACTTCTGACAGAAGGTCGAAGTTAAatcatgaagagtcttctcacgttcagc
tccctaaagcagggtggagtggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaactaaagatgctatatttgctt
aattacattaacatccatctttattttgataaaaaacataaatccgtaagtaaatcaataagtgtgaatcaattagatctctgtagcctatttg
tgattgattaactcaatggattaattctgcaatctttcactgacccttggaaaccatggcaacatgaccccgccattatggccattttgttttg
cttctaactgtttcatcttataagcttttaattatgttatattgtttagtcatattgaagtttcaaataatgttcaaagattctgaatgaagatttggg
acagtgagattctgttgagtttgaatacaataatcattaaatgtaatgtgtttccttgaaatatttaatttcagctagctagagaattgcatcgc
tacataggctaccacagtcaagctgttttagctttaatggtctttgttgtgttttctgtgttctttggggaattggatcatatatactttgcttattctgt
caataaatacacaaaaattgtgcctacgtaaaaaa 
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16.12 
 
tggagtcggagtcccgtctctgtggataatctcatcgagctgttcttctgaagacatcgatATGAAGGCGCTAATAGGGCT
GCTGCTGCTGTTGGTCTTTGGTCACGGTGTGTCCTCAGTGCTTCACTCTATGCAGTTTTTCT
ACACGGCGTCGTCTGGACTCTCAACCTTCCCAGAGTTTGTTGTTGTTGGGATGGTGGATG
GAGTTCAGATGCTTCACTATGACAGCAACAGTAAGAGAGCCGTACCCAAACATGACGCGG
CGGACCAGCTCTTCAGAGATCATCCGGGTGACCTCGAGGGGGACACTGGAAACTTTCTGG
GTGCCCAGCAGATCTTCAAAGCCAACATTGGGACTCTGAAGCAGCGCTTTAACCAGACAG
GAGGTGCCCACATGGTTCAGTTCATGTATGGTTGTGAGTGGGATGATGAGGATGATTCTAC
TGATGGTTATAGACAGTATGGTTATGATGGAGAGGACTTCATATCGTGGGACATGAAGACC
ATGACCTGGGTCGCTCCAGTACGTCAGGCCTTCACCACCAAACAGAGATGGAATCAGAAT
AAAGCTGGTCTACAATACAGGAAGAACTACATCACCAAGGAGTGTGTTGATTGGCTGAAGA
AGTACCTGGCCTATGGGAAGAGCACTCTGCTGAGAACAGATCGTCCGCGGGTGTCTCTGC
TCCAGAGGAGCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTGACAGGG
TGGTGGTGTTCTGGAGGAGAGACGGTCAGGATCTCCAGGAGCAGGTGGACCACGGGGAG
GTCCTCCCCAACCACGACGGGACCTTCCAGGTCAGCGTGGACCTCAACCTCAAGGCCGTC
CCACAGGAGGACTGGAGGAGGTACCAGTGTGTGGTCCAGCTGAGAGGCATCGAGGACAT
CTCCACCCCCCTGGACCCCGCCCTCATCAGGACCAACGGGGGCAAGAGTGGCATCACCG
TCCCCATCATCATTGGGTTCGTTGTTCTCCTCCTCGCTGCTGCTGCTGCTGCTGTTGGAGT
CCTTCTGTACAAGAAGAGGAACGATTCACACAAGCAGCACAAACCAGTTGGTTCTTCTGAC
ACCAGCTCTGAGAACACTGAGGGGCAGAATCTGTCTCCTGAGGCCCGACCTCTGACAGAA
GTTCGAAGTTAAatcatgaagagtcttctcacgttcagcttcctaaagcagggaggagtggatcgcagttcatttataatccttac
aaacaggcttgggacttcagctaactaaagatgctatatttgctaaattacaataacatccatacttaactttattttgataacaatcatgaa
tctgaaagatctgtaaatcaatgagatctctgtatttgtaatagatttgattaattcactggctttaacctgcaatgtttcattgacgcttggaa
accatgacaacacaaactcgccatgatggccattttgttttggttcctgccgcttcaagttataacctttgaatcatgttatagtgtttagtaat
atttaagtttcaaataatggtcaaaggttctgagactagtttttggacagtgagattcggtcaagtttgaatacaataatcgttaaattgtgtg
ttttttcttaaataatattatttgaattgcatcgctacataggctaccacgatcgagctaggcagctttagccttaatccttttgttgtactattttct
ttgttctttggggtatttgatcatagatactttggttattctgtcaataaagtacatccaaattgaaaaaaaaaaaaaaaaaaa 
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16.13 
 
GTCGCTCCAGTACGTCAGGCCTTCACCACCAAACAGAGATGGGATGGGGACAGAGCTCAG
AATGAACGGTATAAGCACTACCACACCAAGGAGTGTGTTGATTGGCTGAAGAAGCTCCTGG
CCTATGGGAAGAGCACTCTGCTGAGAACAGAGCGTCCGCGGGTGTCTCTGCTCCAGAGGA
GCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGT
TCTGGAGGAGAGACAGTCAGGAGCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCC
AACCACGACGGGACCTTCCAGGTCAGCGTGGACCTCAACCTCAAGGCCGTCCCACAGGA
GGACTGGAGGAGGTACCAGTGTGTGGTCCAGCTGAGAGGCATCGAGGACATCTCCACCC
CCCTGGACCCCGCCCTCATCAGGACCAACGGGGGCAAGAGTGGCATCACCGTCCCCATC
ATCATTGGGTTCGTTGTTCTCCTCCTCGCTGCTGCTGCTGCTGCTGTTGGAGTCCATCTGT
ACAAGAAGAGGAACGATTCACACAAGCAGCACAAACCAGTTGGTTCTTCTGACACCAGCTC
TGAGACCACTGAGGGGCAGAATCTGTCTCCTGAGGCCCGACCTCTGACAGAAGTTCGAAG
TTAAatcatgaagagtcttctcacgttcagcttcctaaagcagggtggagtggatcgcagttcatttataatccttacaaacaggcttgg
gacttcagctaactaaagatgctacatttgctaaattacaataacatccatacttaactttattttgataacaatcaggaatctgaaagatct
gtaaatcaatgagatctctgtatttgtaatagatttgattaattctctggctttaacctgcaatgtttcactgacgcttggaaaccatgacgac
acaaactcgccatgatggccattttgttttggttcctgccgcttcaagttataacctttgaatcatgttatagtgtttagtaatatttaagtttcaa
ataatggtcaaaggttctgagactagtttttggacagtgagatccggtcaagtttgaatacaataatcgttaaattgtatgttttttcttaaata
atattatttgaattgcatcgctacataggctaccacgatcaagctcggcagctttagccttaatccttttgttgtactattttctttgttctttgggg
aatttgatcatagatactttggttattctgtcaataaagtacatccaaattgaaaaaaaaaaaaaaaaaaa 
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16.15 
 
gcgtctttgtggatattctcatcgagccttttttccgattacatcgatATGAAGGTGCTAATAGGGCTGCTGTTGTTGT
TCTTTGGTCACGATGTGTCCTCAGTGATTCACTCTGTGCAGGTTTTCTCCACGGCGTCGTC
TGGACTCTCAACCTTCCCTGAGTTTGTGATGGTTCAGATGGTGGATGAGGTTCAGGTTGAG
TACTATGACAGCAACACCCAGAGAATCATAACCAAACAGGACTGGGTGGACCAGGCCAAC
AGAGACAAAGTCCCCGACTACCTGGAGAAGGCAACTGAAAACAGAAAGGGTGAACAGCAG
GTCTTCAAACGCAACATTGGGACCCTGAAGCAGCGCTTTAACCAGACAGGAGGTGCCCAC
ATTGTTCAGAGGATGTTTGGTTGTGAGTTGGATGATGAGGATGATACCACTGATGGTTATG
AGCAGCACGGTTATGATGGAGAGGACTTCCTATCGTTGGACCTGAAGACCCTGACCTGGG
TCGCTCCAGTACATCAGGCTCTCACCACCAAACTGAGATGGGATCACGATACAGCCCGGA
AACAATACTTGAAGAACTTCTACACCAAGGAGTGTGTTGATTGGCTGAAGAAGTACCTGAG
CTACGGGAAGAGCACTCTGCAGAGAACAGAGCGTCCGCGGGTGTCTCTGCTCCAGAGGA
GCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTAACAGGGTGGTGGTGT
TCTGGAGGAGAGACGGCCAGGAGCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCC
CAACCACGACGGGACCTTCCAGGTCAGCGTGGACCTGAACCTAACGGCCGTCCCACAGG
AGGACTGGGGGAAGTACGAGTGTGTGGTCCAGCTGAAAGGCATCGAGGACATCTCCATCC
TCCTGGACCCCGCCCACATCAGGACCAACGGGGGGGACAAGAGTCTCATCCTTGCTTTCA
TCCTCACTGGGGTTGCTGTTGTTGTTGTTGGTGCTGTTGTTGGAGTCTTTCTGTACTGGAA
GAGGAACGATTCAGACAAGCGTCACAAACCACTTGGTTCTTTCGACACCAGCTCTGAGAAC
ACTGAGGTGCAGAAGCCGTCTCCTGAGGCCCAACCTCTGACCACAGGTCAAAGTTAAatcat
gaagaggcttgtcacgttcggcttcctaaaccaggttggagtggatcgctggtcatttataatccttacaatcaggcttgggacttcagcta
actgcagagtctgcatttgctaaattacaattttcaaacttaactttattgtgataacaatcatcaatctgttagaagtgtcaatcaattacatc
tctctatttgtgatatatttgtataactcgctggcttaaacctgcaatatttcactgacgcttggaaaccatagcaacacgacgtcgccatga
tggccatttgggtcccgccgcttcacgttataaacttttaattatgttatattgtttagtaatatttaagtttcaaataatgttcaaagattctgaat
caagatttttgacagtgagattttgtcatgtttcaatacaataatcgattaatttaagttgtatcattaaaatatattatttagcgttctgctagcta
gaggattgcattgctgcataggctaccacaatcgtgctaggctgctttagcctcaattctttttgttgtattttctgtgttatttggggaattggat
agtatacttgggttattctgtcaataaaatacataaaaattgaaaaaaaaaaaaaaaaaaaaaaa 
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16.22 
cctcgtgccgaattcggcacgaggttttattccttgaactcgacagatggaacggtctgcacaggcagggccaaatcgagacgccca
attacttcttggtctcctcctccttggacaaggtcttgattatttcctctttcttggccgcgagacgttcctctctgcgcttgcgagcctccttagtc
ttggagcggcgagcctctgcttggtcagacaagagcttcttgcgggccttgtctgccttcagcttgtggatgtgttccattaggatacgcttg
ttcttgaacacgttacccttggccttaaggtacaggctgtggtacatgtgccggtcgatcttctttgattccctgtagcgacggagaagccg
acgcaagatcctcatgcggcgcatccagcacaacttctctggcatacgggcattggcagtaccctttctcttaccatagcccatgtgtcgt
cccttgcgacgtgcaagggtgttcttgcggcgtcgggcacgagaatgcacggtgacaggcttgcggatgatgagaccatccttaacc
agcttcctgatctgctgacgggagttggcgttggcaatctcattggtctcgttcgggtccaaccataccttcttcttgccacagcgcagaac
gctagaggcaagcctcttctggagcCTGAAGAAGTACCTGGCCTATGGGAAGAGCACTCTGCTGAGAA
CAGATCGTCCGCGGGTGTCTCTGCTCCAGAGGAGCCCCTCCTCCCCAGTGGTGTGCCATG
CTACAGGCTTCTTCCCTGACAGGGTGGTGGTGTTCTGGAGGAGAGACGGTCAGGAGCTCC
AGGAGCAGGTGGACCACGGGGAGGTCCTCCCCAACCACGACGGGACCTTCCAGGTCAGC
GTGGACCTCAACCTCAAGGCCGTCCCACAGGAGGACTGGAGGAGGTACGAGTGTGTGGT
CCAGCTGAGAGGCATCGAGGACATCTCCACCCCCCTGGACCCCGCCTACATCAGGACCAA
CGGGGGCAAGAGTGGCATCACCGTCCCCATCATCATTGGGTTCGTTGTTCTCCTCCTCGC
TGCTGCTGCTGCTGCTGTTGGAGTCCTTCTGTCCAAGAAGAGGAACGATTCACACAAGCA
GCACAAACCAGTTGGTTCTTCTGACACCAGCTCTGAGAACACTGAGGGGCAGAATCTGGC
TCCTGAGGCCCGACCTCTGACAAAAGTTTGGAGTTAAatcatgaagagtcttctcacgttcagcttcctaaag
cagggtggagtggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaactaaagatgctatatttccttaattacaat
aacattaactttattttgataacaatcatgaatctgaaagatctgtaaatcaattagatctctgtatttgtaatagatttgaataattcactggct
ttaacctgcaatgtttcactgacgcttggaaaccatgacaacataaactccccatgatggccattttgttttggttcctgccgcttcaagttat
aaccttttaatcatgttatagtgtttagtaatatttaagtttcaaataatggtcaaaggttctgagactagtttttggacagtgagattcggtcaa
gcttgaatacaataatcgttaaattgtgtgttttttcttaaataatattatttgaattgcatcgctacataggctaccacgatcgagctaggcag
ctttggccttaatccttttgttggactattttctttgttctttggggaattttatcatagatactttgtttattctgtcaataaagtacatcaaaattgaa
aaaaaaaaaaaaaaaa 
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16.60.3 
 
GTCGCTCCAGTACGTCAGGCCTTCACCACCAAACAGAGATGGGATGGGGACAGAGCTCAG
AATGAACGGTATAAGCACTACCACACCAAGGAGTGTGTTGATTGGCTGAAGAAGCTCCTGG
CCTATGGGAAGAGCACTCTGCTGAGAACAGAGCGTCCGCGGGTGTCTCTGCTCCAGAGGA
GCCCCTCCTCCCCAGTGGTGTGCCATGCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGT
TCTGGAGGAGAGACAGTCAGGAGCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCC
AACCACGACGGGACCTTCCAGGTCAGCGTGGACCTCAACCTCAAGGCCGTCCCACAGGA
GGACTGGAGGAGGTACCAGTGTGTGGTCCAGCTGAGAGGCATCGAGGACATCTCCACCC
CCCTGGACCCCGCCCTCATCAGGACCAACGGGGGCAAGAGTGGCATCACCGTCCCCATC
ATCATTGGGTTCGTTGTTCTCCTCCTCGCTGCTGCTGCTGCTGCTGTTGGAGTCCATCTGT
ACAAGAAGAGGAACGATTCACACAAGCAGCACAAACCAGTTGGTTCTTCTGACACCAGCTC
TGAGACCACTGAGGGGCAGAATCTGTCTCCTGAGGCCCGACCTCTGACAGAAGTTCGAAG
TTAAatcatgaagagtcttctcacgttcagcttcctaaagcagggtggagtggatcgcagttcatttataatccttacaaacaggcttgg
gacttcagctaactaaagatgctacatttgctaaattacaataacatccatacttaactttattttgataacaatcaggaatctgaaagatct
gtaaatcaatgagatctctgtatttgtaatagatttgattaattctctggctttaacctgcaatgtttcactgacgcttggaaaccatgacgac
acaaactcgccatgatggccattttgttttggttcctgccgcttcaagttataacctttgaatcatgttatagtgtttagtaatatttaagtttcaa
ataatggtcaaaggttctgagactagtttttggacagtgagatccggtcaagtttgaatacaataatcgttaaattgtatgttttttcttaaata
atattatttgaattgcatcgctacataggctaccacgatcaagctaggcagctttagccttaatccttttgttgtactattttctttgttctttgggg
aatttgatcatagatactttggttattctgtcaataaagtacatccaaattgaaaaaaaaaaaaaaaaaa 
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Figure 3.4:  Sequences found in the reverse complement orientation.  Sequences 
are shown with ORFs in uppercase letters. A)  Clone A16; B) Clone 1.2; C)  
Clone 16.14;  D)  Clone 16.16;  E)  Clone 16.26; F) Clone 17.3 
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A16
 ggcacgaggagtatctacgataaaattccccaaagaacaaagaaaatagtacaacaaaaggattaaggcaaaagctg
cctagcttgatcgtggtagcctatgtagcgatgcaattcaaataatattattaagaaaaaacatacaatttaacgattattgtattcaaactt
gaccgaatcccactgtccaaaaactagtctcagaacctttgaccattatttgaaacttaaatattactaaacactataacatgattcaaag
gttataacttgaagcggcaggaaccaaaacaaaatggccatcatggcgagtttgtgttgtcatggtttcaaagcgtcagtgaaacattg
caggttaaagccagtgaattaatcaaatctattacaaatacagagatctcattgatttacagatctttcagattcatgattgttatcaaaaca
aagttaagtatggatgttattgtaatttagcaaatatagcatctttagttagctgaagtcccaagcctgtttgtaaggattataaatgaactgc
gatccactccaccctgctttaggaagctgaacgtgagaagactcttcatgatTTAACTTTGAACTTCTGTCAGAGGTC
GGGCCTCAGGAGCCAAATTCTGCCCCTAAGTGTTCTCAGAGCTGGTGTCAGAAGAACCAA
CTGGTTTGTGCTGCTTGTGTGAATCGTTCCACTTCTTGTACAGAAGGACTCCAACAGCAGC
AGCGAGGAGGAGAACAACGAACCCAATGATGATGGGGACGGTGATGCCACTCTTGCCCC
CGTTGGTCCTGATGAGGGCGGGGTCCAGGGGGGTGGAGATGTCCTCGATGCCTCTCAGC
TGGACCACACACTCGTACCTCCCCCAGTCCTCCTGTGGGACGGCCTTGAGGTTGAGGTCC
ACGCTGACCTGGAAGGTCCCGTCGTGGTTGGGGAGGACCTCCCCGTGGTCCACCTGCTC
CTGGAGATCCTGACCGTCTCTCCTCCAGAACACCACCACCCTGTCAGGGAAGAAGCCTGT
AGCATGGCACACCACTGGGGAGGAGGGGCTCCTCTGGAGCAGAGACACCCGCGGACGCT
CTGTTCTCAGCAGAGTGCTCTTCCCATAGGCCAGGTACTTCTTCAGCCAATCAACACACTC
CTTGGTGTAGTAGTTCTTATTGTATTGTAGATCAGCTTTATTCTGATCCCATCTCTGTTTGGT
GGTGAAGGCCTGACGTACTGGAGCGACCCAGGTCAGGGTCTTCAGGTCCAACGATATGAA
GTCCTCTCCATCATAACCAAACTGGTCATAACCTTCAGTAGAATTATCCTCATCATCCCACT
CACAACCATACATCCTCTGAACCATGTGGGCACCTCCTGTCTGGTTAAAGCGCTGCTTGGC
AATCCCAATGTTGCCTTTGAAGGTCTGCTGGGCACCCAGAAAGCTTCCAGTTTCCCTCTTC
AGGTAGTCGGGGTCACCTCTGGTGACCTGCTCCATCCAGGCCTGTTTGAGGACTACTCTC
TGGGTGTTGCTGTCATAGTAGTCAAACTGAACTCCATCCACCATCCCAACAACAACAAACT
CTGGGAAGGTTGAGAGTCCAGACGACGCCGTGTAGAAATAATGGAGAGAGTGAAGCAGTG
AGGACACACCGTGACCAAAGACCAACAGCAGCAGCAGCCCTATTAGCGCCTTCATatcgatgt
attcagaagaacagctcgatgagattatccacagagacggg 
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1.2 
ggcacgagggtactttattgacagaataaccaaagtatctatgatcaaattccccaaagaacaaagaaaatagtccaacaaaagga
ttaaggctaaagctgcctagctcgatcgtggtagcctatgtagcgatgcaattcaaataatattattaaagaaaaaacatacaatttaac
gattattgtattcaaacttgaccgaatctcactgtccaaaaactagtctcagaacctttgaccattatttgaaacttaaatattactaaacact
ataacatgattcaaaggttataacttgaagcggcaggaaccaaaacaaaatggccatcatggggagtttgtgttgtcatggtttccaag
cgtcagtgaaacattgcaggttaaagccagtgaattaatcaaatctattacaaatacagagatctaattgatttacagatctttcagagtc
atgattgttatcaaaataaagttatgtatggatgttattgtaatttagcaaatgtagcatctttagttagctgaagtcccaagcctgtttgtaag
gattataaatgaactgcgatccactccaccctgctttaggaagctgaacgtgagaagactcttcatgatTTAACTTTGAACTTT
TGTCAGAGGTCGGGCCTCAGGAGACAGATTCTGCCCCTCAGTGTTCTCAGAGCTGGTGTC
AGAAGAACCAACTGGTTTGTGCTGCTTGTGTGAATCGTTCCTCTTCTTGGACAGAAGGACT
CCAACAGCAGCAGCAGCAGCAGCGAGGAGGAGAACAACGAACCCAATGATGATGGGGAC
GGTGATGCCACTCTTGCCCCAGTTTTTCCTGATGAGGGCGGGGTCCAGGGGGGTGGAGA
TGCCCGCGATGCCTCTCAGCTGGACCACACACTCGTACCTCCTCCAGTCCTCCTGTGGGA
CGGCCTTGAGGTTGAGGTCCACGCTGACCTGGAAGGTCCCGTCGTGGTTGGGGAGGACC
TCCCCGTGGTCCACCTGCTCCTGGAGATCCTGACCGTCTCTCCTCCAGAACACCACCACC
CTGTCAGGGAAGAAGCCTGTAGCATGGCACACCACTGGGGAGGAGGGGCTCCTCTGGAG
CAGAGACACCCGCGGACGCTCTGTTCTCAGCAGAGTGCTCTTCCCATAGGCCAGGTACTT
CTTCAGCCAATCAACACACTCCTTGGTGTAGTAGTTCTTAGTGTATTGTAGAATAGCTTTAT
CCTGATTCAATCTCTGTTTGGTGGTGAAGGCCTGACGTACTGGAGCGACCCAGGTCAGGG
TCTTCAGGTCCAACGATAGGAAGTCCTCTCCATCATAACCATACTGGTGATAACCATCAGTA
GAATCATCCTCATCATCCCACTCACAACCATACATGTTCTGATATAAGTGGGTACCTCCTGT
CTGGTTAAAGCGCTGCTTGGCAATCCCAATGTTGGCTTTGAAGGTCTGCTGGTCACCCTGA
GCCCTTCCAGTGTCCCTCTCGAGTTCACCCGGATGATCTCTGTAGATCTGGTCCGCCGCG
TCATGTTTGGGTACGGCCCTCTTACTGTTGCTGTCATAGTGAACCATCTGAACTCCATCCA
CCATCCCCACAACAACAAACTCTGGGAAGGTTGAGAGTCCAGACGACGCCGTGTAGAAAT
ACTGCATAGAGTGAAGCACTGAGGACACACCGTGACCAAAGACCAACAGCAGCAGCAGCC
CTATTAGCGCCTTCATatcgatgtattcagaagaacagctcgatgagattatccacagagacgggactcccttcaacggct
cagtcttcgccgaactccagaggaaactcctgagatgtccctgctcacagagaaaagagagagagtcagagagaggagggggg
agagagatagatggagaaagaaaaggaaagagagacacacatgatgagtgaagagacgaagagaggatcacttgagggtca
gaacaagtcggggagagtggtgattgcagcagcattactcactagctagtgactagtattgaatgcgcttatcagtctcgttgcgtatac
agggactgacacgacgatgcttctctccacattgtgagcgattcacgactgatcttgtcgagcgtcaattttgacgcaatgcagatgcac
cccatatgctgcaacacctttgctggtgatcgagtggttggagtggactctgaggtccttgcaggcccaggactgcatatgtgccaagat
gccagtgtctctcattcatgcacacatgcatgtctgagacacgcacggatctgtgtattcaaaattgtataatagaatatgaattatttttgtc
gtactgaagccactttgtacccaatcatgataacagattatggtatgtgatcaaaaggcctttcgttttttatttcttcttggtggctgccaattg
cggatgttcccatcaaagaagcaaacctgtgaatggtttcggtcactggaaaaatctacaggattatgtcgtcaacagcagattagattt
attttcatgttgggcatatctggcagtgtagatagtagcgtttaacttattcagagttgtcttattttgtcggtttttttaactgtgatacatataattt
agctgaaggtctaacttgaaactagcttatttagatccccaatgtatccatagtgtaaatataccagaggattaaaaattgtttactgagg
aataaacgttgttaattattattttattaagactcattttagaagcagtgcagcaaattatttgaacattcatcattccacgctcaatatgcactt
actcaaaatacttggttcgacatttaatctgtctgctttttattgatgaggttagaaaatcctcccaaatagattctgcaactccaaaaaata
ggcagttggtaactcacaacttttagacaattaagaaaggccccatgatgtacatgtctattgtccccattaggaattccatgatgtgttat
gttttatttttatttggtatatgtgttttagtcctgtcatattgtattaacctaatgtggaattgcaattccttgttattcacatgtcatggtcatgcaca
ataaaacaatgtgccctcaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa 
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16.14
 ggcacgaggtattttattgacagaataacccaagtatactatccaattcccaaaagaacacagaaaatacaacaaagag
cactaaggctaaagcagcctagcacgattgtggtagcctatgttgtagcaatgcaatgctctagctagcagaacgctcaaataatatat
ttgaatgaaacacattaaattaatcgattattgtattgaaacttgaccgaatctcactttccaaaatcttgattcagaatttttgaacattatttg
aaacttaaatattacttaacaatataacataattaaaaggtttcaacgtgaagcggcggggcccaaatggccatcatggcgacgtcgt
gttgctatggtttccaagcgtcagtgaaagattgcaggtttaagccctcgagttattcaaatctatcacaaatagagagatgtaattgattg
acacttctaacagattgatgattgttatcacaataaagtcaagtttgaaaattgtaatttagcaaatgcagactctgcagttagctgaagtc
ccaagcctgattgtaaggattataaatgaacagcgatccactccatcctggtttaggaagccgaacgtgagaagcctcttcatgatTT
ATGCGGTCAGAGGTTGGTACTCAGCAGACAGCTTCTGCCCCTCAGTGTTCTCAGAACGCA
TGTCAGAACCGTTCCTCTTCTGGTACAGAAAGACTCCAACAACAGCAGCAACAACAACAAC
AGCAACACCAGTGAGGATGAAAGCAAGGATGAGACTCTTGTCCCCCCCGTTGGTCCTGAT
GTGGGCGGGGTCCAGGAGGATGGAGATGTCCTCGATGCCTTTCAGCTGGACCACACACT
CGTACCTCCCCCAGTCCTCCTGTGGGACGGCCTTTAGGTTCAGGTCCACGCTGACCTGGA
AGGTCCCGTCGTGGTTGGGGAGGACCTCCCCGTGGTCCACCTGCTCCTCGAGCTCCTGG
CCGTCTCTCCTCCAGAACACCACCACCCTTTTAGGGAAGAAGCCTGTAGCATGGCACACC
ACTGGGGAGGAGGGGCTCCTCTGGAGCAGAGACACCCGCGGACGCTCTGTTCTCTGCAG
AGTGCTCTTCCCGTAGCTCAGGTACTTCTTCAGCCAATCAACACACTCCTTGGTGTATAAGT
TCTTCAAGTGTTGTTTATAAGCTGTATTCTGATCCAATCTCAGTTTGGTGGTGAGAGCCTGA
TGTACTGGAGCGACCCAGGTCAGGGTCTTCAGGTCCAACGATATGAAGTCCTCTCCATCAT
AACC 
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16.16
 ggcacgaggatatatattaattatattatatgatggccaaatgatactactgcatagacgcatagggtgtaggtacctagtcc
acagaggcctttgctttatattgcgtacacctctccaaaggttgaacaatgcctaacggcaactgacggcctacccgcgtcttacctgct
atgacagacgagttgaccaagtttgcacatcttttaatttgtactacacatcttagagatcccagacttcacttagtttgcgacgcttggtag
agacccgacgtgcctacagcagcttaccatcagctgctctccgacccagaagggcaatataggctttagtgtgcattgcatggtaccat
gcactgctacaatgtgcttgatactacttaggccacggatatcccatcctcagggattttagatccgcaacatcttatgtatttgaagtgatt
attaggcgtacaatagtgttggcatacaatagaggttgagtatgcttgtagaaaaagtttgaagaaatactttgatgcaatgattgtatttg
aattgttatataagattcgactgagtaagttcctcagaatatttgtacttttcgaagaacaatttcttttgaattaaaatagatatttgaaaaaa
aaaaaaaaagttttcgtaaacaccttctttattcgtttcggtagcaaaagcgccagcttgacgttcatgaggtcctggtactcgcggatctg
gcgggccatgtcctgcttggctctctgcagggcatcctccaggtccttgatgcgggacttggcgtcgcgcacggccatctcgccgcgct
cctccgcctcggcgatctgggcctccaggtttccacgctgtcctttgaatccgtcgatctcggccgtcagcctctggatcatgcggttgag
gtcagcgatctcggtcttggtggacctcaggtcgtctccgtaccgggtggccgacgtctgcatctcctcgtacttggacttgtaccaggtct
cggcctcagcgcggctgcggttggcgatgtcctcgtactgggcgcgcacctccgccacgatggagtccatgtccagggtgcggctgtt
gtccatctccacgatgaccgacgtgtccttgatctggctctggagctcacgcagctcctcttcatagatctgcctgaggaagttgatctcgt
cggtcagactctccagcttggcctccagctcaaccttgttcatgtaggcctcgtccacgtccttcttgatgagcacaaagtcgagaataa
ccaaagtatctatgatcaaattccccaaagaacaaagaaaatagtccaacaaaggattaaggctaaagctgcctagctcgatcgtg
gtagcctatgtagcgatgcaattcaaataatatttcttaagaaaaaacacacaatttaacgattattgtattcaaacttgaccgaatctcac
tgtcaaaactagtctcagacttgaccattattgaactaatatactacactatacatgattcaaggtatactgaagcggcaggaaccaaa
accaaaaaaaaagatctatgtatagtccggccatcatgtcgagtttgtgtcgtcatggtttccaagcgtcagtgaaacattgcaggttaa
agccagtgaattaatcaaatctattacaaatacagagatctaattgatttacagatctttcagattcatgactgttatcaaaataaagttaa
gtatggatgttattgtaattaagcaaatatagcatctttagttagctgaagtcccaagcctgtttgtaaggattataaatgaactgcgatcca
ctccaccctgctttaggaagctgaacgtgagaagactcttcatgatTTAACTTTGAACTTCTGTCAGAGGTCGGGC
CTCAGGAGACAGATTCTGCCCCTCAGTGTTCTCAGAGCTGGTGTCAGAAGAACCAACTGG
TTTGTGCTGCTTGTGTGAATCGTTCCTCTTCTTGTAGAGAAGGACTCCAACAGCAGCAGCA
GCAGCAGCGAGGAGGAGAACAACGAACCCAATGATGATGGGGACGGTGATGCCACTCTT
GCCCCCGTTGGTCCTGATGAGGGCGGGGTCCAGGGGGGTGGAGATGTCCTCGATGCCTC
TCAGCTGGACCACACACTCGTACCTCCTCCAGTCCTCCTGTGGGACGGCCTTGAGGTTGA
GGTCCACGCTGACCTGGAAGGTCCCGTCGTGGTTGGGGAGGACCTCCCCGTGGTCCACC
TGCTCCTGGAGATCCTGACCGTCTCTCCTCCAGAACACCACCACCCTGTCAGGGAAGAAG
CCTGTAGCATGGCACACCACTGGGGAGGAGGGGCTCCTCTGGAGCAGAGACACCCGCGG
ACGCTCTGTTCTCAGCAGAGTGCTCTTCCCATAGGCCAGGTACTTCTTCAGCCAATCAACA
CACTCCTTGGTGATGTAGTGCTTCAG 
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16.26
 tggatccaaagtattgacagaataaccaaagtatctatgatcaaattccccaaagaacaaagaaaatagtccaacaaaa
ggattaaggctaaagctgcctagctcgatcgtggtagcctatgtagcgatgcaattcaaataatattattaaagaaaaaacacacaattt
aacgattattgtattcaaacttcaccggatctcactgtccaaaaactagtctcagaacctttgaccattatttgaaacttaaatattactaaa
cactataacatgattcaaaggttataacttgaagcggcaggaaccaaaacaaaatggccatcatggcgagtttgtgtcgtcatggtttc
caagcgtcagtgaaacattgcaggttaaagccagagaattaatcaaatctattacaaatacagagatctcattgatttacagatctttca
gattcatgattgttatcaaaataaagttaagtattgatgttattgtaatttagcaaatatagcatctttagttagctgaagtcccaagcctgtttg
taaggattataaatgaactgcgatcccctccaccctgctttaggaagctgaacgtgagaagactcttcatgatttaactttgaacccctca
gtgttctcagagctggtgtcagaagaacctgggaagtagcagaatgggaggaggtgaagtcatgagctagatgtatctagatctatag
agctgtatagtccagtgagctagatgtaCTAAGCGTTCCTCTTCTTGTACAGAAGGACTCCAACAGCAGC
AGCAGCAGCAGCAGCGAGGGGGAGAACAACGAACCCAATGATGATGGGGACGGTGCTGC
CACTCTTGCCCCCGTTGGTCCTGATGAGGGCGGGGTCCAGGGGGGTGGAGATGTCCTCG
ATGCCTCTCAGCTGGACCACACACTCGTACCTCCTCCAGTCCTCCTGTGGGACGGTCTTG
AGGTTGAGGTCCACGCTGACCTGGAAGGTCCCGTCGTGGTTGGGGAGGACCTCCCCGTG
GTCCACCTGCTCCTGGAGCTCCTGACCGTCTCTCCTCCAGAACACCACCACCCTGTCAGG
GAAGAAGCCTGTAGCATGGCACACCACTGGGGAGGAGGGGCTCCTCTGGAGCAGAGACA
CCCGCGGACGCTCTGTTCTCAGCAGAGTGCTCTTCCCATAGGCCAGGTACTTCTTCAGCC
AATCAACACACTCCTTGGTGTAGTAGTGCTTATCGTATTGTAGATCAGCTTTATCCTGATTC
CATCTCTGTTTGGTGGTGAAGGCCTGACGTACTGGAGCGACCCAGGTCAGGGTCTTCAGG
TCAAACGATAGGAAGTCCTCTCCATCATAACCATACTGGTCATAACCATCAGTAGAATCATC
CTCATCATCCCACTCACAACCATACATGTTCTGATATAAGTGGGTACCTCCTGTCTGGTTAA
AGCGCTGCTTCAGATTCCCAATGTCGGCTTTGAAGGTCTGCTGGTCACCCTGAGAGATTGC
AGTGTTCCTCTCCAGGTAGGCGGGgagaaggccgaacggaaggtcgaccgaccgacgccaaagcgcagcac
gcgtccgctggtgaaggtgcccggctggaagttcaacgtcatgttgtagaacatgttcgccaccgccggagccggcgcctggttcgtg
aactgtgccgtcacgttgctggcgaccaggccgacgctggccgggccgaacgtgaagggcaggcctgcggtgcgcacgtcgaag
accagacccggcgtgctgggcacgacgacgttgccgccgcccggattgcccgtcgctgcattgaacgtgatgctggtgatgtagctg
gggccgttgtaggacaccgtgaaggcattggggtcggtgcgaccggtgacggagttgtcgcccaccagggtcaccgcaaccttgcc
gcggttgggcagtgcctgcgccaccgacgacgagctgtacgggtccaggtcgttcgggtaggtgctgttctccaggatggtgcgcattt
gcgccggtgtcaccgaaagtac 
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17.3 
 
ccaagtatatttgatccaattccccaaagaacacagaaaatacaacaaagagcattacggctaaagcagcctagctcgagtgtggta
gccaacgtagcaatgcaatgctctagctagcagaactctaaaataatacatttgaaggaaacacattcaatttaacgaatattgtattca
aacttgacaaaatctcattgtccaaaattttaattcggaatctttaaacattatttaaaatgtaagtattactaaacaatataacataattaaa
aggttatagcatgaagcggtgggaaccaaaacaaaatggtttccaagcatcagcgaaagattggatgtttaagccagtgagttaatc
aaacagaacacaaatacagcgttttaatttactgacacttttctcacggattgatggttgctatcaaggcaaaataaagttaagtatgaat
gttattgtaattgagcaaatgcagactctgcagttagcccaggtcccaagcttgattgtaaggattataaatgaacagcgatccgctcca
ccctggtggaggaagatgaacgtgcgaagcctcttcaatTTAACTTTGACCTGTGGTCAGAGGTTGGGCCTC
CGGATCCTGCACCTCAGTGTTCTCAAAGCTGGTGTCAGAAGAACCAAGTGGTTTGTGACG
CTTATCTGAATCGTCCCTCTTGCAGTATACCAAGACTCCAGCAGTAGCAACAACACCAACA
ACAGCAACACCAGCGAGGATACCAGCAACAATACTGTGGGGGGGGACGTGCGACGTCTG
AGCCCCGTTGGTCCTGATGAGGGCGGGGTCCAGGGGGGTGGAGATGTCCTCGATGCCTC
TCAGCTCGACCACACACTCGTACCTCCCCCAGTCCTCCTGTGGGACGGCCATGAGGTTGA
GGTCCACGCTGACCTGGAAGGTCCCGTCGTGGTTGGGGAGGACCTCCCCGTGGTCCACC
TGCTCCTGGAGAACCTGACCGTCTCTCCTCCAGAACACCACCACCCTGTCAGTGTAGAAG
CCTGTAGCATGGCACACCACTGGGGAGGAGGGGCTCCTCTGGAGCAGAGACACCCGCGG
ACGGTCTGCCTGCAGAGTGCTCTTCCCATTGGCCAGTAGCTTCTTCAGCCAATCAACCTCC
TTGGTGTAGTAGTCCTTCTTCCTTTGTAAATCAGCTCCATCCTGATCCCATCTCTGTTTGGT
GGAGAAAGCCTGACGTACTGGAGCGACCCAGGTCTTGGTCTTCAGGTCCAACGATAGGAA
GTCCTCTCCATCATAACCATGCCGCTCAAAACCATCAGTAGAATCATCCTCATCATCCAAAT
CACAACCAAACGTCTCCTGATATACATGGACACGTTGTTTGTGGTTAAAGCTCTTCTTGGCA
TTCCCAAGGTTGGCTATGGAGCTCTGCTGGGCAACCAGAAAGCTTCTAGTTGTCGTCACCA
CGTAGGCCGGGTCATCTCTGGTGAACTTCTCCATCCAGTCCGGTTTGAGGAATATTCTCTG
GGTGTTGCTGTCGTAGTACTCAAACTGAACTCCATCCACCATCCCCACAGCAACAAACTCT
GGGAAGGTTGAGAGTCCAGACGACGCCGTGTAGAAATACTGCAGAGAGTGAGGCACTGA
GGACACACCGTGACAAAAGACCAACAGCAGCAACCCTATTAGCGCCTTCATatcgatgtattccga
ggaacaactcgatgagattatccacagagacgtataggctactccgactccaggacgacgcccaaatggttgaatggacagatgcc
gagcggaggcacatcgagacgatctggggcaagatcgacattgatgtctgcggaccactcgcgttgcagagatgcctgattgtgtatc
cgtggacgcagcgctacttcggtagctttggcgacctgagcaccgacgccgctatcgtgggaaaccccaaggtggccaagcacgg
cgtcgtggccctgaccggactgaagacggctctggaccacatggacgacatcaaggccacctacgctgccctgagcgtgctgcact
ccgagaaactgcacgtcgaccccgacaacttccgactgctgtgtgactgcctgacgattgtcgtcgccgggaagatggggaagaga
ctgagccccgagatgcaggctgcgtggcagaagtacctctccgcggtggtttccgccctggggagacagtaccactagaagatgtgt
gttgacgctagcgggggacaacagcaagctacaacttcagtgacaaacccgaaatggatgttttcatctgtcaataaaactattgttta
acagtcaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaa 
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sequence at either their 5’ or 3’ ends.  Additionally, only six sequences, Clones 1.2, 
16.12, 16.13, 16.22 and 16.60.3 had Xho I sites preceding the 3’ vector sequence.  
Therefore, only these six sequences were confirmed to be in the correct orientation.  
Further investigation is needed to confirm that the remaining sequences were indeed 
directionally cloned. 
Of the six clones which aligned in the reverse complement orientation, only two 
sequences had poly-A tails at the 3’ end in the sense orientation.  The structure of one 
of the clones, Clone 1.2, mimicked the structure of Haddock UA pBK-CMV-3 in that it 
appeared to have an inverted open reading frame.  The 5’ end of the sequence shows 
significant similarity with the antisense 3’UTR of Haddock UA pBK-CMV-4.  The 3’ end, 
however, was extremely long and did not align with any other sequences.  It includes a 
polyadenylation signal and poly-A tail in the sense orientation.  Clone 17.3 was the 
other sequence with a sense orientation poly-A tail.  This sequence, however, appeared 
to be linked to the sequence of another gene and will be discussed in the following 
section. 
3.2.2. Linked Sequences 
Five sequences contained portions, either at the 5’ or 3’ ends, which did not align with 
any of the other alleles.  In four of these cases the MH Class I sequence appeared to be 
joined to the sequence of another gene.  A diagram illustrating the sequence structure is 
shown in Figure 3.5.   
Clone C7 is 2416 base pairs (bp) in length.  The first 226bp of sequence did not align 
with any other sequence.  The sequence from 227 to 641bp aligned in the antisense 
orientation with a heat shock protein (HSP) 70 from several fish species including 
Ctenopharyngodon idella (grass carp) and Hypophthalmichthys molitrix (silver carp).  
This stretch of sequences does not include the entire HSP 70 sequence, however.  The 
last of the sequence, from 632bp to 2416bp, aligned in the sense orientation with 
Haddock UA pBK-CMV-4and includes the complete 5’ and 3’ UTRs with the entire ORF.   
  
62 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5:  Diagram illustrating the structure of “linked” sequences.  A)  C7; B) 
16.16, C) 16.22; D) 16.26; E) 17.3 
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Antisense Partial MH Class I Allele Unknown Sequence 
#
1 
#
1557 
#
2052 
D) 16.26 
Unknown Sequence Sense MH Class I Allele Antisense Partial HSP 70 
#
1 
#
227 
#
642 
#
2416 
A) C7 
Antisense L19 Ribosomal Protein Sense Partial MH Class I Allele 
#
1 
#
682 
#
1849 
C) 16.22 
Unknown Sequence with PolyA Tail Antisense Partial MH Class I Allele Antisense Partial Keratin 
#
1 
#
675 
#
1241 
#
2456 
B) 16.16 
Antisense MH Class I Allele Sense Hemoglobin Beta 1 Antisense Joining Sequence 
#
1 
#
1803 
#
2447 
#
1789 
E) 17.3 
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Like Clone C7, Clone 16.16 was comprised of three segments of sequence.  The first 
674pb of the sequence did not show any significant similarity to any other sequences.  
This portion of the sequence, however, had a polyadenylation signal and poly-A tail.   
The next segment of Clone 16.16 was from 675bp to 1241pb.  This segment aligned in 
the antisense orientation with keratin sequences from several fish species including  
Oncorhynchus mykiss (rainbow trout), Gasterosteus aculeatus (stickleback), and 
Ctenopharyngodon idella (grass carp).  Once again, this keratin sequence was only a 
partial sequence.  The final segment was from 1242bp to 2456bp.  This segment 
aligned with Haddock UA pBK-CMV-4 in the antisense orientation.  Unlike Clone C7, 
though, this segment did not contain an entire ORF.  Roughly 500bp of the 5’ ORF were 
missing.  
Clone 16.22 was divided into two sections.  The 5’ section contained a sequence which 
showed significant alignment in the antisense orientation with the ribosomal protein L19 
of several fish species, including Solea senegalensis (sole), Oncorhynchus masou 
(cherry salmon), and Salmo salar (Atlantic salmon).  The 3’ section contained a partial 
sequence for an MH Class I allele.  The first roughly 575 bp of ORF was missing.  This 
sequence aligned with Haddock UA pBK-CMV-4 in the sense orientation.   
Unlike the other clones with “linked” sequences, the non-aligning portion of Clone 16.26 
did not show any significant similarity to other gene sequences.  The 5’ portion of the 
sequence was an MH Class I allele that aligned in the antisense orientation with 
Haddock UA pBK-CMV-4.  Again, the first roughly 220bp of the ORF were missing.  The 
3’ portion of the sequence was roughly 465bp in length.   
Clone 17.3 was divided into two sections.  The 5’ section contained a complete ORF 
and both the 5’ and 3’ UTR of an MH Class I allele, which aligned with Haddock UA 
pBK-CMV-4 in the antisense orientation.  A short sequence of 14bp linked this portion of 
the sequence with the sequence at the 3’ end.  In the antisense orientation this 
sequence is very similar to the sequence that linked the two gene segments seen in 
Haddock UA pBK-CMV-1.  The 3’ portion of the sequence contained a sequence highly 
similar to the hemoglobin beta 1 chain from Gadus morhua (cod) in the sense 
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orientation. Partial coding sequences of beta 1 globin from Boreogadus saida (polar 
cod) and Arctogadus glacialis (artic cod) also showed similarity to the 3’ end in the 
sense orientation.   
It is interesting to note that for Clones 16.22 and 17.3 the sequences are comprised of 
transcripts in both the sense and antisense orientations.  Because of this, both strands 
of the cDNA would contain a poly-A tail.  Since the poly-A tail was used to establish 
directional cloning the exact orientation of these sequences would still be in question. 
3.2.3. Sequence Alignments and Phylogenetic Tree 
All Haddock MH Class I alleles, including those previously isolated and sequenced, 
were aligned with each other.  To compare the alleles themselves non-MH Class I 
sequences were removed and the orientation of any antisense sequences was 
reversed.  The DNA sequence alignment is shown in Figure 3.6.   From this alignment it 
was seen that there were clusters of highly variable sequences.  These were at base 
pairs #240 – 365, #398 – 410, and #531 – 594.  Within the ORF there were two sites 
where certain alleles had large insert sequences.  At bp #969 allele Haddock UA pBK-
CMV-4 had a 30bp insert and allele 17.3 had a 21bp insert.  At bp #1137 both alleles A9 
and 16.11 had a 27bp insert.  Finally, allele 16.26 had a stop codon at position # 1110 
followed by a 93bp insert.  Allele 16.14 had a 30bp deletion which flanked the insert at 
bp #1137.  Additionally, 3 and six nucleotide deletions and additions were noted 
throughout the ORF.  These are summarized in Table 3.1.    
An alignment of the protein sequences was also generated using only the ORFs, and is 
shown in Figure 3.7.  Included in this alignment were alleles from cod identified by 
Perrsons et al,1999 and Miller et al, 2002, and randomly selected rainbow trout MH 
Class I.  As expected the haddock and cod alleles show significant similarity whereas 
the rainbow trout alleles show a very minimal number of conserved residues.  There 
were several small groups of residues conserved between the species.  These were at 
amino acid positions #104 – 108, #119 – 121, #136 – 141, #187 – 190, #214 – 224, #255 – 
259 and #279 – 282.  A potential glycosylation site (NXT/S) is present at position #106, 
which likely accounts for the conservation of residues in this area.  The regions #136 –  
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Figure 3.6:  DNA sequence alignment of MH Class I sequences from isolated 
clones. 
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                    10        20        30        40        50        60            
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  tggagtcggagtcccgtctctgtggataatctcatcgagctgttcttctgaatacatcga  
pBK-CMV-3  cact.gtt....t.ttc...........................................  
pBK-CMV-4  ---------g..tg.....t.....................a......c..t........  
pBK-CMV-6  -------------g..............................................  
A9         cacc........t...............................................  
A16        ------------................................................  
B9         ............................................................  
C7         ccat.cgctc..................................................  
1.1        ------------------------------------------------------------  
1.2        gttgaag.....................................................  
2.4        ------------------------------------------------------------  
2.10       ------------------------------------------------------------  
16.11      ------------------------------------------------------------  
16.12      ....................................................g.......  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      -------------g.....t........t...........ct..t...c..t........  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      ------------------------------------------------------------  
16.60.3    ------------------------------------------------------------  
17.3       c.....a.cctata.........................t.....c..g...........  
 
                    70        80        90       100       110       120         
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  tATGAAGGCGCTAATAGGGCTGCTGCTGCTGTTGGTCTTTGGTCACGGTGTGTCCTCACT  
pBK-CMV-3  ..........................................................G.  
pBK-CMV-4  .........................T..---................A..........G.  
pBK-CMV-6  ..........................................................G.  
A9         ............................................................  
A16        ............................................................  
B9         ..........................................................GG  
C7         ............................................................  
1.1        ------------------------------------------------------------  
1.2        ..........................................................G.  
2.4        ------------------------------------------------------------  
2.10       ----------------------------------.............A..........G.  
16.11      ------------------------------------------------------------  
16.12      ..........................................................G.  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      ........T................T..---...T............A..........G.  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      ------------------------------------------------------------  
16.60.3    ------------------------------------------------------------  
17.3       ...................T........---.........T.................G.  
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                   130       140       150       160       170       180      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  GCTTCACTCTCTCCATTATTTCTACACGGGGTCGTCTGGACTCTCAACCTTCCCAGAGTT  
pBK-CMV-3  ..........A.G..G.T...........C..............................  
pBK-CMV-4  .A..........G..GAT..........TC...T..........................  
pBK-CMV-6  ..........A.G..G.............C................G.............  
A9         A.........A.G..G.T...........C..............................  
A16        .............................C..............................  
B9         .............................C..............................  
C7         ..........A.G..G............................................  
1.1        ------------------------------------------------------------  
1.2        ..........A.G..G.............C..............................  
2.4        ------------------------------------------------------------  
2.10       .A..........G.GGAT..........TC...T......T..................A  
16.11      ------------------------------------------------------------  
16.12      ..........A.G..G.T...........C..............................  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      .A........G.G..GGT.....C.....C........................T.....  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      ------------------------------------------------------------  
16.60.3    ------------------------------------------------------------  
17.3       ..C.........G..G.............C..............................  
 
                   190       200       210       220       230       240      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  TGTTTCTGTGGGGATGGTGGATGGAGTTCAGTTTGACTACTATGACAGCAACACCCAGAA  
pBK-CMV-3  ....G.............................A.........................  
pBK-CMV-4  ...GAGG..T.A...........AG......AC...G......................G  
pBK-CMV-6  ....GT.................A.......A.G.TTC...............GTA...G  
A9         ....GT...T.....................A.G.TTC...............GTA...G  
A16        ....GT...T.................................................G  
B9         ...............................A...........................G  
C7         ....GT...T.....................A.G.TTC.....................G  
1.1        ----------------------------------------------------------.G  
1.2        ....GT.........................A.G.TTC...............GTA...G  
2.4        ------------------------------------------------------------  
2.10       ...GA.A..TCA...........AG......A....G......................G  
16.11      ------------------------------------------------------------  
16.12      ....GT...T.....................A.GCTTC...............GTA...G  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      ...GATG..TCA...........AG......G....G......................G  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      ------------------------------------------------------------  
16.60.3    ------------------------------------------------------------  
17.3       ....G...............................G.....C................G  
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                   250       260       270       280       290       300      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  AACAGTCTTCAAACAGGACTGGATGGAGCAGGTCACCAGAGGTGAC---CCCGACTACCT  
pBK-CMV-3  ..AG...C.................................A....---....C......  
pBK-CMV-4  ..TCA.AAC.............G...TC....C..A.....ACA.AGTC...........  
pBK-CMV-6  .......C......................................---....C......  
A9         .G.C..ACC......T...GC.GC...C...C..TA.....A.C.T---..G.GTG....  
A16        .GT....C.........C............................---...........  
B9         .GT....C......................................---....C......  
C7         .......C.......A.........A....................---....C......  
1.1        .G.C..ACC......T...AC.GC...C...T..TA.....A.C.T---..G.GTG....  
1.2        GG.C..ACC......T...GC.GC...C...A..TA.....A.C.T---..G.GTG.A..  
2.4        ------------------------------------------------------------  
2.10       ..TCA.AAC.............G...TC....C..A....TACA..ATC...........  
16.11      ------------------------------------------------------------  
16.12      .G.C..ACC......T...GC.GC...C...C..TT.....A.C.T---..G.GTG....  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      ..TCA.AAC.............G....C....C..A.....ACA.AGTC...........  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      -------------------------------------------------....C......  
16.60.3    ------------------------------------------------------------  
17.3       ..T.T..C......C.............A..T.........A....---..G.C....G.  
 
                   310       320       330       340       350       360      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  GGAGAGGAACACTGGAAGTGCTCAGAATGCCCAGCAGGTCTTCAAAGTCAACATTGTGAC  
pBK-CMV-3  .......G.A.......AAT.....GG.CA.......AG....................T  
pBK-CMV-4  .......GCG....A...CAGAA..GT.AA.................G........G...  
pBK-CMV-6  .................ACTT..T.GG....................G........G..T  
A9         C...G..G........G.ATT....GC..A........C........C........G..T  
A16        .A.....G.A........CTT..T.GG..........AC........G........G..T  
B9         .......G.A.......TCAGAA..GG.AA.......T...........GG.G...GA..  
C7         .................ACTT....GG..........AC..........GG.....G...  
1.1        C......G.........ACTT..T.GG.T........AC..A.....C........G..T  
1.2        C......G..........G......GG..A.......AC........C........G..T  
2.4        ------------------------------------------------------------  
2.10       .......TCA....A..ACAGAA..GG.CAA.........GC..............G...  
16.11      ------------------------------------------------------------  
16.12      C...G..G.........ACTT..T.GG..........A.........C........G...  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      .....A.GCA....A..ACAGAA..GG..AA...............CG........G...  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      ..............C..TCT.....GG..A.......AC........C.G......G..A  
16.60.3    ------------------------------------------------------------  
17.3       ..T..C..CA...A....CTT..T.GT..........AG..C..T..C....C...G..A  
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                  370       380       390       400       410       420      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  TGCCAAGCAGCGCTTTAACCAGACAGGAGGTGCCCATATAAATCAGAGGATGTATGGTTG  
pBK-CMV-3  ............T.......................C..GGC..................  
pBK-CMV-4  CCTG................................C..TGT....T......C......  
pBK-CMV-6  ...............................A....CT..T.....T.............  
A9         ...............................A....C..GGT....T.....GT......  
A16        ....................................C..GGT..................  
B9         .CTG................................C..GGT....GTC...........  
C7         .CTG.G.........................A....CT..T.....TT............  
1.1        .CTG................................C..GTT....TTC...........  
1.2        ...............................A....CT..T......AC...........  
2.4        ----------------------------------------GT....TTC...........  
2.10       C..G................................C..TGT...........C...C..  
16.11      ------------------------------------------------------------  
16.12      .CTG................................C..GGT....TTC...........  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      CCTG................................C..TGT...........T......  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      .CTG...........................A....CT..T......AC...........  
16.60.3    ------------------------------------------------------------  
17.3       .......A..A..........C.A.CA.C...T....G..T.....GA..C..T......  
 
                   430       440       450       460       470       480      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  TGAGTGGGATGATGAGGATGATTCTACTGAAGGTTATGACCAGCATGGTTATGATGGAGA  
pBK-CMV-3  ..............................T......A......................  
pBK-CMV-4  ......................G.C.....T........G...T................  
pBK-CMV-6  .....T........................T......C.....T................  
A9         ..............................T......A......................  
A16        ...................A.......................TT...............  
B9         ............................................T...............  
C7         .....T........................T......C.....T................  
1.1        ....GT........................T......AGA...T................  
1.2        ..............................T......C.....T................  
2.4        ..............................T............T................  
2.10       ......................A.C.....T........G...T................  
16.11      ------------------------------------------------------------  
16.12      ..............................T......AGA...T................  
16.13      ------------------------------------------------------------  
16.14      ----------------------------------------------..............  
16.15      .....T................A.C.....T........G.....C..............  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      ..............................T............T................  
16.60.3    ------------------------------------------------------------  
17.3       ...T.T........................T....T...G.G..................  
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                  490       500       510       520       530       540      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  GGACTTCATATCGTTGGACCTGAAGACCCTGACCTGGGTCGCTCCAGTACGTCAGGCCTT  
pBK-CMV-3  ............................................................  
pBK-CMV-4  .......C..........................................A......T..  
pBK-CMV-6  ........................T...................................  
A9         .................................................GACG....T.G  
A16        ............................................................  
B9         .......C...................................G................  
C7         .......C....................................................  
1.1        .......C.................T..A...............................  
1.2        .......C....................................................  
2.4        ............................A...............................  
2.10       .......C..........................................A......TC.  
16.11      ----------------------------....G................GACG....T.G  
16.12      ..............G....A........A...............................  
16.13      -------------------------------------.......................  
16.14      ..................................................A......TC.  
16.15      .......C..........................................A......TC.  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      .......C.......T............................................  
16.60.3    -------------------------------------.......................  
17.3       .......C....................AA...........................T..  
 
                   550       560       570       580       590       600      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  CGCCACCAAACAGAAATGGGATCAGAATAAAGCTAGATTACAACATGATAAGAACTACTA  
pBK-CMV-3  .A.................A.....G..................................  
pBK-CMV-4  .A.........T..G......A..C....G....TATAAT...GCCA.G..C........  
pBK-CMV-6  .C...A........G.......GG.G.C.G......GAATG...GGC.....C.......  
A9         T..T.......G..G.......GG.G...GG..CC..AAT...T.CTGG..........T  
A16        .A............G...................GATC.....T.CA.............  
B9         .A............G.......GG.G.C.G....CAGAATG...GGT.....C.......  
C7         .C............G.......GG.G.C.G....TATAATG...GGC.G...C.......  
1.1        .C............G..........G........GATC.....T.CAT..........C.  
1.2        .A............G..T.A.....G.........TTC.....T.CAC............  
2.4        .A............G....A.......................T.CA.............  
2.10       .A...T.....T..G..T......CG...C....T.GAA....T.CTTG.......T...  
16.11      T..T.......G..G.......GG.G...GG..CC..AAT...T.CTGG..........T  
16.12      .A............G....A..............G.TC.....T.CAGG.........AT  
16.13      .A............G.......GG.G.C.G....CAGAATG...GGT.....C.....C.  
16.14      .A.........T..G..T...........C....TATAA......CTTG.......TA..  
16.15      .A.........T..G.........CG...C...CC.GAA....T.CTTG.......T...  
16.16      ----------------------------------------------CTG...C.....AT  
16.22      ------------------------------------------------------------  
16.26      .A............G....A.....G........GATC.....T.C......C.......  
16.60.3    .A............G.......GG.G.C.G....CAGAATG...GGT.....C.....C.  
17.3       .T............G..........G..GG....GAT......AGGA.G...G.......  
 
  
72 
 
                  610       620       630       640       650       660      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  CACCAAGGAGTGTGTTGATTGGCTGAAGAAGCACCTGGCCTATGGGAAGAGCACTCTGCT  
pBK-CMV-3  ...............................T.....T......................  
pBK-CMV-4  ...............................T.....AG...C................A  
pBK-CMV-6  ............................................................  
A9         ................................T....T......................  
A16        ...............................T............................  
B9         ........TC..................................................  
C7         ........TC.....................T.....T.................A....  
1.1        A..................G............T...........................  
1.2        ...............................T............................  
2.4        ........TC.....................T............................  
2.10       ...............................T.....AG...C................A  
16.11      ................................T....T......................  
16.12      ...............................T............................  
16.13      ................................T...........................  
16.14      ...............................T.....AG...C................A  
16.15      ...............................T.....AG...C................A  
16.16      ...............................T............................  
16.22      ----------------------.........T............................  
16.26      ...............................T............................  
16.60.3    ................................T...........................  
17.3       ..........---...................TA......A..................A  
 
                   670       680       690       700       710       720      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  GAGAACAGAGCGTCCGCGGGTGTCTCTGCTCCAGAGGAGCCCCTCCTCCCCAGTGGTGTG  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ................T...........................................  
pBK-CMV-6  .........T..................................................  
A9         .........T..................................................  
A16        ............................................................  
B9         .........T..................................................  
C7         ............................................................  
1.1        ................T...........................................  
1.2        ............................................................  
2.4        .........T..................................................  
2.10       ............................................................  
16.11      .........T..................................................  
16.12      .........T..................................................  
16.13      ............................................................  
16.14      ............................................................  
16.15      ............................................................  
16.16      ............................................................  
16.22      .........T..................................................  
16.26      ............................................................  
16.60.3    ............................................................  
17.3       .---G....C..................................................  
 
  
73 
 
                  730       740       750       760       770       780      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  CCATGCTACAGGCTTCTTCCCTGACAGGGTGGTGGTGCTCTGGAGGAGAGACGGTCAGGA  
pBK-CMV-3  .....................................T......................  
pBK-CMV-4  ......................A.T....G.......T................C.....  
pBK-CMV-6  .....................................T......................  
A9         .....................................T......A...............  
A16        .....................................T......................  
B9         .....................................T......................  
C7         .....................................T......................  
1.1        .....................................T......................  
1.2        .....................................T......................  
2.4        .....................................T......................  
2.10       ......................A..............T................C.....  
16.11      .....................................T......A...............  
16.12      .....................................T......................  
16.13      .....................................T..............A.......  
16.14      ......................A.A............T................C.....  
16.15      ......................A..............T................C.....  
16.16      .....................................T......................  
16.22      .....................................T......................  
16.26      .....................................T......................  
16.60.3    .....................................T..............A.......  
17.3       .................A.A.................T.....................T  
 
                   790       800       810       820       830       840      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  GCTCCAGGAGCAGGTGGACCACGGGGAGGTCCTCCCCAACCACGACGGGACCTTCCAGGT  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ............................................................  
pBK-CMV-6  ............................................................  
A9         ............................................................  
A16        T...........................................................  
B9         ............................................................  
C7         ............................................................  
1.1        T...........................................................  
1.2        T...........................................................  
2.4        ............................................................  
2.10       ...T........................................................  
16.11      ............................................................  
16.12      T...........................................................  
16.13      ............................................................  
16.14      ....G.......................................................  
16.15      ............................................................  
16.16      T...........................................................  
16.22      ............................................................  
16.26      ............................................................  
16.60.3    ............................................................  
17.3       T...........................................................  
 
74 
 
                   850       860       870       880       890       900      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  CAGCGTGGACCTCAACCTCAAGGCCGTCCCACAGGAGGACTGGAGGAGGTACGAGTGTGT  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ............G.....A.C.......................................  
pBK-CMV-6  ...........................................G................  
A9         ...........................................G................  
A16        ...........................................G................  
B9         ..............T............................G................  
C7         ...........................................G................  
1.1        ...........................................G................  
1.2        ............................................................  
2.4        ....................................................A.......  
2.10       ............G.....A.C......................G................  
16.11      ...................G.......................G................  
16.12      ....................................................C.......  
16.13      ....................................................C.......  
16.14      ............G.....A........................G................  
16.15      ............G.....A.C......................G...A............  
16.16      ............................................................  
16.22      ............................................................  
16.26      ......................A.....................................  
16.60.3    ....................................................C.......  
17.3       ....................T......................G................  
 
                   910       920       930       940       950       960      
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  GGTCCAGCTGAGAGGCATCGAGGACATCTCCACCCCCCTGGACCCCGCCCTCATCAGGAC  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ...........A..A.................T..T..............A.........  
pBK-CMV-6  ............................................................  
A9         .............................................GC.............  
A16        ............................................................  
B9         ............................................................  
C7         ............................................................  
1.1        ............................................................  
1.2        ....................C..G...................................A  
2.4        .....................................T......................  
2.10       ...........A....................T..T..............A.........  
16.11      ............................................................  
16.12      ............................................................  
16.13      ............................................................  
16.14      ...........A....................T..T..............A.........  
16.15      ...........A....................T..T..............A.........  
16.16      ............................................................  
16.22      .................................................TA.........  
16.26      ............................................................  
16.60.3    ............................................................  
17.3       ....G.......................................................  
 
  
75 
 
                  970       980       990       1000      1010      1020     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  CAACGGG------------------------------GGCAAGAGTGGCATCACCGTCCC  
pBK-CMV-3  .......------------------------------.......................  
pBK-CMV-4  .......GCTAAGACTGGTGTTGGAGGGGATGGAGGG.A.......CT....CTT.CTTT  
pBK-CMV-6  .......------------------------------.......................  
A9         .......------------------------------.......................  
A16        .......------------------------------.......................  
B9         ....A..------------------------------.............G.........  
C7         ....T..------------------------------.......................  
1.1        .......------------------------------.......................  
1.2        A...T..------------------------------.......................  
2.4        .......------------------------------.......................  
2.10       .......---------------------------GGG.A.......CT....CTT.CTTT  
16.11      .......------------------------------.......................  
16.12      .......------------------------------.......................  
16.13      .......------------------------------.......................  
16.14      .......---------------------------GGG.A.......CT....CTT.CTTT  
16.15      .......---------------------------GGG.A.......CT....CTT.CTTT  
16.16      .......------------------------------.......................  
16.22      .......------------------------------.......................  
16.26      .......------------------------------.............G.........  
16.60.3    .......------------------------------.......................  
17.3       .......GCTCAGACGTCGCACGTCCCC---------CC.C.C...---..TGTT.CTGG  
 
                   1030      1040      1050      1060      1070      1080     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  CATCATCATTGGGTTCGTTGTTCTCCTCCTCGCTGCTGCTGCT---GCTGCTGTTGGAGT  
pBK-CMV-3  ...........................................---..............  
pBK-CMV-4  ....C...C...TG.T.C....G.T------.T..T....------....T.........  
pBK-CMV-6  ...........................................---..............  
A9         ...........................................GCT..............  
A16        ..................................------------..............  
B9         ........................................------..............  
C7         ...........................................GCT..............  
1.1        ............A..............................---..............  
1.2        ...........................................GCT...---........  
2.4        ...........................................GCT...---........  
2.10       ....C...C...TG.T.C....G.TGCTG.TTT..T....------.T..T.........  
16.11      ...........................................GCT..............  
16.12      ...........................................---..............  
16.13      ...........................................---..............  
16.14      ....C...C...TG.T.C....G.T------.T..T....------....T.........  
16.15      ....C...C....G.T.C....G.T------.T..T..G.------....T.........  
16.16      ...........................................---..............  
16.22      ...........................................---..............  
16.26      ..........................C................GCT..............  
16.60.3    ...........................................---..............  
17.3       T...C..GC...TG.T.C....G.T------.G..T..T.------...A...C......  
 
76 
 
                   1090      1100      1110      1120      1130      1140     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  CCTTCTGTACAAGAAGAGGAACGATTCACACAAGCAGCACAAACCAGTTGGTTCT-----  
pBK-CMV-3  .......................................................-----  
pBK-CMV-4  .T........CG................G......GT.........C........-----  
pBK-CMV-6  ........C..............................................-----  
A9         ..................................................A...ACACAA  
A16        ................T......................................-----  
B9         .T.....................................................-----  
C7         .......................................................-----  
1.1        ........C.......T......................................-----  
1.2        ........C..............................................-----  
2.4        .......................................................-----  
2.10       .T........CG................G......GT..................-----  
16.11      ..................................................A...ACACAA  
16.12      .......................................................-----  
16.13      ..A....................................................-----  
16.14      .T........C............G...TG...T..GT-----------------------  
16.15      .T........TG................G......GT.........C........-----  
16.16      ......C................................................-----  
16.22      ........C..............................................-----  
16.26      .......................C..AGt...tct...t..ctgg.c.atacagctctat  
16.60.3    ..A....................................................-----  
17.3       .T.GG.A...TGC......G........G.T....GT.........C........-----  
 
                   1150      1160      1170      1180      1190      1200     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  ------------------------------------------------------------  
pBK-CMV-3  ------------------------------------------------------------  
pBK-CMV-4  ------------------------------------------------------------  
pBK-CMV-6  ------------------------------------------------------------  
A9         GCGACCCATATCAGTTGGTTCT--------------------------------------  
A16        ------------------------------------------------------------  
B9         ------------------------------------------------------------  
C7         ------------------------------------------------------------  
1.1        ------------------------------------------------------------  
1.2        ------------------------------------------------------------  
2.4        ------------------------------------------------------------  
2.10       ------------------------------------------------------------  
16.11      GCGACCCATATCAGTTGGTTCT--------------------------------------  
16.12      ------------------------------------------------------------  
16.13      ------------------------------------------------------------  
16.14      ------------------------------------------------------------  
16.15      ------------------------------------------------------------  
16.16      ------------------------------------------------------------  
16.22      ------------------------------------------------------------  
16.26      agatctagatacatctagctcatgacttcacctcctcccattctgctacttcccaggttc  
16.60.3    ------------------------------------------------------------  
17.3       ------------------------------------------------------------  
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                   1210      1220      1230      1240      1250      1260     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  -TCTGACACCAGCTCTGAGAACACAGAGGGGCAGAATCTGGCTCCTGAGGCCCGACCTCT  
pBK-CMV-3  -...........................................................  
pBK-CMV-4  -.......................T....T......G...T............A......  
pBK-CMV-6  -.......................T...................................  
A9         -.......................T....T...........A......A.......T...  
A16        -.......................TT...........T......................  
B9         -.......................T..T................................  
C7         -.......................T...................................  
1.1        -.......................T...........C.......................  
1.2        -.......................T...............T...................  
2.4        -.......................T...............T...................  
2.10       -.......................T....T......G...T............A......  
16.11      -.......................T....T...........A......A.......T...  
16.12      -.......................T...............T...................  
16.13      -...................C...T...............T...................  
16.14      -------------...........T...........G...T..G.....TA..A......  
16.15      -.TC....................T....T......G.C.T............A......  
16.16      -.......................T...............T...................  
16.22      -.......................T...................................  
16.26      t.......................t......-----------------------------  
16.60.3    -...................C...T...............T...................  
17.3       -.............T.........T....T....------.A...G.......A......  
 
                   1270      1280      1290      1300      1310      1320     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  GACAGAAGTTCGAAGTTAAatcatgaagagtcttctcacgttcagcttcctaaagcaggg  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ...CAC..G..A..................g...g........g..........c....a  
pBK-CMV-6  ....A.....T.................................................  
A9         ........G......................................c............  
A16        ...........A................................................  
B9         ..........TT................................................  
C7         ....A......A.........---....................................  
1.1        ....A.....T.................................................  
1.2        ....A......A................................................  
2.4        ...........A................................................  
2.10       ...CACT.G..A..................g...g........g..........c....a  
16.11      ........G......................................c............  
16.12      ............................................................  
16.13      ............................................................  
16.14      ...C.C.---------..............g............g..........c....a  
16.15      ...CAC..G..A..................g...g........g..........c....t  
16.16      ...........A................................................  
16.22      ....A.....T.G...............................................  
16.26      --------...a................................................  
16.60.3    ............................................................  
17.3       ...CAC..G..A.........--.......g....g........t......cc.c.....  
 
78 
 
                   1330      1340      1350      1360      1370      1380     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  tggagtggatcgcagttcatttataatccttacaaacaggcttgggacttcagctaacta  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ..........t..t.g...................t.......................g  
pBK-CMV-6  ............................................................  
A9         ............................................................  
A16        ............................................................  
B9         ............................................................  
C7         ............................................................  
1.1        ............................................................  
1.2        ............................................................  
2.4        ............................................................  
2.10       .............t.g...................t................--------  
16.11      ............................................................  
16.12      a...........................................................  
16.13      ............................................................  
16.14      .............t.....................t.......................g  
16.15      .............t.g...................t.......................g  
16.16      ............................................................  
16.22      ............................................................  
16.26      .....g......................................................  
16.60.3    ............................................................  
17.3       .....c.......t.....................t..a.........c.gg.......g  
 
                   1390      1400      1410      1420      1430      1440     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  aagatgctacatttgctaaattacaataacatccatacttaactttattttg-----ata  
pBK-CMV-3  ....................................................-----...  
pBK-CMV-4  c...gt..g..................t---.t..a.............g..-----...  
pBK-CMV-6  .........t.......t..............-------.............-----...  
A9         .........t.......t.......t..........g.-----.........-----...  
A16        .........t....................................g.....-----...  
B9         ....................................................-----...  
C7         .........t..........................................-----...  
1.1        .........t.......t..................................-----...  
1.2        ......................................a.............-----...  
2.4        .........t..........................................-----...  
2.10       ------------------------------------------------------------  
16.11      .........t.......t.......t..........------..........-----...  
16.12      .........t..........................................-----...  
16.13      ....................................................-----...  
16.14      c...gt..g..................t---.t..a....g........g..-----...  
16.15      c...gt..g..................t---.t..a.............g..-----...  
16.16      .........t.......t..................................-----...  
16.22      .........t....c..t..............ta.-------..........-----...  
16.26      .........t.......................a..................-----...  
16.60.3    ....................................................-----...  
17.3       c...gt..g........c..............t...................ccttg...  
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                  1450      1460      1470      1480      1490      1500     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  acaatcatgaatctgaaag-------atc--tgtatatcaatgagatctctgtatttgta  
pBK-CMV-3  ...................-------...--....a......t.................  
pBK-CMV-4  ........c...g..tt..-------.ag--...ca......t.c......c.......g  
pBK-CMV-6  ...................-------...--....a......t.................  
A9         .a..a...a....c.t...taaatca..aag...ga......t...........gcctat  
A16        ...................-------...--....a........................  
B9         ...................-------...--....a......t.................  
C7         ...................-------...--....a......t.................  
1.1        ...................-------...--....a......t.................  
1.2        ..........c........-------...--....a......t.................  
2.4        ...g...............-------...--....a......t.................  
2.10       ------------------------------------------------------------  
16.11      .a..a...a....c.t...taaatca..aag...ga......t...........gcctat  
16.12      ...................-------...--....a........................  
16.13      .......g...........-------...--....a........................  
16.14      ........c......tt..-------.ag--...ca......t.c......c.......g  
16.15      ........c......tt..-------.ag--...ca......t.c......c.......g  
16.16      ...g...............-------...--....a......t.................  
16.22      ...................-------...--....a......t.................  
16.26      ...................-------...--....a........................  
16.60.3    .......g...........-------...--....a........................  
17.3       g...c...c....c.tg..-------.aaag...cag.a...t.a.a.g..........g  
 
                   1510      1520      1530      1540      1550      1560     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  atagatttgattaattctctggctttaacctgcaatgtttcactgacgcttggaaaccat  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ...t......a...c..g.......a..........c.......................  
pBK-CMV-6  ..........a......a..........................................  
A9         t.gtga........c..aa...a..a.tt.......c..........c............  
A16        .................a.................................t........  
B9         ............................................................  
C7         .c..........................................................  
1.1        .................a..........................................  
1.2        .................a..........................................  
2.4        .................a..........................................  
2.10       --------------------------..........c.......................  
16.11      t.gtga........c..aa...a..a.tt.......c..........c............  
16.12      .................a........................t.................  
16.13      ............................................................  
16.14      ..........a...c..gag.....a..........c.......................  
16.15      ...t.....ta...c..g.......a..........a.......................  
16.16      .................a..........................................  
16.22      ..........a......a..........................................  
16.26      ............................................................  
16.60.3    ............................................................  
17.3       t.ctg.........c..a.......a...a.c....c....g....t.............  
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                  1570      1580      1590      1600      1610      1620     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  gacgacacaaactcgccatgatggcca---------------------ttttgttttggt  
pBK-CMV-3  ...........................---------------------............  
pBK-CMV-4  cg.a....g.cg...............---------------------------.....g  
pBK-CMV-6  ...a...t...................---------------------............  
A9         .g.a...tg.c.c......t.......---------------------..........c.  
A16        ...a.......................---------------------............  
B9         ...........................---------------------............  
C7         ...a.......................---------------------............  
1.1        ...........................---------------------............  
1.2        ...a..........c............---------------------............  
2.4        ...a.......................---------------------............  
2.10       ag.a....g.cg...............---------------------------.....g  
16.11      .g.a...tg.c.c......t.......---------------------..........c.  
16.12      ...a.......................---------------------............  
16.13      ...........................---------------------............  
16.14      ag.a....g.cg...............---------------------------.....g  
16.15      ag.a....g.cg...............---------------------------.....g  
16.16      ...............a..........ggactatacatagatctttttt...g........  
16.22      ...a...t......c............---------------------............  
16.26      ...........................---------------------............  
16.60.3    ...........................---------------------............  
17.3       t-----------.t.t--------------------------------------......  
 
                   1630      1640      1650      1660      1670      1680     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  tcctgccgcttcaagttataacctttgaatcatgttatagtgtttagtaatatttaagtt  
pBK-CMV-3  ............................................c...............  
pBK-CMV-4  .t.c.........c............t...t........t....................  
pBK-CMV-6  ............................................................  
A9         ..taa.t.t....tc......g....t...t........t........c.....g.....  
A16        ............................................................  
B9         ......................................t.....................  
C7         ............................................................  
1.1        ......t.....................................................  
1.2        ............................................................  
2.4        ........t...................................................  
2.10       ...c.........c..c.........t...t........t....a...............  
16.11      ..taa.t.t....tc......g....t...t........t........c.....g.....  
16.12      ............................................................  
16.13      ............................................................  
16.14      c..c.........c...ga.......t...t........t....a...............  
16.15      ...c.........c.......a....t...t........t....................  
16.16      .............---gtat.....-.........-.......--....-....--....  
16.22      ..........................t.................................  
16.26      ............................................................  
16.60.3    ............................................................  
17.3       ...ca........t.c..........t...t........t............c...ca..  
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                   1690      1700      1710      1720      1730      1740     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  tcaaataatggtcaaaggttctgagactagtttttggacagtgagatccggtcaagtttg  
pBK-CMV-3  ............................................................  
pBK-CMV-4  ..........t......a......at.a..a....t...........ttt.........c  
pBK-CMV-6  .................c..t...a......................t........c...  
A9         ..........t......a......atga..a...g............t.t..tg......  
A16        ...........................................g...t............  
B9         ............................................................  
C7         ............g..................................t............  
1.1        ...............................................t........c...  
1.2        ...............................................t............  
2.4        ............................................................  
2.10       ..........t......a......at.a..a....t.........g.ttt.........c  
16.11      ..........t......a......atga..a...g............t.t..tg......  
16.12      ...............................................t............  
16.13      ............................................................  
16.14      ..........t.....aa......at.a..a.......a........t...........c  
16.15      ..........t......a......at.a..a....t...........ttt....t....c  
16.16      -...-..........---g...............--...........t............  
16.22      ...............................................t........c...  
16.26      ....................................................g.......  
16.60.3    ............................................................  
17.3       .t........t.t....a...c..atta.aa.........a......ttt..........  
 
                   1750      1760      1770      1780      1790      1800     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  aatacaataatcgttaaattgtatgttttttcttaaataatattattt------------  
pBK-CMV-3  ................................................------------  
pBK-CMV-4  .............a.t....ta.at.g...ca.....at.........-agcgttctgca  
pBK-CMV-6  ......................g.........................------------  
A9         ............a......gta....g...c...g..at..t.a....cagctagctaga  
A16        ..................................-.............------------  
B9         ..........at....................................------------  
C7         ..................................t.............------------  
1.1        ......................g..............a..........------------  
1.2        ..................................t.............------------  
2.4        ................................................------------  
2.10       .............a.t....ta.gt.g...ca.....at.........-agcgttctgct  
16.11      ............a......gta....g...c...g..at..t.a....-cagctagctag  
16.12      ......................g.........................------------  
16.13      ................................................------------  
16.14      .............a.t....ta....g...ca..c..at.........gagcgttctgct  
16.15      .............a.t....ta.gt.g.a.ca.....at.........-agcgttctgct  
16.16      ......................g.............ga..........------------  
16.22      ......................g.........................------------  
16.26      ......................g...........t.............------------  
16.60.3    ................................................------------  
17.3       .........t...........a....g...c...c..atg........tagagttctgct  
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                   1810      1820      1830      1840      1850      1860     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  -------gaattgcatcgctaca---taggctaccacgatcgagctaggcagctttag-c  
pBK-CMV-3  -------................---................................a.  
pBK-CMV-4  agctaga.g.......t......---...........a...ct.......c.......-.  
pBK-CMV-6  -------................---................................-.  
A9         -------................---...........ag..a....-----.t.....-.  
A16        -------................---...............a..............t.-.  
B9         -------................---................................-.  
C7         -------................---................................-.  
1.1        -------................---................................-.  
1.2        -------................---................................-.  
2.4        -------................---.......................t.....c..-.  
2.10       agctaga.........t...g..---...........a...ct.......c.......-.  
16.11      a------................---...........ag..a....-----.t.....-.  
16.12      -------................---................................-.  
16.13      -------................---...............a....c...........-.  
16.14      agctaga.c.......t......aca...........a....t.......t.......-.  
16.15      agctaga.g.......t...g..---...........a....t.......t.......-.  
16.16      -------................---................................-.  
16.22      -------................---..............................g.-.  
16.26      -------................---................................-.  
16.60.3    -------................---...............a................-.  
17.3       agctaga.c.......t.....g---.t.........ac...........t.......-.  
 
                   1870      1880      1890      1900      1910      1920     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
pBK-CMV-1  cttaatcctttt-gttgtactattttctttgttctttggggaatttgatcatagatactt  
pBK-CMV-3  ............-...............................................  
pBK-CMV-4  ..c...t.....---...tg........g........t.......g...--agt......  
pBK-CMV-6  ............-.................................t.............  
A9         t.....gg.c..t....---.g......g................g.......t......  
A16        ............-.................................t...g........-  
B9         ............-..............................................-  
C7         ............-....g...................t......................  
1.1        a...........-.................................t.............  
1.2        ............-....g..........................................  
2.4        ............-...............................................  
2.10       ..c...t.....---...tg........g................g...--agt......  
16.11      t.....gg.c..---...tg.g......g................g.......t......  
16.12      ............-............................t..................  
16.13      ............-...............................................  
16.14      ....g.g..c..---...tg........g........t.......g...--agt......  
16.15      ..c...t.....---...tg........g....a...........g...--agt......  
16.16      ......-.c...-....g..........................................  
16.22      ............-....g............................t.............  
16.26      ............-....g..........................................  
16.60.3    ............-...............................................  
17.3       .g....g..c..---...tg........g................g.....a.t......  
 
  
83 
 
                  1930      1940      1950      1960      1970          
           ....|....|....|....|....|....|....|....|....|....|....|.. 
pBK-CMV-1  tggttattctgtcaataaagtacatccaaa---------------------------  
pBK-CMV-3  ..-------------------------------------------------------  
pBK-CMV-4  g..................a.....aa...ttgaaaaaaaa----------------  
pBK-CMV-6  ..............................ttgaaaaaaaaaaaaaaaa---aaa--  
A9         ..c................-....caa...a-                           
A16        -----------------------cct.gtgcc-------------------------  
B9         -.............................---------------------------  
C7         ..............................---------------------------  
1.1        ..........................a...ttgaaaaaa------------------  
1.2        .......................cct.gtgcc-------------------------  
2.4        ..............................---------------------------  
2.10       g..................a.g...aa...ttgaaaaaaaaaaa-------------  
16.11      ..c................-....caa...ttgtgcctacgtaaa-aaa--------  
16.12      ..............................ttgaaaaaaaaaaaaaaaaaaa-----  
16.13      ..............................ttgaaaaaaaaaaaaaaaaaaa-----  
16.14      g..................a...c..gtg-cc-------------------------  
16.15      g..................a.....aa...ttgaaaaaaaaaaaaaaaaaa-aaaaa  
16.16      ..........-----------------------------------------------  
16.22      ..t.......................a...ttgaaaaaaaaaaaaaaaaaa------  
16.26      .................ctt.gg.....-----------------------------  
16.60.3    ..............................ttgaaa---aaaaaaaaaaaaaaa---  
17.3       g.-------------------------------------------------------  
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Table 3.1:  Summary of the small nucleotide additions and deletions noted in the 
ORF of haddock MH Class I alleles. 
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Nucleotide Deletions Nucleotide Additions 
#90–92 #612–614 #663–665 #1008–1010 #1047–1052 #1062-1064 #1236-1241 #288–290 #1065–1067 
pBK-CMV-4 17.3 17.3 17.3 pBK-CMV-4 pBK-CMV-4 17.3 pBK-CMV-4 pBK-CMV-6 
16.15    16.14 B9  2.10 C7 
17.3    16.15 2.10  16.15 1.2 
    17.3 16.14   2.4 
     16.15   16.26 
     17.3    
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Figure 3.7:  Amino acid alignment of haddock, cod and rainbow trout MH Class I 
allele sequences. Highlighted in yellow are the residues involved in 
binding β2-microglobulin. Highlighted in red are the residues essential for 
binding peptide.   
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Leader Peptide 
                        10         
               ....|....|....|.... 
pBK-CMV-1      MKALIGLLLLLVFGHGVSS 
pBK-CMV-3      ................... 
pBK-CMV-4      .........-.....D... 
pBK-CMV-6      ................... 
A9             ................... 
A16            ................... 
B9             ................... 
C7             ................... 
1.1            ------------------- 
1.2            ................... 
2.4            ------------------- 
2.10           -----------....D... 
16.11          ------------------- 
16.12          ................... 
16.13          ------------------- 
16.14          ------------------- 
16.15          ..V......-.F...D... 
16.16          ------------------- 
16.22          ------------------- 
16.26          ------------------- 
16.60.3        ------------------- 
17.3           .........-...C..... 
Cod-UB6-36d    .........-.....D... 
Cod-UF6        ..L.T....-......... 
Cod-UF8        ..L.T....-......G.. 
Cod-c28        ....T....-......... 
Cod-c41        ------------------- 
Cod-c33        ------------------- 
Cod-c39        ------------------- 
Cod-c20        ------------------- 
Cod-c32        ------------------- 
Cod-c24        ------------------- 
Onmy-UBA-4101  ..GI.L.V.GIGLL.TA.A 
Onmy-UBA-4201  ..SF.L..G-IA-L.SS.A 
Onmy-UBA-4401  .NG..L.VQGICLL.T..A 
Onmy-UBA-4501  ..SF.L..G-IA-L.SS.A 
Onmy-UBA-4601  ----------ICLL.T..A 
Onmy-UBA-4701  .NG..L.VQGICLL.T..A 
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α1 
 20        30        40        50        60        70        80        90       100        
 |....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|.... 
pBK-CMV-1      LLHSLHYFYTGSSGLSTFPEFVSVGMVDGVQFDYYDSNTQKTVFKQDWMEQVTRGD-PDYLERNTGSAQNAQQVFKVNIVTAKQRFNQTG 
pBK-CMV-3      V...MQF...A...........A.........N........K.L..........D.-.A....E..KS.GH..S......I......... 
pBK-CMV-4      VI...QI...S...........R.E...E..TE.......RIIT....VV.AN.DKV......A.E.RKVN.....G..G.L........ 
pBK-CMV-6      V...MQ....A.....A.....V.....E..MVH....SKR..L............-.A.......NFLG......G..GI......... 
A9             ....MQF...A...........V........MVH....SKRA.P.H.AAD.LY.DH-.GD..GD..GF.AD..A..A..GI......... 
A16            ..........A...........V.................RV.L..A.........-....K.E...FLG...T..G..GI......... 
B9             G.........A....................I........RV.L............-.A....E..IRKGN..F...GVG.L........ 
C7             ....MQ................V........MVH......R..L.....K......-.A.......NF.G...T...G.G.LR....... 
1.1            ----------------------------------------RA.P.H.TAD.FY.DH-.GD...D..NFLGS..TY.A..GIL........ 
1.2            V...MQ....A...........V........MVH....SKRA.P.H.AAD.IY.DH-.GE...D..R..GD..T..A..GI......... 
2.4            ------------------------------------------------------------------------------------------ 
2.10           VI...RI...S...F.....Y.T.Q...E..IE.......RIIT....VV.AN.YNI......S.ENRKGQ...A....G.......... 
16.11          ------------------------------------------------------------------------------------------ 
16.12          V...MQF...A...........V........MLH....SKRA.P.H.AAD.LF.DH-.GD..GD..NFLG...I..A..G.L........ 
16.13          ------------------------------------------------------------------------------------------ 
16.14          ------------------------------------------------------------------------------------------ 
16.15          VI..VQV.S.A...........M.Q...E..VE.......RIIT....VD.AN.DKV.....KA.ENRKGE.....R..G.L........ 
16.16          ------------------------------------------------------------------------------------------ 
16.22          ------------------------------------------------------------------------------------------ 
16.26          -----------------------------------------------------------......AIS.GD..T..AD.GNL........ 
16.60.3        ------------------------------------------------------------------------------------------ 
17.3           VP...Q....A...........A.........E.......RIFL.P....KF..D.-.A.VVTT.R.FLV...SSIA.LGN..KS..HKQ 
Cod-UB6-36d    VI...QV...............N.V...E...E.......RIIT....AD.DY.E.-..S.V.E.ENRKGQ...A.G..G.L.K...... 
Cod-UF6        V....QF...A....TA.....A.........Y.......RA.L.........S..-A...K...ENS.GS..A..A..GI......... 
Cod-UF8        V....QF...A....TA.....A.........Y.......RA.L.........SAH--...K...ENS.GS..A..A..GI......... 
Cod-c28        V.........A....T......A........MLH...VSKRA.A......RYA.E.-R....GQ..GL.GQ..T..A..GI......... 
Cod-c41        ------------------------------------------------------------------------------------------ 
Cod-c33        ------------------------------------------------------------------------------------------ 
Cod-c39        ------------------------------------------------------------------------------------------ 
Cod-c20        ------------------------------------------------------------------------------------------ 
Cod-c32        ---------------------------------------------------------------E.ENRKGL..G..A.MG.L........ 
Cod-c24        ------------------------------------------------------------------------------------------ 
Onmy-UBA-4101  AT...K.......EVPN.....A........MFH....S.RA.P....VNKAADPQ---.W.....NCKGS..T..AS.DIV......S. 
Onmy-UBA-4201  VI..WKA.L.A.T...D.....ALNL..DELMG.F.TK.NRFEG..S.V.EKLGQQ---.M..QENILRGTS.S....VGI.ME.....K 
Onmy-UBA-4401  VT..MQ.IV.AV...DEI..HTE......Q..V....VLK.IIP.T..I.KNVDAS---.WK.E.DRNIATE.T..S.VAI.MT.....R 
Onmy-UBA-4501  VI..WKA.L.A.T...D.....ALNL..DELMG.F.TK.NRFEG..S.V.EKLGQQ---.M..QENILRGTS.S....VGIVME.....K 
Onmy-UBA-4601  VT..MQ.IV.AV...DEI..HTE......Q..V....VLK.IIP.T..I.KNVDAS---.WK.E.DRNIATE.T..S.VAI.MT.....R 
Onmy-UBA-4701  VT..MQ.IV.AV...DEI..HTE......Q..V....VLK.IIP.T..I.KNVDAS---.WK.E.DRNIATE.T..S.VAI.MT.....R 
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α2 
               110       120      130       140       150       160       170       180       190       200          
               |....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|.. 
pBK-CMV-1      GAHINQRMYGCEWDDEDDSTEGYDQHGYDGEDFISLDLKTLTWVAPVRQAFATKQKWDQNKARLQHDKNYYTKECVDWLKKHLAYGKSTLLRT 
pBK-CMV-3      ...MA...............D..N...........................T.....N.D.....................Y.S......... 
pBK-CMV-4      ....V.W.S.........A.D..E.Y.......L.............H...T..LR.EH.R.YN.AKN.............Y.S......Q.. 
pBK-CMV-6      .T.LY.W.....L.......D..H.Y............N............PN..R..GDR..NERH.H........................ 
A9             .T.MV.W.V...........D..N.......................DE.C...RR..GDR..N.YW...F..........L.S......... 
A16            ...MV............N.......F.........................T...R......D..YN..............Y........... 
B9             ...MV.V..................L.......L...........A.....T...R..GDR.QNERY.H....V................... 
C7             .T.LY.L.....L.......D..H.Y.......L.................P...R..GDR.YNERQ.H....V.......Y.S.....M... 
1.1            ...MF.F.....V.......D..R.Y.......L.....SM..........P...R...D..D..YI...Q......G...L........... 
1.2            .T.LY.N.............D..H.Y.......L.................T...RLN.D..I..YT..............Y........... 
2.4            ----V.F.............D....Y..............M..........T...R.N.......YN......V.......Y........... 
2.10           ....V...S.........T.D..E.Y.......L.............H..LTI.LRL.HDT.WK.YL..F...........Y.S......Q.. 
16.11          ----------------------------------------.S.....DE.C...RR..GDR..N.YW...F..........L.S......... 
16.12          ...MV.F.............D..R.Y.........W.M..M..........T...R.N....G..YR...I..........Y........... 
16.13          -------------------------------------------........T...R..GDR.QNERY.H.H..........L........... 
16.14          --------------------------.....................H..LT..LRL...T.YK..L..L...........Y.S......Q.. 
16.15          ....V...F...L.....T.D..E.........L.............H..LT..LR..HDT..K.YL..F...........Y.S......Q.. 
16.16          ------------------------------------------------------------------L.H.I..........Y........... 
16.22          ------------------------------------------------------------------------------...Y........... 
16.26          .T.LY.N.............D....Y.......L.F...............T...R.N.D..D..Y..H............Y........... 
16.60.3        -------------------------------------------........T...R..GDR.QNERY.H.H..........L........... 
17.3           RV.VY.ETF..DL.......D.FER........L......K..........S...R...DG.D..RK.D.....-......L..N.....Q-A 
Cod-UB6-36d    ...VF.T.D........GT..............LAW...........H..LT..RR.E..R.LMEQY.Y............F........Q.. 
Cod-UF6        ...MA.L.C........GT.D..N.QA......L......M....A.....S...R..GL..FNEQQ.H...V........Y........Q.. 
Cod-UF8        ...MA.L.C........GT.D..N.QA......L......M....A.....S...R..GL..FNEQQ.H...V........Y........Q.. 
Cod-c28        ...MF.W........D....D..E.F.......L....EH..............R...ED..I..YK...H..........Y........Q.. 
Cod-c41        ---------------------------------------------------------------------...V........Y........Q.. 
Cod-c33        ----------------------------------------------------------------------------------........Q.. 
Cod-c39        ------------------------------------------------------.R...D..D..YI...Q..........Y.V......... 
Cod-c20        -----------------------------------W...........H..VT..HR.E..R.LMEQQ.H....V.......Y........Q.. 
Cod-c32        ....L...D........GT....E..........................VT..HRLE..R.LMEEK.H............Y.V......Q.. 
Cod-c24        ------------------------.......................H..LT..H..E..R.LMERQ.H............L........Q.. 
Onmy-UBA-4101  .V..F.Y....T...S-GVID.FR.I.......LVY.M..FK.I..KQ..EI.QHR.NN.P.EIAQR.S.I.Q...E....Y.D...DS.M.. 
Onmy-UBA-4201  .V.TV.L.....LG.D-GI.R.DF.Y....A..L...KS....T.ANQK.VI..L...ATG.DANFQ...LENT.IE....YVN...D..E.K 
Onmy-UBA-4401  .V.T.........N..TGA.G..F.D........AF....K..I..KP..VI..L...SDI.MTEQK.H.L.Q..IE....Y.D......MT. 
Onmy-UBA-4501  .V..V...........TGV...FN..........AF....TK.I..TP..VI..H...S.TV.NEQK...L.QT.IE....YVD......M.. 
Onmy-UBA-4601  .V.TV.L.....LG.D-GI.R.DF.Y....A..L...KS....T.ANQK.VI..L.L.ATG.EANFQ...LENT.IE....YVN...D..E.K 
Onmy-UBA-4701  .V..Y.Y....M...DSGV...HR.Y.......LVYNM..F..I..KQ.SEI.QR..NNEP.QMEYL.S.I.Q..IE....YVD......M.. 
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α3 
                     210       220       230       240       250       260       270       280       290       300      
               ..|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|... 
pBK-CMV-1      ERPRVSLLQRSPSSPVVCHATGFFPDRVVVLWRRDGQELQEQVDHGEVLPNHDGTFQVSVDLNLKAVPQEDWRRYECVVQLRGIEDIST-PLDPALIRTNG 
pBK-CMV-3      ..............................F..........................................................-........... 
pBK-CMV-4      ...W.....................N.G..F.................................T................KD.....I-L....H..... 
pBK-CMV-6      D.............................F.........................................G................-........... 
A9             D.............................F.K.......................................G................-....P...... 
A16            ..............................F......D..................................G................-........... 
B9             D.............................F...............................I.........G................-..........R 
C7             ..............................F.........................................G................-..........W 
1.1            ...W..........................F......D..................................G................-........... 
1.2            ..............................F......D..............................................AG...-........K.W 
2.4            D.............................F............................................K.............-........... 
2.10           .........................N....F.................................T.......G........K......I-L....H..... 
16.11          D.............................F.K...............................E.......G................-........... 
16.12          D.............................F......D.....................................Q.............-........... 
16.13          ..............................F....S.......................................Q.............-........... 
16.14          .........................K....F........E................................G........K......I-L....H..... 
16.15          .........................N....F.................................T.......GK.......K......I-L....H..... 
16.16          ..............................F......D...................................................-........... 
16.22          D.............................F..........................................................-.....Y..... 
16.26          ..............................F..................................T.......................-........... 
16.60.3        ..............................F....S.......................................Q.............-........... 
17.3           D......................YT.....F......V..........................M.......G......E.........-........... 
Cod-UB6-36d    .......................Y.N....F........H....P.................T.T.......E........K.......-....P...... 
Cod-UF6        .......................Y......F........H.L..P...........................G................-........... 
Cod-UF8        .......................Y......F........H.L..P...........................G................-........... 
Cod-c28        D......................Y......F........H....P.......N...................G........K.......-........... 
Cod-c41        D......................Y......F.T......H....P...........................G........K.......-..........S 
Cod-c33        .......................Y......F........H....P........................-...................-.....N..... 
Cod-c39        .......................Y......F........H....P.................D.........G........K.......-..........S 
Cod-c20        .........................N....F........H....P.................D.T.......G........K.......-..........R 
Cod-c32        .........................N....F........H....P.................Y.T.......G........K.......-..........R 
Cod-c24        .........................N....F........H....P...................T.......G........K.......-T....H..... 
Onmy-UBA-4101  VP.S.....KT.....T......Y.SG.M.S.HK...DHH.D.E...I.Q.D.....K.SH.TVTPEEWKN-NK.Q....VT..QKDFIKV.TESE.Q..W 
Onmy-UBA-4201  V..S.....KT.....T......Y.SG.M.F.QK....QHGD.E...I.Q.D.....K.TH.TVTPEEWKN-NK.Q.....A....DI.KV.IESE.Q..F 
Onmy-UBA-4401  VP.S.T...KT.....T......Y.SG.M.F.QK...DQHGD.E...T...D.....K.TH.T.TPEEWKK-KQ.Q....VT..KEDFIKV.TESE.K..W 
Onmy-UBA-4501  VP.L...F.KTS..L.T......Y.SD.MLS.QK...DHH.D.EY..T...D.....K.IH.TVTPEDRKN-SK.Q....VK..KEDFIKV.PDPDAAN-- 
Onmy-UBA-4601  V..S.....KT.....T......Y.SG.M.F.QK....QHGD.E...I.Q.D.....K.TH.TVTPEEWKN-NK.Q.....A....DI.KV.IESE.Q..F 
Onmy-UBA-4701  VP.S...F.KT.....T......Y.SD.M.S.QK...DHH.D.EY..T...N.....K.IH.TVTPDDRKN-NK.Q....VK..MEDFIKV.TDPDAAN-- 
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Transmembrane Domain  Cytoplasmic Domain 
                    310       320       330       340           350       360       370       380       390   
               .|....|....|....|....|....|....|....|....  |....|....|....|....|....|....|....|....|....|.... 
pBK-CMV-1      ----------GKSGITVPIIIGFVVLLLAAAA-AAVGVLLY  KKRNDSHKQHKPVGS---------SDTSSENTEGQNLAPEARPLTEVRS*  
pBK-CMV-3      ----------......................-........  ...............---------.........................*  
pBK-CMV-4      AKTGVGGDGGD..L.LAF.LT.VA.V--VV.--.V...F..  R.....D.R...L..---------.........V.K.S...Q...TGQ.*  
pBK-CMV-6      ----------......................-.......S  ...............---------.....................K.*--  
A9             ----------......................A........  .............D.HKRPISVGS.........V...D....L...G..*  
A16            ----------...................----........  ..W............---------........*..............Q.*  
B9             ----------....S................--.....F..  ...............---------........D..............L.*  
C7             ----------......................A........  ...............---------.....................K.Q.*  
1.1            ----------......................-.......S  ..W............---------.....................K.*--  
1.2            ----------......................A.-.....S  ...............---------.............S.......K.Q.*  
2.4            ----------......................A.-......  ...............---------.............S.........Q.*  
2.10           ---------GD..L.LAF.LT.VA.VAVFV.--VV...F..  R.....D.R......---------.........V.K.S...Q...TGQ.*  
16.11          ----------......................A........  .............D.HKRPISVGS.........V...D....L...G..*  
16.12          ----------......................-........  ...............---------.............S...........*  
16.13          ----------......................-.....H..  ...............---------......T......S...........*  
16.14          ---------GD..L.LAF.LT.VA.V--VV.--.V...F..  Q...G.DMR-------------------.......K.SA.YQ...A---*  
16.15          ---------GD..L.LAF.LT.VA.V--VVG--.V...F..  W.....D.R...L..---------F........V.KPS...Q...TGQ.*  
16.16          ----------......................-........  ...............---------.............S.........Q.*  
16.22          ----------......................-.......S  ...............---------.....................K.W.*  
16.26          ----------....S...........P.....A........  ....A*--------------------------------------------  
16.60.3        ----------......................-.....H..  ...............---------......T......S...........*  
17.3           AQTSHVP---PH.-.VAG.LA.VA.V--GVV--.TA...V.  C..D..D.R...L..---------....F....V.--D...Q...TGQ.*  
Cod-UB6-36d    ---------GD..H.LAF.LT.VA..AVV..--.V...F..  R...NYE.R....D.----------........V.K....YQ..STGQ.*  
Cod-UF6        GRT------RLRVAF.I..........P....-.V......  ...KP.DQR....AT---------......DA*-----------------  
Cod-UF8        GRT------RLRVAF.I..........P....-.V......  ...KP.DQR....AT---------......DA*-----------------  
Cod-c28        ----------....H.I.....LL........AV-......  ....A.D.R...D..----------...........P....Q...TGQ.*  
Cod-c41        ----------....L.I.....LL........AV-......  ....A.D.R......----------...........P....Q...TG*--  
Cod-c33        ----------....L.I.....LL........-.V......  ....A.D.R......----------.....G.....P....Q...TG*--  
Cod-c39        ----------....P.I.....LL........AV-......  ....--D.R......----------.S.........P....Q...TG*--  
Cod-c20        ---------E.-.H.LAF.LT.VA..AVVV.--.V...V..  Q.....D.R....D.----------..........K....YQ..ST.Q.*  
Cod-c32        ---------E.-.H.LAF.LT.VA..AVVV.--.V...F..  ......D.R......----------..........K.....Q...T.Q.*  
Cod-c24        ---------GD-.H.LAF.LT.VA.VA-.V.--VV...F.C  R.....E.C....D.----------..........K....YQ..STGQ.*  
Onmy-UBA-4101  DDPAP---------NI.L..GVV.A...VVV.-VV...VIW  ..KS--K.GFV.AST---------...E.D.SGRAAQMT*----------  
Onmy-UBA-4201  GK-TNRG--SNDPNTIGL..G.VIA.-.VII.-VV-..VIW  ..K.--K.GFV.AST---------...D...SGKGIQKI*----------  
Onmy-UBA-4401  NNPAP---------NI.L..GVV.A...VIV.-VV-..VIW  ..KS--K.GFIQAQ.---------...D.D.SGRAAQQI*----------  
Onmy-UBA-4501  ---------------V....V.V.A...VIV.-VV...VIW  ...S--K.GFV.AST---------...D.D.SGRAVPQI*----------  
Onmy-UBA-4601  GK-TNRG--SNDPNTIGL..G.VIA.-.VII.-VV-..VIW  ..K.--K.GFV.AST---------...D...SGKGIQKI*----------  
Onmy-UBA-4701  ---------------I....G.V.A...VVV.-VV...VIW  R..S--K.GFV.TST---------...D...SGKAAPQI*----------  
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141 and #255 – 259 surround residues known to be important in β2-microglobulin 
binding.  The region at position #187 – 190 contains a residue important in peptide 
anchoring and is in close proximity to a cystine residue which forms a disulfide bond 
linking the α2 and α3 domains.  It is interesting to note that one of the 3 nucleotide 
deletions noted earlier results in a deletion of this cysteine in allele 17.3.  The regions at 
position #214 – 224 and #279 – 282 also contain cysteines involved in a disulfide bond 
between the α2 and α3 domains. 
Several key residues have been highlighted within the alignment.  Highlighted in yellow 
are residues known to be vital in binding β2-microglobulin.  Very few of these residues 
showed a substitution in the haddock and cod alleles.  Highlighted in red in the protein 
alignment are the nine highly conserved residues responsible for anchoring the peptide 
termini to the binding grove.  Several of the haddock and cod alleles had more than one 
substitution at these positions.  These differences are summarized in Table 3.2.  It is 
interesting to note that the lysine (K) at position #165 is not well conserved throughout 
the haddock and cod alleles, but was substituted with arginine (R).  Furthermore, lysine 
and arginine are chemically very similar amino acids, which make it possible for this 
substitution to have little effect on antigen anchoring.  Therefore, this substitution was 
ignored when tallying the number of substituted residues for each allele.  The other 
substituted amino acids were also compared to the expected amino acids for chemical 
similarity.  In alleles 2.10 and 16.15 a phenylalanine (F) was substituted for tyrosine at 
position 191.  Although phenylalanine and tyrosine are both aromatic amino acids, 
phenylalanine is non-polar and tyrosine is polar due to its hydroxyl group.  In this case, 
further study would be required to determine if this substitution would affect the antigen 
anchoring.  For all other substitutions the substituted amino acids are chemically 
different from the expected amino acid, and therefore, these substitutions would have 
an impact on antigen anchoring.  Only eight of the 13 full length alleles had fewer than 2 
substitutions.  Of these eight, two had inverted ORFs and two were joined with other 
gene sequences.  This left only four alleles, pBK-CMV-4, A16, B9, and 16.12, with 
typical, conserved sequences for classical MH Class I. 
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Table 3.2: Summary of the amino acid residues substitutions and structural 
modifications of the haddock and cod alleles.  Only full length alleles are 
shown since the partial alleles were missing the sequences containing all or 
some of the residues of interest. Expected amino acid residues, with 
positions indicated, were based on work by Shum et al., 1999.  The number 
of differences of these residues does not include the arginie (R) substitution 
for lysine (K). 
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 Expected Amino Acid Residues # 
Diff. 
ORF 
Inversion 
“Linked” 
Sequence  Y28 Y79 R104 F142 T162 K165 W/L166 Y179 Y191 
pBK-CMV-1 - - - - - - - - H 1  √ 
pBK-CMV-3 - - - - - - - - - 0 √  
pBK-CMV-4 - - - - - R - - - 0   
pBK-CMV-6 - - - - N R - - H 2   
A9 - D - - - R - - L 2   
A16 - - - - - R - - - 0   
B9 - - - - - R - - H 1   
C7 - - - - - R - - - 0  √ 
1.2 - E - - - R - - - 1 √  
2.10 - - - - I R - F - 2   
16.12 - D - - - R - - - 1   
16.15 S - - - - R - F L 3   
17.3 - - S - - R - - L 2   
Cod-UB6-36d - - - - - R - - F 1   
Cod-UF6 - S - - - R - - - 1   
Cod-UF8 - - - - - R - - - 0   
Cod-c28 - - - - - - - - - 0   
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 Using the amino acid sequence alignment a phylogenetic tree, shown in Figure 3.8, 
was constructed.  The tree was comprised of two sub-trees:  the rainbow trout alleles 
and the haddock and cod alleles.  From the haddock and cod sub-tree three distinct 
groups of alleles could be seen.  The first group contained the majority of the haddock 
alleles and no cod alleles.  The second group contained only cod alleles.  The third 
group contained both cod and haddock alleles.  One haddock allele, 17.3, however did 
not group with any of the others. This tree was constructed using both full and partial 
alleles, some of which were missing most of the α1 and α2 domains.  Since most of the 
allelic variances occur in these domains two additional trees of haddock and cod alleles 
were constructed.   
The first was constructed using the complete amino acid sequences of the full length 
alleles.  This tree is shown in Figure 3.9.  This tree mirrored the pattern found in the tree 
of all alleles in that there were distinct groups of haddock only, cod only and haddock 
and cod alleles, and allele 17.3 did not group with other alleles.  To determine if there 
were any allelic lineages based on the α1 and α2 domains a second tree was 
constructed using the nucleotide sequence of the α1 and α2 domains and is shown in 
Figure 3.10.  In this tree the alleles grouped quite differently than in the previously 
described trees in that the haddock and cod alleles did not group separately.  The 
alleles were divided into three groups.  The low bootstrap values of the first group, 
shown in purple, may be a result of the possibility that these alleles were actually part of 
distinct lineages which, due to the limited number of alleles available for analysis, were 
not clearly visible.    The last two groups, however, had high bootstrap values indicating 
that these groups form distinct allelic lineages.  Furthermore, the last group was 
identical to the Group C found in the other trees.   
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Figure 3.8:  Neighbour-joining tree of haddock, cod and rainbow trout MH Class I 
alleles. The tree was constructed using both full and partial alleles.  The 
Poisson correction model was used with complete deletion of gaps or 
missing data.  Bootstrap values were based on 1000 replicates.  A) The 
complete tree clearly shows the distance between the rainbow trout 
sequences and the haddock and cod sequences.  B)  An expanded view of 
the haddock and cod sub-tree.  Within this sub-tree there are three 
groupings:  a group of haddock only alleles, a group of cod only alleles and 
a group with both haddock and cod alleles.  One allele from haddock, 17.3, 
did not fit into any of the groups. 
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A) Complete Tree 
Haddock and cod sub-tree 
Rainbow trout sub-tree 
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B) Haddock and cod sub-tree 
Group A:  
Haddock Alleles 
Group B: 
Cod Alleles 
Group C: 
Haddock and 
Cod Alleles 
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Figure 3.9:  Neighbour-joining tree of full length haddock and cod alleles.  The 
amino acid sequences of the 13 full length haddock alleles as well as the 
four full length cod alleles were used. The tree was constructed using the 
Poisson correction model with complete deletion of gaps.  Bootstrap values 
were based on 1000 replicates.   
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Group A:  
Haddock Alleles 
Group B: 
Cod Alleles 
Group C: 
Haddock and 
Cod Alleles 
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Figure 3.10:  Neighbour-joining tree of the α1 and α2 domains of full length 
haddock and cod alleles.  The nucleotide sequences of the α1 and α2 
domains of the full length haddock and cod alleles were used in the Jukes 
and Canter model with complete deletion of gaps.  Bootstrap values were 
based on 1000 replicates.  
  
102 
 
  
103 
 
4. Discussion 
In 1999, a study by Perrson et al. of cod MH Class I revealed an unusually high number 
of genes and consequently a high number of expressed alleles.  These finding were 
reflected in another study by Miller et al. in 2002.  This high number of expressed alleles 
presents a potential problem.  As T-cells develop in the thymus, MH molecules are 
displayed on the surface of thymus cells and partake in the selection process which 
removes self-reactive and non-reactive T-cells from the population (Takahama, 2006).  
This process drives the need to establish a working balance between having too many 
and too few MH alleles.  A sufficient number of alleles are needed to protect against a 
variety of diseases, while having too many alleles would lead to the deletion of too many 
developing T-cells.   
Since haddock is a species closely related to cod experiments were undertaken to 
determine if these abnormalities in cod were also present in haddock.  The results of 
these experiments showed that haddock also possessed an unusually high number of 
MH Class I genes and that these were expressed (unpublished data).  This lead to 
experiments to determine what, if any, mechanisms were in place to limit the number of 
functional MH Class I molecules being expressed. 
A total of 22 unique alleles have been isolated from an individual haddock and based on 
analysis of these sequences three mechanisms have been proposed to be responsible 
for reducing the number of alleles expressed into functional molecules.  The first 
mechanism is inversion of the open reading frame and the second is linking the allele 
with another gene or transcript to produce a polycystronic-like sequence.  An inverted 
ORF when read in the sense orientation would essentially be nonsense and would likely 
not begin with the necessary nucleotide sequence “ATG”.  In the case of the 
polycystronic-like transcripts, the ribosome would dissociate from the mRNA at the end 
of the first gene product and the MH Class I sequence would never be translated.  
Therefore, both of these mechanisms would effectively prevent translation of the 
transcripts into functional protein.   Additionally, the amino acid sequences of several of 
these alleles suggest that most of the alleles have mutations in amino acids critical for 
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classical MH class I antigen presentation function, making them into non classical MH 
molecules, and therefore, they may not be involved in T-cell selection or immune 
responses.    
A total of seven alleles aligned in the antisense orientation.  A distinction must be made, 
however, between the alleles with inverted ORFs and those in which the entire 
transcript was antisense.  Alleles Haddock UA pBK-CMV-3 and 1.2, had antisense 
ORFs but sense poly-A tails.  Furthermore, directional cloning of these alleles was 
verified by identification of the restriction enzyme sites and linker sequences used for 
the library creation.  The remaining five alleles differ in that they did not have poly-A tails 
in the sense orientation, and the directional cloning could not be completely confirmed.  
Only the 5’ Eco RI enzyme site and linker was found.  Since this linker was added by 
blunt end ligation it could be added to both ends of the transcript and therefore, cannot 
be used solely to confirm directional cloning.  It is possible that the antisense orientation 
of these five alleles was a result of erroneous directional cloning, and not the inversion 
mechanism seen in Haddock pBK-CMV-3 and 1.2.   
Six alleles were found “linked” with sequences of other genes.  Two of these alleles 
were notable for several reasons.  Alleles Haddock UA pBK-CMV-1 and 17.3 both 
contained full sequences of an MH Class I allele and the other gene, ribosomal protein 
L12 and hemoglobin beta 1 respectively.  Additionally, both of these alleles were linked 
with the other genes using a very similar sequence.  This linking sequence was not part 
of any sequences used for creating the library.  Since it is highly unlikely that the same 
sequence would be randomly joined in between the transcripts, the linked nature of 
these alleles appears to be another mechanism for inactivating allele expression.  The 
remaining four alleles did not show a linking sequence of any kind.  Furthermore, all but 
one were partial sequences.  Since blunt end ligation was used it is possible that 
independent transcripts were ligated together during the library creation.  Therefore, it is 
necessary to validate the linked nature of these sequences.   
Both classical and non-classical MH Class I molecules play an important role in immune 
function but only classical alleles are thought to function in antigen presentation and T 
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cell selection.  One key difference between classical and non-classical molecules are 
the residues at nine key positions within the α1 and α2 subunits.  These nine residues 
are involved in anchoring peptide to the binding grove, and as shown by Shum et al. in 
1999, are highly conserved throughout different species.   
Analysis of these nine key residues within the MH Class I sequence has reveled 
another potential way haddock may prevent excessive T-cell loss during development.  
Five of the 13 full length alleles showed two or more substitutions at these positions.  
Functional analysis of MHC molecules in mammals shows that two or more 
substitutions of these residues are sufficient to change the function of the molecules 
from classical to non-classical (Shum et al., 1999).  Therefore, it is highly likely that 
these five alleles in haddock are non-classical.  As such, it is possible that they would 
not participate in T-cell selection in the thymus.   
Residues involved in binding β2-microglobulin as well cystine residues involved in 
disulfide bonds between the α2 and α3 sub-units were also examined.  These residues 
showed a high degree of conservation, which indicates that they are not involved in 
limiting allele expression.  One interesting exception is a missing cystine in allele 17.3.  
Since this allele would have a significantly different conformation its function would also 
differ significantly.  The implications of this result require further study. 
To summarize, 22 unique MH Class I alleles were isolated from an individual haddock.  
Eight alleles were found to have classical MH Class I sequences.  Of these eight, two 
had inverted ORFs and two were linked with other gene sequences.  Therefore, there 
are only four remaining classical MH Class I sequences which could be expressed into 
functional protein.  This number reflects the number of alleles typically seen expressed 
in other fish species.  Therefore, haddock appear to have a set of classical and non-
classical MH Class I genes and use two novel mechanisms for limiting the expression of 
classical MH Class I alleles. 
Prior to research on haddock, a dodecaploid Xenopus species was the only example of 
a species limiting its MH(C) Class I gene expression (Sammut et al., 2002).  Due to its 
high ploidy it would be expected that these animals would have a high number of MHC 
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Class I alleles.  However, Southern blot analysis and cDNA analysis revealed that 
individuals possessed a maximum of four alleles.  This species, therefore, removes the 
DNA encoding additional MHC Class I genes to prevent the expression of too many 
alleles.  This expression limiting method differs greatly from what has been shown in 
haddock.  The three mechanisms of inverted ORFs, joined sequences and non-classical 
mutations therefore represent novel mechanisms used to limit the expression of MH 
Class I alleles. 
Further research in this area is clearly warranted.  There is clear evidence of three 
mechanisms for limiting the number of functional MH Class I molecules expressed by 
an individual.  For two of these mechanisms not all of the experimental data is 
conclusive.  The orientation of alleles A16, 16.14, 16.16, 16.22, 16.26 and 17.3 needs to 
be confirmed.  Also, the linkage of alleles Haddock UA pBK-CMV-3, C7, 16.16, 16.22, 
16.26, and 17.3 needs to be verified.  Full length sequences of the partial clones are 
also required.  In both cases, the questions concerning the validity of the results stems 
from the process of the library creation.   Using cDNA from an individual haddock, PCR 
reactions with allele specific primers could confirm linkages.  Verifying the orientation of 
alleles would require investigations of the genomic DNA. 
Since haddock show such unusual properties for the regulation of their MH Class I 
genes the possibilities for future research are broad.  It would be interesting to 
investigate whether the changes in orientation and the gene linking occur at the DNA or 
RNA level.  What is the significance of the unknown sequences attached to several of 
the alleles?  Are different alleles being expressed in different tissues?  How does the 
high level of expression impact the number of T cells?  Are there mechanisms that limit 
expression at the protein level?  These are some of the questions that could be asked 
as we attempt to gain a deeper understanding of the immune function of this unusual 
and interesting species.   
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Appendix I 
ZapExpress
®
 Vector System 
The ZapExpress Vector System makes use of two types of phage and two strains of E. 
coli, XL1-Blue-MRF’ and XLOLR.  The first phage, which will be referred to as “library 
phage”, is a modified lambda phage and is the vector into which cDNA fragments are 
cloned.  The second type of phage is referred to as “helper phage” and is used in the 
conversion of the lambda phage into the plasmid pBK-CMV.  
The library phage are propagated in the E. coli strain XL1-Blue-MRF’.  They grow with a 
typical lytic life-cycle and the plaques are small with complete lysis of host cells 
(plaques are completely clear). These phage can be converted to phagemids by a 
process called excision.  Mass excision can be performed on an entire library, whereas 
a simple excision is done on an individual clone.   The excision process is accomplished 
by co-infecting a culture of XL1-Blue-MRF’ with both the library phage and the helper 
phage8.  The helper phage acts through a double cross-over to remove the genes of the 
lambda phage necessary for lysis of the host cell at the end of its life cycle.  The result 
is a phagemid, which contains the insert, that is capable of infecting but not lysing cells.  
This phagemid is used to infect the E. coli strain XLOLR.  This strain of E. coli is 
resistant to lambda phage infection so that contamination from any remaining library 
phage is prevented.  Once the phagemid infects XLOLR the DNA, including the insert, 
is replicated as a plasmid. 
  
                                            
8
 The helper phage plaque morphology is different than that of the library phage. It is a larger plaque with 
incomplete lysis (i.e. opaque in appearance). 
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Appendix II 
Zap Express
®
 cDNA Library Construction Kit 
The cDNA library used in this project was created using the Zap Express® cDNA Library 
Construction Kit.  A poly-T primer linked with an Xho I restriction enzyme (REN) site is 
used during first strand synthesis.  The poly-T primer binds to the poly-A tail of the 
mRNA transcripts and synthesis is carried out by a high-fidelity reverse transcriptase.  
In the first strand synthesis reaction 5-methyl dCTP is used in the mix of dNTPs so that 
the newly synthesized cDNA is protected against digestion with RENs.   In the second 
strand synthesis reaction RNase H is added, which nicks the mRNA bound to the first 
cDNA strand.  These nicked fragments act as primers for synthesis by DNA polymerase 
I.  Synthesis is carried out using a regular mix of dNTPs so that the second cDNA 
strand can be cut with RENs.  Following the second strand synthesis an EcoR I adaptor 
is blunt-end ligated using T4 DNA ligase.  Finally, Xho I is used to cut the 3’ end.  The 
final product is a transcript with a 5’ EcoR I site and a 3’ Xho I site.  The diagram in 
Figure A.1 was modified from the Zap Express cDNA Library Construction Kit Manual, 
and illustrates the process.   
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Figure A.1:  Diagram of the method of the cDNA library construction. 
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mRNA AAAAAAAAAAAAAAA 5’ 3’ 
5-methyl cDNA TTTTTTTTTTTTTTTTTTGAGCTC 3’ 5’ 
cDNA AAAAAAAAAAAAAAACTCGAG 5’ 3’ 
5-methyl cDNA TTTTTTTTTTTTTTTTTGAGCTC 3
’ 
5’ 
Reverse Transcriptase, 
5-methyl dCTP, dATP, dGTP, dTTP 
First Strand 
Synthesis 
Second Strand 
Synthesis 
RNase H, 
DNA Polymerase I 
dNTPs 
Xho I 
Digestion 
Xho I Restriction Enzyme 
GAATTC… 
G… 
cDNA AAAAAAAAAAAAAAAC 5’ 
5-methyl cDNA TTTTTTTTTTTTTTTTTGAG
CT 
3’ 
3’ 
5’ 
GAATTC… 
G… 
cDNA AAAAAAAAAAAAAAACTCGAGGAATTC 5’ 3’ 
5-methyl cDNA TTTTTTTTTTTTTTTTTGAGCTCCTTAAG 3’ 5’ 
Adaptor 
Addition 
EcoR I 
Adaptors,  
T4 DNA Ligase 
5’ GAATTCGGCACGAGG 3’ 
3’             GCCG TGCTCC 5’ 
EcoR I Adaptor 
mRNA AAAAAAAAAAAAAAA 5’ 3’ 
3’ TTTTTTTTTTTTTTTTTTGAGCTC 5’ 
Poly-T Primer Linker 
